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Habitual consumption of energy-dense foods is a notable contributor to the high incidence of 
obesity and metabolic syndrome worldwide. The extent to which calories from alcohol 
contribute to overweight and obesity is debatable. ∆
9
-tetrahydrocannabinol (THC), the main 
psychoactive constitute of marijuana, mainly activates cannabinoid subtype 1 and 2 receptors 
(CB1R and CB2R) to modulate many behavioral and metabolic processes, including feeding and 
glucose homeostasis. For several reasons, reports on the long-term effects of alcohol and THC 
use on energy balance, glucose homeostasis, and cognitive behaviors in both human and rodent 
studies are fraught with inconsistencies. Further, alcohol and marijuana co-use is believed to be 
more detrimental to health and safety, yet surprisingly little is known about the specific 
physiological domains impacted by such a pattern of drug use. There is also a dearth of research 
on the neurobiological mechanisms that mediate the unique effects of joint alcohol and THC use 
on metabolism and behavior. To bridge the gap in our understanding of the effects of separate or 
combined alcohol and THC use on feeding behavior, cognitive function, and metabolic fitness of 
young adults, we implemented three studies using relatively young Long-Evans rats.  
Chapters 1 and 2 reviewed published reports on this topic and outlined the Specific Aims 
of this dissertation, respectively. Chapter 3 investigated the effects of chronic moderate alcohol 
consumption on energy balance, cognitive behaviors, and glucose homeostasis in young male 
and female rats. We observed that rats who voluntarily consumed moderate doses of alcohol 
compensated for the calories supplied by the beverage. Intermittent moderate alcohol 
consumption (for 14 weeks) did not appreciably alter object recognition memory and emotion-
like behavior in both sexes of rats. But such drinking pattern and duration altered glucose 
homeostasis in males. Chapter 4 established two rodent models of alcohol and THC co-use that 
differed in terms of the route of THC administration. In the first model, adolescent male rats 
were entrained to consume a sweetened alcohol solution immediately after receiving increasing 
subcutaneous THC doses. To closely capture the voluntary nature of human drug co-use and the 
trendy consumption of THC via edibles, we implemented a second co-use model where rats 
voluntarily consumed a sweetened alcohol solution and THC-laced cookies. In the first model, 
moderate alcohol consumption attenuated the immediate hyperphagic effect of subcutaneous 
THC. Separate or combined alcohol and THC use under both models did not alter daily caloric 
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intake and learning and memory, but differently affected alcohol intake, weight gain, and sucrose 
consumption during abstinence. Western blot analyses uncovered insignificant changes in CB1R 
protein expression and basal glycogen synthase kinase-3 beta (GSK-3β) activity in the medial 
prefrontal cortex (mPFC; center for executive function control), mediobasal hypothalamus 
(MBH; energy balance regulator), and hippocampus (HIP; involved in spatial learning) during 
drug abstinence. GSK-3β is a ubiquitously-expressed signaling molecule in the central nervous 
system. CB1R and GSK-3β activity help regulate cellular homeostasis. Finally, subcutaneous 
THC and alcohol co-exposure modestly improved peripheral glucose homeostasis. Chapter 5 
examined whether a metabolic challenge using high-fat diet (HFD; 45% kcal from fat) exposure 
during young adulthood would help uncover robust metabolic effects of adolescent alcohol and 
THC consumption. There were no effects of oral drug treatment and no interaction between drug 
treatment and later dietary fat consumption on all the metabolic measures examined. 
Interestingly, rats exposed to HFD for a short duration demonstrated a hyperphagic response that 
produced modest weight gain. Four days of HFD feeding altered systemic glucose tolerance as 
reflected by the modest hyperglycemia and hyperinsulinemia both during a brief fast and in 
response to an oral glucose load. Although the HFD consumers had a higher basal blood glucose 
concentration following a mild fast, percent visceral adiposity, and plasma leptin content 
compared with the chow group, both diet groups responded similarly to exogenous insulin.  
Collectively, this set of experiments indicates that separate or combined chronic moderate 
alcohol and THC use can alter energy balance and glucose homeostasis under different 
experimental conditions. While we detected no long-term changes in cognition, emotion-like 
behaviors, and neurobiology (CB1R expression and GSK-3β activity) following periods of 
separate or combined alcohol and THC use, studies with more sensitive analytical assays may 
reveal subtle detrimental effects of drug use. The adolescent alcohol and THC co-use model 
developed in this dissertation is the first to utilize an edible THC product to truly capture the 
growing pattern of human alcohol and THC co-use. Considering the lenient regulation of 
alcohol, the ongoing societal acceptance of marijuana, and the burden of metabolic syndrome on 
public health, more research to decipher the neurobiological mechanisms that mediate the effects 
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CHAPTER 1: LITERATURE REVIEW 
Metabolic syndrome: an overview 
The World Health Organization (WHO) and other health care governing boards define metabolic 
syndrome as a constellation of clinical conditions that include hypertension, insulin resistance, 
high blood sugar, unhealthy lipid profiles, abdominal or central obesity, leptin resistance, and 
systemic inflammation that increase an individual’s risks for cardiovascular diseases, stroke, 
cancer, diabetes, subfertility, neurological and mental illness, and death (Eckel et al. 2005; 
Mensah et al. 2004). Data from the National Health and Nutrition Examination Survey 
(NHANES) show that the prevalence of metabolic syndrome among U.S. adults increased 
between the year 2003 (32.9%) and 2012 (34.7%) (Aguilar et al. 2015). Metabolic syndrome is a 
complex disorder that is not confined to Westernized societies or only associated with adulthood 
or obesity. Some facets of metabolic syndrome, especially diabetes and cardiovascular diseases, 
afflict otherwise lean or normal weight inhabitants of developing countries at an alarming rate 
(Atun et al. 2017). There is also a growing rate of obesity and metabolic syndrome among 
pediatric and adolescent populations worldwide (ACOG 2017; Ogden et al. 2014). The latter 
point is distressing because childhood obesity is often comorbid with psychiatric and behavioral 
disorders that can persist into adulthood (Kalarchian and Marcus 2012). Management of 
metabolic syndrome strains the economies of many countries in the forms of exorbitant health 
care spending and lost productivity (Atun et al. 2017; Mensah et al. 2004; Ricci et al. 2017). The 
importance of research efforts aimed at uncovering the predisposing factors for metabolic 
syndrome cannot be overemphasized. 
In addition to genetic and epigenetic influences, several environmental and lifestyle 
factors are culpable for the burden of metabolic syndrome, including consumption of energy-
dense foods and alcohol in Western diet, sedentary lifestyles, stress, and exposure to exogenous 
drugs and toxicants (ACOG 2017; Eckel et al. 2005; Mensah et al. 2004). Hence, a holistic 
understanding of the mechanisms linking lifestyle factors and the environment with an 
individuals’ risk of developing metabolic diseases will be advantageous for public health 
promotion. Work in this dissertation will examine the effects of moderate alcohol, ∆
9
-
tetrahydrocannabinol (the primary psychoactive component of Cannabis sativa), and their 
combined use on energy balance, glucose homeostasis, cognitive functions, and neurobiological 
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changes in a rodent model. In the context of metabolic and cognitive fitness, we will also 
investigate the possible interactions between drug and high-fat diet exposure on the 
aforementioned health variables. Empirical findings on the association between moderate alcohol 
and cannabinoid use with the risk of developing metabolic diseases will inform future research 




Alcohol drinking motives and patterns 
Alcoholic beverages are typically consumed for their rewarding, mood-elevating, stress-
relieving, and pain-reducing properties across numerous environmental/social contexts (Eckardt 
et al. 1998; Schrieks et al. 2014). Thus, alcohol consumption often promotes gregarious 
behaviors in humans. The effects of alcohol on physiology and behavior are strongly dictated by 
drinking patterns and quantity consumed per unit time (He et al. 2007; Nelson et al. 2016; 
Schrieks et al. 2014). Most of the positive health effects of alcohol are realized following 
moderate but not binge consumption. Because different amounts of alcohol can mean different 
things to different individuals, a unified definition of the two broad drinking patterns is 
appropriate. 
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), binge 
alcohol drinking is a pattern of drinking that increases blood alcohol concentration (BEC) to 80 
mg/dl or greater. In a strict sense of the definition, a BEC ≥ 80 mg/dl is achieved after men 
consume five or more drinks or after women consume four or more drinks within two hours. 
Chronic binge drinking can injure the brain damage and produce detrimental health effects that I 
will expand upon later (George and Koob 2017; Monti et al. 2005; Siqueira et al. 2015; World et 
al. 1985).  
Low-to-moderate alcohol drinking is the consumption of non-intoxicating amounts of 
alcohol. Health-conscious individuals who consume alcohol in moderation reap its rewarding 
psychoactive effects, as well as its purported beneficial health effects (Eckardt et al. 1998; 
Goldberg et al. 1999; Hendler et al. 2013; Kloner and Rezkalla 2007; Koppes et al. 2005). The 
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2015–2020 Dietary Guidelines for Americans recommend that women and men of the legal 
drinking age (21 years and over) who use alcohol should not consume more than one and two 
standard drinks per day, respectively (DeSalvo et al. 2016). In North America, one standard 
drink corresponds to a beverage that contains 14 g (or 0.6 fluid ounces) of pure alcohol or 12 
fluid ounces of regular 5% beer. In other cultures, however, consumption of up to six standard 
drinks per day is considered moderate drinking (Harper et al. 1988; Wannamethee and Shaper 
1996). A more apt definition for moderate drinking should be in terms of BEC kinetics or the 
BECs attained and maintained across time, which should be below 80 mg/dl (Hendler et al. 
2013; Nelson et al. 2016). The bioavailability of a given dose of alcohol varies based on body 
composition (lean vs. fat mass) and the activity of alcohol metabolizing enzymes, which is 
further determined by age, sex, ethnicity/genetics, or drinking history, amongst other factors 
(Baraona et al. 2001; Gemma et al. 2006). Consequently, a “moderate” amount of alcohol may 
not be tolerated by everyone alike.  
An individuals’ pattern of alcohol use can be influenced by social expectation or the 
specific motivation for consuming alcoholic beverages (e.g., to relieve stress and pain or to get 
drunk). The manner of alcohol use can also be modified by biological sex, age, or an interaction 
between both factors. Sex differences in alcohol drinking are known to emerge during 
adolescence, when experimentation with exogenous drugs often begins (Crews et al. 2016; 
Gulley and Juraska 2013; Nixon and McClain 2010). In humans, males consume more alcohol 
compared with females (Gruchow et al. 1985; SAMHSA 2017; Schulte et al. 2009), though the 
rate of binge-drinking among females is steadily rising (reviewed in (Dir et al. 2017)). Sex 
differences in alcohol drinking behavior might be influenced by the disparate rate of alcohol 
metabolism among men and women or by the increased susceptibility of females to experience 
more severe unpleasant consequences of repeated alcohol use (Baraona et al. 2001; Dir et al. 
2017; Mumenthaler et al. 1999). Adolescents are known to consume higher amounts of alcohol 
than adults do (Crabbe et al. 2011; Spear 2018). Among other factors, the age differences in 
alcohol drinking behavior can be partly explained by not only personality traits (sensation-
seeking behavior) and environmental factors (peer, sibling, and parental influence) (Siqueira et 
al. 2015), but also by the heightened sensitivities of adolescents to the rewarding effects of 
alcohol or by their reduced sensitivities to alcohol’s aversive properties (Crews et al. 2016; 
Nixon and McClain 2010). Evidence suggests that an early age at onset of alcohol use and binge 
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drinking during adolescence predicts problem with alcohol use in adulthood (Crews et al. 2007; 
Crews et al. 2016; Grant and Dawson 1997; Nixon and McClain 2010). Among young adults and 
the aged population, a greater proportion of men consume alcohol in moderation or excess 
compared with women (Colditz et al. 1991; Jones et al. 1982; Schulte et al. 2009). Yet it was 
also discovered that a slightly higher proportion of aged women (aged 70–89 years) were heavy 
drinkers compared with aged men (Jones et al. 1982).  
Alcohol drinking behavior is not unique to humans. Fruit flies, zebrafish, rodents, and 
primates are some model organisms employed in the study of not only the neural systems that 
regulate alcohol drinking, but also the consequences of excessive drinking (Phillips 2002). 
Rodents are the commonly used preclinical animal models in the alcohol field (Phillips 2002). 
Alcohol researchers have devised several paradigms to induce moderate to high alcohol drinking 
in rats and mice (Crabbe et al. 2011; Ron and Barak 2016). When provided with an incentive to 
drink alcohol (e.g., use of sweetened alcohol solutions or intermittent access), rats can 
voluntarily regulate their alcohol intake to maintain BECs close to or below 80 mg/dl (Carnicella 
et al. 2014; Roberts et al. 1999; Vetter-O'Hagen et al. 2009). To simulate the voluntary nature of 
human alcohol consumption, we will employ intermittent drinking paradigms where rodents will 
be allowed to voluntarily consume saccharin-sweetened or unsweetened alcohol solutions in the 
experiments described in this dissertation.  
As in humans, the pattern of alcohol consumption in rodents varies by sex and age, 
amongst other factors. In rats, sex differences in alcohol intake are predominantly influenced by 
age. Adolescent males can consume more grams of alcohol per body weight compared with 
adolescent females and adults of both sexes, although findings have been inconsistent (Doremus 
et al. 2005; Lancaster et al. 1996; Marco et al. 2017; Vetter-O'Hagen et al. 2009). Several 
groups, including ours, have shown that adolescent or adult female rats can consume higher 
doses of alcohol compared with adolescent or adult males, respectively (Cailhol and Mormede 
2001; Doremus et al. 2005; Nelson et al. 2017; Sherrill et al. 2011a; Vetter-O'Hagen et al. 2009). 
Additionally, age differences in alcohol intake have been found to depend on the specific alcohol 
exposure context or protocol employed. Under the stress of single housing, adult but not 
adolescent male rats consume lower doses of alcohol compared with their group-housed 
counterparts (Doremus et al. 2005). There have also been reports of no sex or age differences in 
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adolescent rats’ alcohol intake (Doremus et al. 2005; Lancaster et al. 1996; Marco et al. 2017; 
Vetter-O'Hagen et al. 2009) or in BECs attained in adult animals (Vetter-O'Hagen et al. 2009). 
Finally, genetic background and the concentration of alcohol solution presented can affect 
alcohol drinking behavior in rats (Cailhol and Mormede 2001; Vetter-O'Hagen et al. 2009). 
Above all, the fact that rodents can reliably consume alcohol to achieve behaviorally-relevant 
BECs renders them a useful experimental model. 
 
Effects of alcohol on caloric intake and body weight 
The caloric value of alcohol (7 kcal/g) is between that of carbohydrate (4 kcal/g) and fat (9 
kcal/g) (Suter 2005; Yeomans 2010). Alcohol is commonly consumed alongside food during 
dinner and festive occasions, especially in Westernized societies where the beverage features 
prominently in diets. Among regular drinkers in the United States, calories derived from 
alcoholic beverages can comprise close to 30% of the recommended daily calorie intake in men 
and women (Bebb et al. 1971; Jones et al. 1982; Shelton and Knott 2014). The high global 
incidence of obesity and the fact that social drinkers are often not mindful of the caloric content 
of alcohol necessitates careful study of the relationship between alcohol use and energy balance 
(Suter 2005; Yeomans 2010). 
The effects of alcohol on food intake and body weight are complex. For unclear reasons, 
men, but not women, who consume moderate amounts of alcohol with meals can adjust their 
daily caloric intake such that alcohol calories displace some calories from food (Cordain et al. 
1997; Ferro-Luzzi et al. 1988). Some researchers found that there were no immediate or enduring 
changes in caloric intake, weight gain, and percent body fat in a group of healthy men who 
consumed wine for six weeks (Cordain et al. 1997). By contrast, women alcohol drinkers 
consumed excess daily calories and gained more weight compared with men (Ferro-Luzzi et al. 
1988). Furthermore, alcohol can differently affect energy balance in humans since not everyone 
can efficiently utilize calories from alcohol. Compared with their lean counterparts, women with 
higher body mass index (BMI) who consumed 30 g of alcohol per day for three months required 
less calories from solid food in order to maintain their baseline body weight – a finding that 
suggest women with higher BMI can efficiently utilize calories from alcohol and carbohydrate 
compared with lean subjects (Clevidence et al. 1995). Conversely, substitution of 20–30% of 
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daily calories with alcohol in lean men resulted in no net gain in weight compared with obese 
subjects that gained weight (Crouse and Grundy 1984). The differential findings sometimes 
observed in men and women reinforce why it is necessary to include male and female subjects in 
physiology experiments. 
Several large epidemiological studies reported that moderate-to-high alcohol intake is 
associated with decreases in dietary carbohydrate, protein, and fat consumption (Colditz et al. 
1991; Gruchow et al. 1985; Jones et al. 1982; Tremblay et al. 1995). Such decreases in 
macronutrient intake, however, might not preclude an increase in total caloric intake. In those 
studies, alcohol drinkers did not gain extra weight and were not heavier than non-drinkers. 
(Colditz et al. 1991; Gruchow et al. 1985; Jones et al. 1982; Tremblay et al. 1995). In fact, 
women who drank moderate amounts of alcohol had lower obesity index relative to non-drinking 
controls; and there was an inverse relationship between BMI and the amount of alcohol 
consumed by men (Gruchow et al. 1985; Jones et al. 1982). A U-shaped relationship between 
alcohol intake and BMI was observed in women, where low and excessive alcohol intake are 
associated with weight gain (Colditz et al. 1991). By contrast, alcohol consumption had no effect 
on BMI in men (Colditz et al. 1991). The above findings speak to the fact that alcohol may 
prevent the efficient utilization of dietary macronutrients in a sometimes sexually-dimorphic 
fashion.  
Alcohol is sometimes used as an aperitif or appetite stimulator prior to a meal. For 
example, experimental research has documented that alcohol consumption can favor excess 
caloric intake in men and women (Caton et al. 2004; Caton et al. 2007; Poppitt et al. 1996; 
Schrieks et al. 2015), possibly by increasing the rewarding value of savory foods (Schrieks et al. 
2015). In one study, alcohol calories (red wine) contributed to excess caloric intake when it was 
consumed before or alongside a meal (Caton et al. 2007). Other researchers have shown that the 
appetite-stimulating effects of alcohol was dose-dependent, which indicates that there is a 
threshold for alcohol to serve as an aperitif (Caton et al. 2004; Hetherington et al. 2001).  
The above studies in humans are, however, limited by their “artificial” nature. In most 
studies, data were generated from survey, questionnaires, or unnatural laboratory settings. The 
reliability of data generated through these means might not be guaranteed due to bias in self-
reports or problem with retrospective recall. Further, the correlational nature of most of the 
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studies precludes the establishment of a cause-effect relationship between alcohol use and energy 
balance. More empirical evidence from animal studies may help clarify how alcohol use affects 
appetite and body weight control.  
Rodent studies have also revealed mixed findings regarding the effects of alcohol on food 
intake and weight gain. Some studies show that rodents can compensate for the calories supplied 
by alcohol, while others reported no compensation. Rats forced to consume alcohol solution as 
the only liquid available to them reduced their food intake, but their daily caloric intake (sum of 
kcal from food and alcohol) and body weight remained unaffected (Cornier et al. 2002; 
Richardson et al. 1990; Richter 1926; Richter 1941). In two other studies, four weeks of forced 
alcohol consumption in rats was associated with reduced solid food intake and body weight but 
unchanged total caloric intake relative to a control group that consumed water (Benicky et al. 
2000; Strbak et al. 1998). Interestingly, McCoy and colleagues observed that although alcohol-
derived calories supplanted portions of the daily caloric intake in Syrian golden hamsters, 
involuntary consumption of high concentration of alcohol solution slowed the rate of weight gain 
(McCoy et al. 1981). Furthermore, rats fed ethanol-containing liquid diet consumed fewer daily 
calories and gained less body weight compared with those fed control diet (Reidelberger et al. 
1996). Another study found that because rats that received intravenous or intragastric infusions 
of 3% alcohol solution did not sufficiently reduce their consumption of solid food to account for 
the energy supplied by alcohol, they maintained higher daily caloric intake but unchanged weight 
gain relative to controls (Giner and Meguid 1993). Our lab has previously shown that the effects 
of alcohol on caloric intake and body weight in rats rely on the BEC time course. While rats who 
consumed moderate doses of alcohol reduced their intake of solid food in proportion to the 
calories derived from alcohol, a prolonged binge-like BEC reduced food intake and body weight 
to a greater degree compared with the effect of a shorter binge-like BEC (Nelson et al. 2016). 
The sedative effects of binge alcohol had little to do with our results since the activity level of 
the alcohol- and saline-injected rats were indistinguishable 3 h after the single binge dose as well 
as on the subsequent days when alcohol was not administered.  
Several neural and hormonal mechanisms may mediate the appetite altering effects of 
alcohol. For instance, human and rodent studies have shown that alcohol-related changes in the 
secretion of appetite-stimulating (orexigenic; e.g., neuropeptide Y, ghrelin) or appetite-
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suppressing hormones (anorexigenic; e.g., cholecystokinin, leptin, glucagon-like peptide-1) can 
differently affect food intake as excellently reviewed in (Yeomans et al. 2003) and (Traversy and 
Chaput 2015). Alcohol can alter appetite by modulating GABAergic, dopaminergic, 
serotonergic, and opioidergic neurotransmissions (Traversy and Chaput 2015; Yeomans et al. 
2003). Further, alcohol can suppress hepatic fatty acid oxidation and induce heat production and 
dissipation when alcohol is metabolized via the “energy-wasteful” microsomal ethanol-oxidizing 
system (MEOS) (Suter 2005; Suter et al. 1992). Consequently, frequent alcohol consumption can 
erroneously inform the brain that the body is in a state of energy deficit and promote caloric 
intake (Suter et al. 1992; Yeomans 2010; Yeomans et al. 2003). Paradoxically, while the alcohol-
induced sparing of fat from oxidation may increase adiposity in the long run, metabolism of 
alcohol via the activation of MEOS can prevent weight gain. Moreover, a recent study that 
utilized an assortment of molecular techniques showed that binge doses of alcohol acutely 
increased food intake in singly-housed mice via stimulation of hypothalamic AgRP neurons 
(Cains et al. 2017). In that study, in vitro slice electrophysiological recording, calcium imaging, 
and chemogenetic experiments indicated that alcohol dose-dependently activates AgRP neurons 
in the arcuate nucleus of the hypothalamus to levels comparable to that in fasted animals (Cains 
et al. 2017). Whether binge and moderate alcohol doses differentially affect the neural-hormonal 
systems that regulate energy balance deserves attention. 
The supposed appetite-stimulating property of alcohol cannot be attributed solely to the 
drink’s biologic effects. Alcohol promotes gregarious behaviors, and social cues may interact 
with the psychoactive effects of alcohol to promote excess caloric intake (de Castro and de 
Castro 1989). For example, excess caloric intake was not observed when experimental human 
subjects consumed alcohol in isolation (Poppitt et al. 1998). Such observation is yet another 
testament to the complex interaction between alcohol and caloric intake in humans (Yeomans et 
al. 1999). Alcohol may also facilitate or forestall socially-driven feeding behavior and learned 
food preference in rodents. Alternatively, species differences (i.e., ethological characteristics) 
and other subtle experimental/housing characteristics may partly explain the sometimes-
opposing findings. More carefully-controlled human and preclinical studies are needed to fully 




Effects of alcohol on cognitive outcomes 
The detrimental neurobiological effects of binge doses of alcohol are prominent during prenatal 
and postnatal development (Gil-Mohapel et al. 2014; Ikonomidou et al. 2000). Human and 
animal research has repeatedly shown that low, moderate, and high doses of alcohol can elicit 
neuro-chemical, -immune, and -anatomical changes in several brain regions, with attendant 
cognitive deficits (Coleman et al. 2011; Cui and Koob 2017; Eckardt et al. 1998; Fadda and 
Rossetti 1998; Kuzmin et al. 2012; Obernier et al. 2002; Pascual et al. 2007; Vetreno et al. 2016). 
For example, alcohol consumption results in dose-dependent memory impairments in humans 
(Dry et al. 2012; Ryback 1971). Severe memory deficits that manifest at higher doses can 
culminate in blackout, or the temporary inability to recall details of events during the 
intoxication state (Goodwin et al. 1969; Nash and Takarangi 2011). At an extreme end of the 
spectrum of alcohol-related cognitive pathology is the Wernicke-Korsakoff syndrome – a brain 
disease characterized by loss of motor coordination, mental confusion, and the inability to form 
new declarative memories or to recall old memories following chronic heavy drinking to 
substantially high BECs (Fadda and Rossetti 1998). The syndrome is often observed in chronic 
alcohol abusers, and is associated with severe malnutrition, thiamine deficiency, and reduced life 
expectancy (World et al. 1985).  
Multiple studies have shown that adolescents and females may be uniquely sensitive to 
the detrimental effects of alcohol on brain structure and functions when compared with adults 
and males, respectively (Maynard et al. 2018; Monti et al. 2005; White and Swartzwelder 2004). 
An earlier age of onset of alcohol use elicits neuroadaptations that can increase the risks for 
psychiatric disorders later in life (Broadwater et al. 2017; Crews et al. 2007; De Bellis et al. 
2000; Spear 2011). Adolescents who begin using alcohol before 15 years of age have an 
increased risk of transitioning into heavy drinking adults who may become dependent on the 
drink as compared with those that begin drinking after 20 years of age (Grant and Dawson 1997). 
An age-dependent effect of alcohol on cognitive functions was reflected in the finding of greater 
semantic memory impairment in young adults aged 21–24 years compared with those aged 25–
29 years (Acheson et al. 1998). Recent data from the National Consortium on Alcohol and 
NeuroDevelopment in Adolescence (NCANDA), a large cross-sectional study of 831 adolescents 
aged 12–21 years, show that adolescents with more alcohol drinking experience not only 
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performed poorer than the no/low drinkers on neuropsychological tasks that assessed 
autobiographical memory, cognitive ability, attention, emotional control, and motor functions, 
but were also more impulsive (Sullivan et al. 2016). Remarkably, the older no/low alcohol 
drinkers outperformed the younger no/low drinkers on measures of attention, cognitive ability, 
motor performance, and impulse control (Sullivan et al. 2016) – findings that mirror the age-
dependent effects of alcohol shown by Acheson and co-workers (Acheson et al. 1998). Finally, 
sex differences in the effects of alcohol on cognitive functions are less clear, with boys 
outperforming girls on some but not all cognitive measures (Sullivan et al. 2016). The available 
human studies to date do not reveal whether alcohol consumption is a cause or consequence of 
cognitive dysfunctions. The ongoing Adolescent Brain Cognitive Development (ABCD) project, 
a large-scale prospective longitudinal study that tracks a cohort of over 11,000 drug-naïve 
children aged nine to ten years who reside in the United States, monitors adolescent drug use 
behavior or the lack of it (https://abcdstudy.org/). Findings from the ABCD study will shed light 
on how alcohol and other substance use can affect brain development, cognitive outcomes, and 
general health during the formative years (Volkow et al. 2018). 
The detrimental effects of alcohol on cognitive functions are not restricted to the 
adolescent period or solely associated with the duration and pattern of drinking. A recent 
longitudinal study conducted in the United Kingdom reported that moderate and heavy alcohol 
consumption by adult men and women could pose a significant risk for cognitive decline as they 
aged (Topiwala et al. 2017). The researchers found that moderate alcohol drinking was 
associated with higher likelihood of hippocampal atrophy in regular drinkers compared with 
abstainers. They also documented that individuals with a history of heavy alcohol use had more 
pronounced hippocampal atrophy, disruption of white matter architecture, and cognitive decline 
when compared with moderate drinkers and abstainers (Topiwala et al. 2017).  
Not all studies have documented alcohol-related memory impairments. Moderate alcohol 
use did not impair performance in driving and divided attention tasks in adolescents and young 
adults (Lenne et al. 2010; Macavoy and Marks 1975). In the study by Topiwala et al., 
performance of aged men and women on some cognitive tasks was not significantly affected by a 
history of alcohol use (Topiwala et al. 2017). An inverted-U relationship between alcohol use 
and risk for cognitive decline has previously been proposed, where low-to-moderate drinking 
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protects against dementia in the elderly (Ruitenberg et al. 2002) and may be innocuous to the 
cognitive functioning of individuals with a history of heavy drinking (Goodwin et al. 1973). A 
recent cross-sectional study found that low-to-moderate alcohol consumption was associated 
with increased total brain volume in an elderly population without dementia (Gu et al. 2014). 
That study also reported that the positive association between alcohol use and total brain volume 
was mostly driven by red wine consumption, but not by beer or other types of alcoholic 
beverages (Gu et al. 2014). This observation raises the possibility that anti-inflammatory 
flavonoids and polyphenols abundant in red wine might be the crucial beneficial element of wine 
consumption on healthy brain aging.  
Research with animal models has also provided valuable insight into the effects of 
alcohol on cognitive outcomes. As in humans, alcohol can dose-dependently impair cognitive 
functions in rodents (Acheson et al. 2001; Markwiese et al. 1998). For instance, adolescent rats 
demonstrated robust spatial memory deficits in a Morris water maze (MWM) task compared 
with adult rats (Markwiese et al. 1998), though this age-dependent effect was not noticeable after 
sufficiently low (0.5 g/kg) and high (2.5 g/kg) doses of alcohol were administered (Acheson et 
al. 2001). In the latter study, acute 0.5 g/kg dose of alcohol had no effect on spatial learning in 
adolescent and adult male rats, while the 2.5 g/kg dose impaired acquisition of the spatial MWM 
task in both age groups (Acheson et al. 2001). Spear and her colleagues showed that adolescent 
male rats exposed to 0.5 and 1.0 g/kg alcohol subsequently displayed worse odor discrimination 
learning compared with adults (Land and Spear 2004). Their results further suggest that an intact 
hippocampus may not be dispensable for odor discrimination learning in adolescent rats as it is 
for adult rats (Land and Spear 2004). Another study observed that intermittent binge alcohol 
exposure during adolescence impaired object recognition memory in both male and female rats, 
though sex-specific brain changes were noted (Marco et al. 2017). Collectively, the above studies 
show that alcohol can dose-dependently alter behaviors that rely on different memory systems. 
As previously mentioned, the female brain is believed to be sensitive to the damaging 
effects of binge alcohol exposure. Sex differences in the effects of alcohol on neuroanatomy and 
cognitive functions in rats may be brain-region-specific and rely on the type of behavioral task 
employed, respectively (Koss et al. 2012; Maynard et al. 2018; West et al. 2018). Leasure and 
co-workers observed that the hippocampus, but not the medial prefrontal cortex (mPFC), of adult 
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female rats may be more sensitive than that of adult males to the detrimental effects of binge 
doses of alcohol (Maynard et al. 2018; West et al. 2018). This sex difference in the neural effects 
of alcohol (reduced neuron number in the dentate gyrus in adult females) was reflected in greater 
impairment in hippocampus-dependent task in the adult females compared with males (Maynard 
et al. 2018). The Juraska group, however, found that treatment of adolescent male and female 
rats with binge doses of alcohol had no effect on neuron number in the mPFC and basolateral 
amygdala during adulthood, but was associated with reduced glia number only in the mPFC of 
males (Koss et al. 2012). The functional significance of the reduced glia number was not 
investigated in that study, but it may be associated with abnormal changes in cellular 
homeostasis and functional connectivity in the mPFC. Thus, changes in the neural-hormonal 
milieu associated with age in rodents and possibly humans may mediate some of the sex-specific 
effects of alcohol on brain architecture and function. 
The mechanisms responsible for the age and sex differences in the neurotoxic effects of 
alcohol are not well understood. Alcohol disrupts synaptic activity at hippocampal CA3-CA1 
synapses, and the effects are more robust in slices from adolescent-exposed brains compared 
with those from adult-exposed brains (White and Swartzwelder 2004). In one report, the 
concentrations of alcohol that attenuated NMDA-mediated long-term potentiation (LTP) in 
hippocampal slices from adolescent rats were ineffective at disrupting LTP in slice preparations 
from adult rats (Pyapali et al. 1999). Fulton Crews and his crew have shown that acute and 
chronic alcohol administration dose-dependently alters hippocampal neurogenesis in adolescent 
and adult rats by inhibiting neural precursor cell proliferation and survival (Crews et al. 2006; 
Morris et al. 2010; Nixon and Crews 2002). Cellular and histological assays have been used to 
link acute and chronic alcohol administration to increased cell death in the dentate gyrus of 
young rats (Gil-Mohapel et al. 2014; Ikonomidou et al. 2000; Morris et al. 2010; Obernier et al. 
2002; Pascual et al. 2007). In rats, chronic binge alcohol exposure during adolescence activates 
microglia in the dentate and Cornu Ammonis (CA) fields of the hippocampus, and such 
microglial response can persist into adulthood (McClain et al. 2011). Findings from preclinical 
animal studies suggest that, among many possibilities, binge doses of alcohol induce cell death, 
promote microgliosis, reduce trophic factors, hinder neurogenesis, and alter neurotransmission to 




Some of the detrimental effects of alcohol on the brain and behavior can be reversed by 
healthy lifestyle changes, including abstinence, aerobic exercise, and adequate nutrition. Further, 
preclinical rodent studies have shown that immunotherapy (particularly non-steroidal anti-
inflammatory drugs and antioxidants) may minimize some of the negative neuro-immune effects 
of chronic alcohol use (Pascual et al. 2007). However, a history of binge drinking during 
adolescence can leave indelible marks on brain development and executive functions that might 
not be erased by abstinence alone. Crews et al. opined that the negative impact of adolescent 
binge drinking on executive functions can persist into adulthood even following a period of 
sobriety (Crews et al. 2007). Combinations of lifestyle and therapeutic interventions may be 
effective at reversing some alcohol-related brain and behavioral changes. 
 
Is alcohol consumption a risk factor for metabolic syndrome? 
Scientists have long debated the relationship between alcohol consumption and cardio-metabolic 
health (Fernandez-Sola 2015; Molina et al. 2014; Yeomans 2010). The term “French Paradox” 
was coined in the early 1990s to describe the reduced prevalence of cardiovascular diseases 
among inhabitants of France, despite their substantial consumption of dietary fats and alcohol. 
This initial observation inspired other studies that also concluded that low-to-moderate alcohol 
consumption may have beneficial effects on metabolic and cardiovascular health in men and 
women (Dixon et al. 2002; Kao et al. 2001; Koppes et al. 2005; Phillips and Safrit 1971; Rasouli 
et al. 2014). A case-control study conducted in Sweden concluded that regular alcohol 
consumption (specifically wine) was associated with improved insulin sensitivity and reduced 
risk of type 2 diabetes in adult men and women (Rasouli et al. 2014). The researchers observed a 
U-shaped dose-dependent relationship, where abstainers had higher odds of developing type 2 
diabetes compared with moderate drinkers. The investigators also found that every 5 g/day 
increase in alcohol consumption within the range of 0.6–23 g/day was associated with 5% lower 
odds of developing type 2 diabetes (Rasouli et al. 2014). The purported beneficial cardio-
metabolic effects of light-to-moderate alcohol consumption can be mediated via increases in 
antioxidants from wine as well as favorable lipid profiles, specifically increases in high-density 
lipoprotein (HDL) cholesterol (Dixon et al. 2002; Goldberg et al. 1999). Conversely, others have 
shown that alcohol can be toxic to the liver and pancreas (Miyake et al. 2016; Phillips and Safrit 
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1971). A study conducted in the Japanese population found that any amount of alcohol 
consumption increases an individual’s risks for developing non-alcoholic fatty liver disease and 
glucose intolerance (Miyake et al. 2016). Furthermore, a population-based study showed that 
alcohol consumption during adolescence increases the risk of type 2 diabetes during adulthood 
(Liang and Chikritzhs 2014), suggesting that adolescence is a period of heightened susceptibility 
to the effects of a metabolic disruptor like alcohol. The discrepancies on the effects of alcohol on 
diabetes risk may be explained by the type of alcohol consumed (beer, wine, liquor), ethnic 
differences in alcohol metabolism, the sick quitter effect, or bias in retrospective self-reporting, 
amongst other confounds.  
Related to its association with weight gain and obesity is the scare that alcohol may be a 
significant risk factor for certain facets of metabolic syndrome, including insulin resistance and 
impaired glucose tolerance. Insulin resistance and glucose intolerance are some of the defining 
hallmarks of diabetes. Exposure to binge doses of ethanol not only injured the liver of genetically 
obese Zucker rats by upregulating markers of apoptosis, inflammation, and mitochondrial 
dysfunction, but also promoted hepatic steatosis, and lowered the activity of antioxidants in 
hepatocytes (Carmiel-Haggai et al. 2003). A study with inbred rats showed that chronic binge-
like alcohol consumption damages the pancreas and liver and resulted in impaired glucose 
tolerance (Lee et al. 2015). Reports on the effects of alcohol on insulin receptor signaling are 
often at odds. Some researchers posit that moderate alcohol consumption has beneficial effects 
on hepatic insulin sensitivity (Furuya et al. 2005; He et al. 2007), while others show that chronic 
binge alcohol consumption impairs insulin signaling in liver, adipose, muscle, and brain tissues 
(de la Monte et al. 2012; de la Monte et al. 2009; He et al. 2007; He et al. 2006; Lindtner et al. 
2013; Onishi et al. 2003). Collectively, it appears that the effects of alcohol on glucose 
homeostasis and insulin action are dose-dependent or biphasic and may depend on the specific 
tissues analyzed (He et al. 2007; Onishi et al. 2003). The inconsistent reports outlined above 
reflect the ongoing debate on whether regular alcohol consumption is healthful (Burton and 







Cannabinoid neuropharmacology in brief 
Humans have cultivated the marijuana plant (Cannabis sativa) for centuries (Earleywine 2002; 
Farrimond et al. 2011). Portions of the hemp plant have been consumed as food, or used to 
produce fiber, fabrics, paper, personal care products, and medicines. Concoctions prepared with 
the plant are used for certain religious rituals (due to the plant’s mind-altering effects), and have 
proven useful for the treatment of an array of medical conditions ranging from menstrual cramps 
to poor appetite, asthma, convulsions, insomnia, earache, headache, glaucoma, and myriad other 
ailments (Earleywine 2002).  
Despite some of its known therapeutic potential, marijuana is currently classified by the 
U.S. federal government as a schedule I controlled substance – a category that includes 
substances with high abuse potential, no accepted medical use, and lack of safe use (e.g., heroin, 
ecstasy, and hallucinogens). Yet, marijuana continues to be the most widely used illicit 
recreational drug in the United States and in several countries (National Academies of Sciences 
2017). An estimated 2.7–4.9% or 129–238 million individuals around the world used marijuana 
in 2015 (UNODC 2017). The progressive decrease in the number of young people who believe 
marijuana use is risky stems in part from the rarity of overdose from marijuana when compared 
to the perils of using “more harmful” drugs like heroin and cocaine. Owing to advances in 
cannabis research and the growing public support for marijuana legalization, the political 
landscape governing recreation and medicinal marijuana continues to change. The possession of 
certain quantities of marijuana is no longer considered a criminal offense in several U.S. states 
and growing (National Academies of Sciences 2017). 
∆
9
-tetahydrocannabinol (THC) is one of over 100 known phytocannabinoids derived 
from the marijuana plant. THC is typically administered via inhalation (smoking) of marijuana 
cigarettes or “joints” and by oral consumption of edibles prepared with marijuana extracts. The 
psychoactive effects of marijuana are brought about mainly by the actions of THC and its active 
metabolite (11-hydroxy-tetrahydrocannabinol) within the endocannabinoid system in the brain 
and select peripheral tissues (Grotenhermen 2003; Kirkham et al. 2002; Mackie 2005; Tseng et 
al. 2004; Volkow et al. 2017). In brief, the endocannabinoid system is composed of anandamide 
(AEA) and 2-diacyl glycerol (2-AG), their main receptors (cannabinoid receptors 1 and 2, CB1R 
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and CB2R), as well as their synthesizing and metabolizing enzymes. In the central nervous 
system (CNS), AEA and 2-AG are synthesized on-demand and retrogradely act on CB1R, which 
is a Gi/o subtype of G-protein coupled receptors. CB1R activation by AEA, 2-AG, THC, and other 
agonists triggers a collection of cellular activities that result in the attenuation of presynaptic cell 
activity (see (Castillo et al. 2012; Lu and Mackie 2016; Silvestri and Di Marzo 2013; Volkow et 
al. 2017) for excellent reviews). Amongst other functions, the CNS endocannabinoid system is 
involved in the modulation of appetite, executive functions, mood, motivation, stress reactivity, 
and pain (Di Marzo and Matias 2005; Earleywine 2002; Volkow et al. 2017; Williams and 
Kirkham 2002a). CB1R and CB2R expressed in glial cells and in peripheral tissues also play 
important roles in the hedonic, homeostatic, or mnemonic mechanisms that regulate food intake 
and energy balance (Bowles et al. 2015; Silvestri and Di Marzo 2013; Thaler et al. 2012).   
 
Effects of THC on caloric intake, alcohol intake, and body weight 
Anecdotal reports of the appetite-stimulating property of marijuana (Tart 1970) have been 
corroborated by clinical reports of the efficacy of dronabinol (a schedule 3 medication containing 
synthetic THC) in promoting food intake and reversing weight loss in HIV/AIDS-infected 
subjects that present with anorexia (Beal et al. 1997; DeJesus et al. 2007). In a laboratory setting, 
smoked marijuana increased the consumption of palatable food in healthy volunteers (Foltin et 
al. 1988). Another study with casual marijuana users found that the hunger-stimulating effect of 
smoked marijuana wanes over time (Greenberg et al. 1976). It remains to be seen whether THC 
administered via other routes stimulates appetite in humans.  
More empirical support for the endocannabinoid system’s role in regulating energy 
balance comes from rodent studies where infusion of AEA and 2-AG into the ventromedial 
hypothalamus and nucleus accumbens stimulated food intake in rats (Jamshidi and Taylor 2001; 
Kirkham et al. 2002). Interestingly, compared with satiated rats, fasted rats had elevated levels of 
AEA and 2-AG in brain regions that modulate the homeostatic and hedonic aspects of food 
intake (Kirkham et al. 2002). AEA, THC, and other exogenous CB1R agonists dose-dependently 
stimulated food intake in rats (Farrimond et al. 2010; Merroun et al. 2009; Williams and 
Kirkham 1999; Williams and Kirkham 2002b; Williams et al. 1998). Pretreatment with 
SR141716A (rimonabant; a selective CB1R antagonist) or AM251 (a CB1R inverse agonist) 
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averted the effects of CB1R agonists on consumption of energy-dense foods in rodent (Colombo 
et al. 1998; Williams and Kirkham 2002b) and primate (Simiand et al. 1998) models, thus 
verifying that the orexigenic effects of cannabinoids are mainly transduced via CB1R 
stimulation. Additionally, oral THC or subcutaneous AEA administration was found to increase 
the motivation for food in pre-fed rats by reducing the latency to feeding bouts and increasing 
feeding duration and frequency (Farrimond et al. 2010; Williams and Kirkham 2002a). The 
cellular and molecular bases for the “munchies” have been reviewed elsewhere (Koch 2017; 
Morozov et al. 2017; Patel and Cone 2015), as have the effects of many other cannabinoid drugs 
or marijuana constituents on eating behavior (Farrimond et al. 2010; Farrimond et al. 2011; 
Pagotto et al. 2006). 
Cannabinoid receptor stimulation does not always elicit a hyperperphagic response. WIN 
55,212-2, a full CB1R and CB2R agonist, dose-dependently reduced motivation for and 
consumption of a food reward (casein pellets) in an operant behavior task in rats (Drews et al. 
2005). The reduced food intake observed at a higher dose of WIN was not driven by the 
locomotor-altering effects of CB1R activation. Compared with controls, 0.6 mg/kg WIN 
stimulated locomotor activity but suppressed consumption of casein pellets, while 1.8 mg/kg 
WIN had no effect on locomotor activity but reduced casein consumption (Drews et al. 2005). 
Other rodent studies have also shown that THC can increase, reduce, or have no effect on food 
intake depending on the doses administered and other experimental specifics (Farrimond et al. 
2011; Graceffo and Robinson 1998; Pagotto et al. 2006; Rubino et al. 2008). For instance, a 
previous research study demonstrated the biphasic effects of THC on feeding, where 1 mg/kg 
THC acutely reduced while 2 mg/kg THC increased food intake in fasted female Sprague-
Dawley rats (Glick and Milloy 1972). Thus, it is logical to suspect that unforeseen biological 
factors or experimental subtleties may explain the often contradictory effects of cannabinoids on 
appetite and motivation.  
The endocannabinoid system also regulates alcohol intake; and endocannabinoid 
dysregulation is thought to be implicated in alcohol use disorder (Ceccarini et al. 2014). 
Stimulation of CB1R in neural circuits that control alcohol reinforcement increases rodents’ 
motivation to obtain and consume alcoholic beverages – an effect that was averted by 
pretreatment with SR141716A (Colombo et al. 2002; Gallate et al. 1999). However, McGregor 
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and his team have called attention to the fact that the effect of THC in promoting alcohol 
consumption in rats was non-specific since intake of “near-beer” and a non-alcohol containing 
beverage (sucrose) can be enhanced by THC (McGregor et al. 2005). More research is needed to 
determine the factors that may explain the unclear effects of exogenous cannabinoids on alcohol 
consumption. 
The effects of THC on body weight are less clear. Epidemiological data have shown that 
habitual marijuana users have lower BMI and waist circumference when compared with non-
marijuana users (Penner et al. 2013). Chronic marijuana smoking have been found to increase 
weight gain in humans (Greenberg et al. 1976). The fact that THC use produces the “munchies” 
that can in turn engender weight gain and obesity partly motivated the development of 
rimonabant for the treatment of metabolic syndrome associated with obesity (Matias and Di 
Marzo 2007; Pagotto et al. 2006). However, this drug was pulled from the market due to the 
accompanying unpleasant side effects. A rodent study observed that twice a day intraperitoneal 
administration of 2.5–10 mg/kg THC (BID, 5–20 mg/kg/day) reduced caloric intake and weight 
gain in adolescent male and female rats (Rubino et al. 2008). In line with the study by Rubino et 
al., another study reported that mutant mice with enhanced CB1R activity neither consumed 
more high-fat and low-fat foods nor gained more weight compared with controls (Marcus et al. 
2016).  
The contrasting findings on the effects of THC on caloric intake and weight gain may 
also be explained by the fact that THC is a partial CB1R and CB2R agonist, can elicit opposing 
synaptic effects, and may activate a combination of other putative cannabinoid receptors like 
GPR55, GPR199, and TRPV1. Indeed, CB1R activation can elicit hyperphagia or hypophagia 
depending on the cell population on which it is expressed. Selective activation of CB1Rs located 
on presynaptic glutamatergic terminals in hypothalamic networks account for the orexigenic 
effects of THC, while selective activation of CB1Rs expressed on presynaptic GABAergic 
terminals account for the anorexigenic effects of THC (Bellocchio et al. 2010; Matias and Di 
Marzo 2007). The balance between inhibitory and excitatory endocannabinoid transmission in 
the brain and endocannabinoid signaling in the gut differentially influences the action of 
orexigenic hormones (ghrelin, glucocorticoid, orexin, melanin-concentrating hormone), 
anorexigenic peptides (leptin, cholecystokinin, corticotropin-releasing hormone), and ventral 
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striatal dopamine transmission that all affect feeding behavior and energy balance (Bellocchio et 
al. 2010; Di Marzo et al. 2001; Di Marzo et al. 2009b; Matias and Di Marzo 2007; Silvestri and 
Di Marzo 2013). The inconsistent findings regarding the effects of THC on energy balance 
underscores the need for more empirical research aimed at uncovering additional factors that 
dictate the effects of THC on energy balance. 
 
Effects of THC on cognitive outcomes 
Existing reports on the effects of THC on several cognitive domains are inconsistent (Broyd et 
al. 2016). Studies in humans have shown that recreational THC doses (2.6, 5.2, and 20 mg/kg 
THC cigarette, 2.4% THC NIDA cigarette) impair performance on tasks that require sustained 
attention and quick reaction time (Leirer et al. 1991; Lenne et al. 2010; Macavoy and Marks 
1975; Perez-Reyes et al. 1988). Others found that smoking of 1.75% and 3.33% THC cigarettes 
had no effect on driving performance (Liguori et al. 2002). A recently published longitudinal 
study concluded that children with low intelligence quotient (IQ) were more likely to initiate 
cannabis use during adolescence, though adolescent cannabis use was not associated with further 
cognitive decline (Meier et al. 2018). Conversely, preliminary findings from an ongoing 
longitudinal study demonstrate that medicinal marijuana use is associated with modest 
improvement in some aspects of executive function (Gruber et al. 2016).  
It can be difficult to establish a definite cause-effect relationship between marijuana use 
and cognitive deficits in human subjects because evidence of reciprocal casualty exists. 
Cognitive dysfunctions can precede the initiation of marijuana use or can occur because of 
repeated use in vulnerable individuals and thwart successful substance abuse treatment 
outcomes. Other extraneous variables can also complicate result interpretation. One of such 
variables is the ratio of THC to cannabidiol (CBD) present in recreational and medicinal 
marijuana products. CBD, the primary non-psychoactive component of marijuana, antagonizes 
some of the effects of THC and is purported to confer the medicinal benefit of the marijuana 
plant. Marijuana cultivated for recreational use has higher THC to CBD ratio compared with 
those grown for medical purposes (Volkow et al. 2017; Wilson et al. 2019). Moreover, the THC 
and CBD contents of recreational marijuana can differ between geographical locales. In general, 
the use of high potency cannabis that is increasingly available is especially harmful to the global 
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cognitive wellbeing of adolescents (Wilson et al. 2019). An epidemiological study published in 
The Lancet estimated that frequent use of marijuana with high THC content is associated with 
increased risk of mental illness (Di Forti et al. 2019). The researchers, however, relied on self-
reports of cannabis use that were not verified with biological measures (e.g., quantification of 
cannabinoids and their metabolites in urine, saliva, blood, or hair samples), and they did not 
adequately control for many lifestyle factors, including co-use of medications or other drugs of 
abuse. 
Because the results from studies of human marijuana use are confounded by several 
extraneous factors that are beyond the control of researchers, preclinical studies are necessary. 
Rodent studies have documented cognitive impairment (Cha et al. 2007; Han et al. 2012; 
Murphy et al. 2017; Varvel et al. 2005; Zamberletti et al. 2015) and lack of impairment (Bilkei-
Gorzo et al. 2017; Cha et al. 2007) due to acute or chronic THC administration. The detrimental 
effects of THC on spatial and non-spatial learning can differ based on age and sex. Persistent 
working memory deficits and repetitive behaviors were observed in rodents chronically dosed 
with 3 mg/kg THC (i.p.) during adolescence (P28–P48) but not during adulthood (P69–P89) 
(Murphy et al. 2017). Interestingly, the detrimental effects in adolescents were reversed when 
THC and CBD (3 mg/kg each) were co-administered (Murphy et al. 2017). That finding agrees 
with the view that CBD can reverse some detrimental effects of THC. Another study that 
included adolescent and adult male and female rats found that 5 and 10 mg/kg THC (i.p.) acutely 
disrupted both spatial and non-spatial learning to a greater extent in adolescent and female rats 
compared with adult and male rats, respectively (Cha et al. 2007; Cha et al. 2006). The 
pronounced vulnerability of adolescents was not observed when testing occurred twenty-eight 
days after the end of a 21 consecutive-day exposure to 5 mg/kg THC (Cha et al. 2006), 
suggesting that the timing of drug treatment relative to behavioral testing is crucial. Conversely, 
researchers found that old mice chronically dosed with 3 mg/kg/day delivered via 
subcutaneously-implanted osmotic minipumps for 28 days demonstrated improved spatial 
memory along with enhanced synaptic marker proteins, enhanced hippocampal spine density, 
and favorable epigenetic changes (Bilkei-Gorzo et al. 2017). The neurobiological mechanisms 
that mediate the detrimental effects of acute or chronic THC exposure on cognitive functions are 
similar to those that mediate the effects of alcohol, and have been extensively reviewed 
elsewhere (Han et al. 2012; Keeley et al. 2015b; Mizrahi et al. 2017; Renard et al. 2017; Rubino 
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et al. 2015; Rubino et al. 2009; Rubino et al. 2008; Zamberletti et al. 2015). A better 
understanding of these mechanisms may help explain the relatively high susceptibility of 
adolescents and females to drug-induced cognitive deficits.  
 
Is the use of THC a risk factor for metabolic syndrome? 
CB1 and CB2 receptors are ubiquitously expressed in the nervous system and peripheral tissues 
(liver, skeletal muscle, pancreas, and fat) involved in energy homeostasis (Mackie 2005; Onaivi 
et al. 2006). It is little wonder that THC plays an important role in the regulation of energy 
balance and metabolism (Gatta-Cherifi and Cota 2016; Mazier et al. 2015; Pagotto et al. 2006; 
Silvestri and Di Marzo 2013). Chronic activation of peripheral and central cannabinoid receptors 
by THC (especially CB1R) induces glucose intolerance, adipose tissue insulin resistance, and 
visceral adiposity in relatively healthy humans (Hollister and Reaven 1974; Maccarrone et al. 
2015; Matias and Di Marzo 2007; Muniyappa et al. 2013; Podolsky et al. 1971). In parallel with 
this observation, pharmacological antagonism of CB1Rs reduces dyslipidemia and glucose 
intolerance in overweight and obese individuals (Matias and Di Marzo 2007; Triay et al. 2012). 
In rats, CB1R antagonism with AM251 can reverse the glucose intolerance caused by acute 10 
mg/kg AEA (Bermudez-Siva et al. 2006). Additionally, endogenous and exogenous 
cannabinoids acting through CB1R activation stimulate appetite for dietary fat (Di Marzo and 
Matias 2005; DiPatrizio et al. 2013), slow gastric emptying (McCallum et al. 1999), and reduce 
energy expenditure (Mazier et al. 2015), thereby permitting greater lipid absorption and adipose 
tissue expansion (especially the expansion of white adipocytes). Prolonged high-fat diet 
consumption has also been associated with neuroinflammation and injury to the mediobasal 
hypothalamus (MBH) that can perpetuate metabolic syndrome in humans and rodents (Thaler et 
al. 2012; Valdearcos et al. 2018). The observation that elevated circulating levels of AEA and 2-
AG are related to abdominal adiposity led some to propose that marijuana use engenders 
metabolic dysregulation in obese but not in normal weight subjects (Cote et al. 2007; Di Marzo 
et al. 2009a; Gatta-Cherifi and Cota 2016). The reasons for such findings are unclear and may be 
related to hypothalamic pituitary adrenal (HPA) axis dysregulation in obese individuals. 
Preclinical research shows that expression of glucocorticoid-induced metabolic dysregulation 
required peripheral and central CB1R activation (Bowles et al. 2015). Moreover, chronic 
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corticosterone treatment increased hepatic and circulating levels of AEA, suggesting a cross-talk 
between peripheral endocannabinoid signaling and the hypothalamic pituitary adrenal axis in 
regulation of energy homeostasis (Bowles et al. 2015). 
Not all human and rodent studies support the notion that cannabis use is detrimental to 
cardio-metabolic health. Administration of THC via inhalation (but not via intravenous injection) 
had no effect on glucose tolerance and plasma insulin levels in healthy non-obese males 
(Hollister and Reaven 1974; Permutt et al. 1976). Another study observed no effect of cannabis 
smoking on pancreatic β-cell function and lipid profiles in men and women (Muniyappa et al. 
2013). In fact, others have shown that chronic cannabis smoking was associated with low BMI, 
low abdominal fat, favorable lipid profiles, and improved insulin sensitivity (Penner et al. 2013; 
Warren et al. 2005). Several prominent cross-sectional and longitudinal studies (NHANES, 
NSDUH, and CARDIA) consistently found null or negative association between marijuana use 
and indices of metabolic syndrome [though a cross-sectional analysis of data from CARDIA 
uncovered a modest positive association between marijuana use and incidence of prediabetes 
(reviewed in (Sidney 2016)]. Furthermore, administration of THC and JZL195 (a potent inhibitor 
of the enzymes that break down AEA and 2-AG) to transgenic mice expressing desensitization-
resistant CB1Rs did not result in positive energy balance or impaired glucose homeostasis when 
compared with wild-type controls (Marcus et al. 2016). Collectively, the effects of marijuana use 
on diabetes risk in humans may be 1) dose-dependent, where large doses may favor glucose 
intolerance, 2) route-of-administration-dependent, and 3) minimized by the development of 
tolerance to recreational doses in regular users. Given the inadequate control of genetic and 
lifestyle factors that often confound human research, more empirical evidence is needed before a 
definite association between THC exposure and metabolic syndrome can be established.  
 
Alcohol and THC co-use 
Regardless of the imposed restrictions on their accessibility, alcohol and marijuana remain the 
most widely used legal and illegal substance in most countries, respectively. In the year 2016, an 
estimated 137 or 24 million Americans over the age of 12 reported current use of alcohol or 
marijuana, respectively (SAMHSA 2017). The high prevalence of alcohol and marijuana use 
increases the occasions of their co-use, especially by adolescents and young adults (Briere et al. 
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2011; Pape et al. 2009; Subbaraman and Kerr 2015). Co-use of both drugs tends to be favored 
under specific social contexts (Lipperman-Kreda et al. 2018), and for different reasons, including 
use for self-medication, for relaxation, to be “cross-faded,” or to be social and conform to peers 
(Lukas and Orozco 2001; O'Hara et al. 2016; Patrick et al. 2018; Skalisky et al. 2019). 
Consequently, and in parallel with the animal literature, adolescents who regularly consume 
alcohol are likely to use marijuana and vice versa (Grella et al. 2014; O'Hara et al. 2016). 
 
Effects on energy balance and glucose homeostasis 
To my knowledge, no study has documented the effects of alcohol and THC co-use on food 
intake, energy balance, and glucose homeostasis. Considering the vast literature that links 
alcohol or cannabis use with the incidence of metabolic diseases (reviewed above), it will be 
important to understand how the combined use of both drugs may predispose an individual to 
metabolic syndrome.  
 
Effects on cognitive outcomes 
Investigations of the effects of alcohol and marijuana co-use on memory and performance have 
arrived at dissimilar conclusions. In some studies, alcohol and THC co-use impaired 
psychomotor performance of males and females in a driving simulator (Downey et al. 2013; 
Perez-Reyes et al. 1988; Sutton 1983). Researchers have also investigated the additive or 
synergistic pharmacodynamics interaction between alcohol and THC. Additive interaction of two 
drugs on a particular variable is approximately equivalent to the arithmetic sum of the individual 
effect of each drug; while synergistic interaction is when the combined effect of the two drugs is 
supra-additive. In one study, the additive or synergistic interaction between alcohol and THC 
varied as a function of BEC, where higher peak BECs (e.g., approximately 110 mg/dl) were 
associated with worse performance outcomes compared with lower peak BECs (e.g., < 60 mg/dl) 
(Perez-Reyes et al. 1988). Others have found no additive effects of alcohol and THC 
combination on performance in specific measures of driving ability (Lenne et al. 2010; Liguori et 
al. 2002). In a within-subject cross-over study, low doses of alcohol (0.1 g/kg) or THC (2.5 
mg/kg) administered to healthy male and female volunteers moderately impaired cognitive 
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performance but no additive or synergistic effects were uncovered when both drugs were 
combined (Ballard and de Wit 2011). Nevertheless, the presence of additive effects but lack of 
synergistic effects of combined alcohol and THC treatment on cognitive performance have been 
found by other researchers (Chait and Perry 1994; Chesher et al. 1976).  
The lack of agreement between studies may be explained by the fact that volunteers in 
most of those studies were casual alcohol and marijuana users. Regular drugs users may not only 
metabolize a given amount of drug faster than infrequent users would, but also may experience 
lower degrees of the subjective effects. In a divided attention task, individuals with a lifetime of 
THC use showed no impairment under a specific alcohol + THC dose combination compared 
with never-users who demonstrated greater impairment (Macavoy and Marks 1975). Also, 
because most of the studies evaluated the effects of the drugs in a driving simulator, a more 
experienced driver may outperform a less experienced one (Lenne et al. 2010). The ability of an 
experienced drug user to adapt their behavior to perform optimally under shifting task demands 
(behavioral tolerance) may partly explain the paradoxical observations.  
Past preclinical studies have examined the interactive effects of alcohol and THC on 
cognitive functions. Two rodent studies observed impairments in object recognition/working 
memory caused by additive or synergistic interactions between alcohol and THC (Ciccocioppo et 
al. 2002; Swartzwelder et al. 2012). In adult Marchigian Sardinian alcohol-preferring rats, 
neither moderate alcohol consumption nor 2 or 5 mg/kg THC (i.p.) impaired working memory, 
but their combination effectively impaired working memory (Ciccocioppo et al. 2002). The use 
of the genetically selected alcohol-preferring rats limits the extent to which the result can be 
generalized to other subjects. Furthermore, adolescent and adult Sprague-Dawley rats that 
received instant 1.0 mg/kg THC + 1.5 g/kg alcohol (i.p.) displayed memory impairment 
compared with when they received either drug alone (Swartzwelder et al. 2012). In that study, 
however, the acute effects of alcohol, THC, and their combination were studied in the same 
subjects, thus not controlling for drug tolerability or practice effect. Additionally, it was recently 
demonstrated that a potential mechanism by which combined exposure to alcohol and CB1R 
stimulation may affect cognitive function is via reduced neurogenesis and increased cell death in 
the hippocampus (Khatri et al. 2018). More preclinical research on the cognitive effects of 
chronic moderate alcohol and THC co-use is needed.  
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Adolescent model of alcohol and THC co-use 
In both humans and animal models, adolescence marks the end of childhood and the beginning 
of adulthood. It is a developmental stage characterized by robust synaptic pruning, change in 
hormone and neurotransmitter receptor densities, as well as the maturation and remodeling of 
brain circuits that orchestrate cognitive, emotional, reproductive, and reward-related behaviors 
(Crews et al. 2007; Sisk and Foster 2004; Spear 2000). It is hypothesized that adolescents may be 
more sensitive to the rewarding effects, but less sensitive to the aversive effects of alcohol and 
exogenous drugs compared with adults (Crews et al. 2016; Nixon and McClain 2010; Spear 
2011). This combination can facilitate the transition from experimentation with drugs to 
excessive use by vulnerable individuals.  
Alcohol and cannabis co-use is typically initiated during adolescence (Briere et al. 2011; 
Grella et al. 2014; Pape et al. 2009). According to the 2017 Monitoring the Future survey, over 
60% and 45% of high school seniors have experimented with alcohol and marijuana/hashish in 
their lifetime, respectively (Johnston et al. 2018). Adolescent exposure to either drug can result 
in unwanted changes in brain areas that regulate cognitive, appetitive, affective, and reward-
related behaviors (Ellgren et al. 2008; Gulley and Juraska 2013; Koss et al. 2012; Philpot et al. 
2009; Renard et al. 2017; Rubino et al. 2015; Rubino et al. 2008). For example, exposure to 
alcohol or THC during adolescence can alter the maturation of the prefrontal cortex (PFC) – the 
principal brain region important for executive function control (Koss et al. 2012; Rubino et al. 
2015). Compared with their separate use, the co-use of alcohol and THC during adolescence 
predicts poor academic achievements and is believed to be more detrimental to general health 
and safety (Subbaraman and Kerr 2015; Yurasek et al. 2017). In fact, when alcohol or 
cannabinoid use begins during adolescence, there is a greater chance that problem drug use and 
other psychopathology will manifest in adulthood (Crews et al. 2007; Crews et al. 2016; Renard 
et al. 2014; Spear 2016; Spear 2018; Wilson et al. 2019). Finally, given that adolescents are 
sensitive to lasting metabolic alterations caused by alcohol and cannabinoid use (Liang and 
Chikritzhs 2014; Renard et al. 2014), studies that systematically examine the mechanisms that 
mediate the effects of alcohol and THC co-use on metabolic and behavioral outcomes during 
adulthood are needed.  
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CHAPTER 2: DISSERTATION OBJECTIVES 
Food intake and preference are governed by a myriad of neurohormonal and mnemonic 
mechanisms (Schneider et al. 2013; Schwartz et al. 2000). In addition, exogenous substances like 
alcohol and cannabinoids alter appetite, energy homeostasis, and cognitive functions. Unhealthy 
ingestive behavior is responsible, at least in part, for the global economic burden of metabolic 
syndrome (a collection of health conditions that include obesity, dementia, type 2 diabetes, and 
cardiovascular diseases) and several psychiatric disorders. A clear understanding of the 
mechanisms by which alcohol and cannabinoid use are culpable for the metabolic syndrome 
interests the general public and the entire medical community (Muniyappa et al. 2013; Sidney 
2016; Suter 2005; Yeomans 2010).  
Prevailing research on the link between alcohol use and metabolic syndrome, especially 
type 2 diabetes mellitus, often arrives at contrasting conclusions (Goldberg et al. 1999; Phillips 
and Safrit 1971; Pietraszek et al. 2010). Individuals who adhere to the Dietary Guidelines for 
Americans drink alcohol in moderation for its mood-elating and stress-reducing effects (DeSalvo 
et al. 2016; Eckardt et al. 1998). Similarly, most rodents do not voluntarily consume alcohol to 
the point of intoxication (Crabbe et al. 2011; Nelson et al. 2016). Because low-to-moderate 
alcohol consumption alters neurophysiology and peripheral organ functions (Cui and Koob 2017; 
Eckardt et al. 1998; Molina et al. 2014), it is likely that moderate alcohol consumption will alter 
ingestive behaviors, glucose metabolism, and cognitive functions.  
∆
9
-tetrahydrocannabinol (THC) is recognized as the main psychoactive cannabinoid 
derived from the marijuana plant. THC primarily acts as a partial CB1 receptor agonist. THC can 
act in the central nervous system to stimulate appetite for palatable/energy-dense foods in most  
(Foltin et al. 1988) but not all studies (Graceffo and Robinson 1998). THC can also stimulate 
CB1 and CB2 receptors in peripheral tissues to trigger metabolic dysregulation (Matias and Di 
Marzo 2007; Silvestri and Di Marzo 2013). Anecdotal and epidemiological reports show that 
marijuana use impairs cognitive functions (Bolla et al. 2002; Tart 1970), but such observations 
are not universal across a variety of experimental conditions (Broyd et al. 2016; Pattij et al. 




Despite the popularity of alcohol and the increasing public acceptance of marijuana, 
research on the effects of chronic moderate alcohol and THC co-use on energy balance and 
cognitive functions are scarce. Empirical knowledge of the mechanistic links between their co-
use and development of metabolic syndrome will facilitate therapy development to mitigate the 
detrimental outcomes associated with their use. We predict that, compared to their separate use, 
alcohol and THC co-use will predispose an individual to overweight, type 2 diabetes, and 
cognitive deficits via triggering pronounced and lasting neurobiological dysregulations in 
vulnerable subjects like adolescents who are predisposed to co-use both drugs (Lipperman-Kreda 
et al. 2018; Yurasek et al. 2017).  
Adolescence, the developmental stage between childhood and adulthood, is characterized 
by thrill-seeking behaviors, including experimentation with alcohol and drugs of abuse. Because 
of the systematic neurobiological reorganizations that occur during adolescence, the brains of 
adolescents are particularly sensitive to the harmful influence of exogenous substances like 
alcohol and cannabinoids (Gulley and Juraska 2013; Spear 2000; Spear 2015). The 
endocannabinoid system plays a crucial role in the neurobiological remodeling that occurs during 
adolescence (Rubino et al. 2015; Spear 2016). Chronic exposures to alcohol or cannabinoids can 
alter the expression and function of components of the endocannabinoid system to produce 
abnormal neuroplastic changes (Ceccarini et al. 2013; Ellgren et al. 2008; Farquhar et al. 2019; 
Rubino et al. 2008) in brain circuits that regulate feeding, cognitive behavior, and energy 
metabolism.  
The objective of my dissertation is to determine how separate or combined alcohol and 
THC use affects energy balance, metabolic fitness, and cognitive outcome using an adolescent 
rat model. My central hypothesis was that repeated alcohol or THC use would change food 
intake and negatively alter glucose homeostasis and cognitive functions. I further predicted that 
alcohol or THC use during adolescence would alter the expression of key protein/enzyme in the 
brain (CB1R and GSK-3β) during abstinence, and would prime the subject for heightened 
metabolic dysregulation upon subsequent physiological challenge (high-fat diet consumption) in 
adulthood. Importantly, I expected that, compared to separate drug use, combined alcohol and 
THC use would uniquely affect energy balance and be associated with more detrimental effects 
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on glucose homeostasis, cognitive outcomes, and neurobiology. I tested my hypotheses in two 
specific aims outlined below:  
Aim 1: Examine the effects of alcohol on energy balance, memory, and emotion-like 
behaviors.  
My working hypothesis was that adolescent-onset chronic intermittent alcohol consumption 
would alter memory, emotion-like behaviors, and glucose tolerance during adulthood. 
Experiment one (Chapter 3) tested this hypothesis by employing conventional rodent behavioral 
tasks and an oral glucose tolerance test. This experiment also explored potential sex differences. 
Aim 2: Investigate the acute or long-term effects of adolescent alcohol and THC exposure, 
alone or in combination, on energy balance, glucose homeostasis, and cognitive behaviors. 
My working hypotheses were that, compared with the effects of their separate use, chronic 
moderate alcohol and THC co-use during adolescence would 1) uniquely alter caloric intake, 
cognitive behaviors, glucose homeostasis, and neurobiology, and 2) elicit worse metabolic 
outcomes following a high-fat diet (HFD) challenge in adulthood. Experiment two (Chapter 4) 
established a rodent model of alcohol and THC co-use and used it to examine the effects of 
adolescent drug exposure on food intake, body weight, and cognitive behaviors during treatment 
and abstinence. Experiment two also assessed the effects of drug exposure on behavioral 
anhedonia, glucose homeostasis, and changes in brain CB1R protein expression and GSK-3β 
activity during abstinence. Experiment three (Chapter 5) assessed whether adolescent drug 
exposure would alter ingestive behaviors and metabolic response following a period of HFD 








CHAPTER 3: CHRONIC MODERATE ALCOHOL DRINKING ALTERS PLASMA 
INSULIN CONCENTRATION WITHOUT AFFECTING COGNITIVE AND EMOTION-





Because the consumption of alcoholic beverages prevails in society, its effects on diabetes risk is 
a subject of interest. Extant literature on this topic often disagrees. Here, we probed the effects of 
chronic moderate alcohol consumption on glucose metabolism in rats. The effect of chronic 
moderate alcohol drinking on depression- and anxiety-like behaviors and memory was also 
explored. Adolescent male and female Long-Evans rats consumed saccharin-sweetened 5% (one 
week) and 10% ethanol (seven weeks) under a 7.5-h/day (Monday–Friday) access schedule. This 
exposure was followed by sucrose preference and elevated plus maze (EPM) tests during an 
intervening week before a 6-week intermittent access (Monday, Wednesday, Friday) to 20% 
unsweetened ethanol in a 2-bottle choice drinking paradigm was implemented (EtOH). A free-
feeding control group received water (Water). Our prior work revealed that voluntary ethanol 
consumption decreases food intake in rats. Hence, a second control group that received water 
was mildly food-restricted (FR) and their average body weight was matched to that of the EtOH 
group. During the week following week 6 of intermittent access to 20% ethanol, rats were 
submitted to sucrose preference, EPM, and novel object recognition (NOR) tests. Insulin 
response to a glucose load was subsequently assessed via an oral glucose tolerance test (OGTT). 
Rats attained and maintained blood ethanol concentrations of ~55 mg/dl that correlated with the 
dose of sweetened 10% ethanol ingested within 1–3 h. Relative to intake by Water controls, 
EtOH rats consumed less chow. There was no body weight difference between both groups. 
Neither sex of EtOH rats showed increased depression- and anxiety-like behaviors, as 
respectively measured by sucrose preference and EPM, nor did they show deficit in object 
recognition memory during abstinence. Male EtOH rats, however, showed signs of reduced 
general activity on the EPM. During OGTT, male EtOH rats showed a time-dependent 
                                                          
1
 This chapter is an updated version of a manuscript previously published as: Nelson NG, Suhaidi FA, 
Law WX, Liang NC (2017) Chronic moderate alcohol drinking alters insulin release without affecting 
cognitive and emotion-like behaviors in rats Alcohol 70:11-22 doi:10.1016/j.alcohol.2017.12.001. The 
copyright owner has granted permission to reprint. 
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potentiation of insulin concentration for proper glucose clearance. Such an effect was not 
observed in females. This preliminary study shows that chronic moderate alcohol consumption 
can have negative metabolic consequences in the absence of overt behavioral deficits, especially 
in males.  
 
Introduction 
Alcohol consumption is a behavior that prevails in society. Most drinkers consume alcohol in 
moderation (14–30 g or 1–2 drinks/day), especially with meals and during special occasions. 
Excessive drinking, however, is common among adolescents and young adults (Crews et al. 
2007; SAMHSA 2015). Problematic drinking behavior is strongly associated with risk of 
developing alcohol use disorder, bodily injury and death, poor academic performance, delinquent 
behaviors, and many health consequences (Burton and Sheron 2018; Crews et al. 2007; Klarich 
et al. 2015; Saitz 2005; Siqueira et al. 2015; White and Hingson 2013). Habitual alcohol use can 
be deleterious to multiple organ systems (Eckardt et al. 1998; Molina et al. 2014). Habitual 
alcohol use has also been associated with ill health outcomes, including hyperglycemia and 
insulin resistance, which are core features of diabetes mellitus (Fernandez-Sola 2015; Metz et al. 
1969). 
Diabetes mellitus is a debilitating metabolic disease that affects over 400 million people 
worldwide, and this number is projected to exceed 600 million by 2040 (Ogurtsova et al. 2017). 
The American Diabetes Association declares that 1.5 million Americans are diagnosed with 
diabetes yearly, and diabetes ranks as the seventh leading cause of death in America (American 
Diabetes Association  2018). Management of diabetes and its associated health complications 
cost American tax payers a staggering $327 billion in 2017 (American Diabetes Association  
2018). Clinicians and other health-care experts emphasize the necessity for avoidance of 
obesogenic diets in favor of exercise and pharmacotherapy or cell-based therapy in diabetes care 
(Knowler et al. 2002; Kobayashi 2006). Unfortunately, insufficient attention has been directed to 
the contribution of a modifiable lifestyle risk factor such as alcohol consumption to the diabetes 
epidemic.   
Reports on the association between alcohol consumption and diabetes risk in men and 
women are equivocal. Several investigators posit that regular moderate (not excessive) alcohol 
consumption has no effect on insulin sensitivity and cardiovascular health (Cordain et al. 2000; 
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Goldberg et al. 1999; Zilkens et al. 2003), or could improve indices of insulin sensitivity and 
efficient glucose utilization in both men and women (Baliunas et al. 2009; Carlsson et al. 2005; 
Kao et al. 2001; Kiechl et al. 1996; Koppes et al. 2005; Pietraszek et al. 2010). Others, however, 
caution against alcohol use by pre-diabetic individuals or those predisposed to diabetes due to 
their genetic or environmental endowments (Babor et al. 2012; Baliunas et al. 2009; Greenhouse 
and Lardinois 1996; Pietraszek et al. 2010; Vaeth et al. 2014). The supposed benefits of 
moderate alcohol use by healthy individuals may not generalize to others due to the possibility of 
interaction with medications or detriment to general health (Emanuele et al. 1998; Fernandez-
Sola 2015; Greenhouse and Lardinois 1996; Molina et al. 2014). The few studies that 
investigated the potential for sex differences in the link between moderate alcohol consumption 
and diabetes risk often disagree (Kao et al. 2001; Koppes et al. 2005). Hence, more empirical 
studies on the topic are warranted. 
Sex differences in ethanol intake often appear during human adolescent years, with men 
consuming more alcohol than women did (SAMHSA 2015; Schulte et al. 2009). This trend also 
persists into adulthood (Schulte et al. 2009). Findings from rodent studies are inconsistent. 
Around adolescence (P35–P48), male rats can consume higher ethanol doses relative to females 
(Lancaster et al. 1996; Vetter-O'Hagen et al. 2009). Others reported no sex difference in rodent 
drinking behavior during adolescence (Doremus et al. 2005). We and others, however, have 
shown that adult female rats consistently consume more ethanol than males do (Broadwater et al. 
2013; Lancaster et al. 1996; Nelson et al. 2016; Sherrill et al. 2011b). Hence, it would be 
important to investigate how sex differences in ethanol intake will translate into contrasting 
vulnerabilities to developing type 2 diabetes in male and female rats. 
Disagreements between findings from clinical studies and meta-analysis conducted to 
date illustrate the complexity of this topic. In human studies, subtle variations in how data were 
collected, handled and interpreted limit comparison between findings from different labs 
(Goldberg et al. 1999; Koppes et al. 2005; Waki et al. 2005). Most human studies utilize 
questionnaires that rely on the ability of subjects to recall details of their drinking episodes. In 
situations where comprehensive medical records are available (Babor et al. 2012; Chen and 
Garcia-Webb 2014), the chronicle of alcohol consumption is often lacking or inaccurate at best 
(Saitz 2005). Preclinical animal studies on the topic are sparse. It was recently shown that 
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chronic alcohol consumption impaired glucose metabolism and increased diabetes risk in outbred 
rats (He et al. 2006), experimental diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats 
(Lee et al. 2015), and aldehyde 1B1 knockout mice (Singh et al. 2015). This was indicated either 
by hyperglycemia during an intraperitoneal glucose challenge test or altered insulin signaling. It 
is noteworthy that, in addition to the use of modified rodent strains as subjects in two of those 
studies, when rodents were exposed to high ethanol doses (5–13 g/kg/day) involuntarily or via 
ethanol-containing diet as the only calorie source, blood ethanol concentrations (BECs) were 
seldom reported, and potential sex differences were not investigated.  
Several human and rodent studies have documented impaired cognitive functions due to 
alcohol administration that was associated with a myriad of detrimental brain changes (Coleman 
et al. 2011; Obernier et al. 2002; Pascual et al. 2007; Vetreno et al. 2016). Studies that found 
learning and memory impairments in rodents employed binge-like ethanol doses via involuntary 
ethanol administration (Obernier et al. 2002; Pascual et al. 2007). Binge-like ethanol doses result 
in intoxicating BECs (e.g., ≥ 80 mg/dl) that is often accompanied by noticeable motor-
incoordination (Carnicella et al. 2014; Sherrill et al. 2011b). Since outbred rats tend not to 
voluntarily consume ethanol to achieve intoxicating BECs (Furuya et al. 2003; Nelson et al. 
2016), the extent of cognitive decline, if any, remains to be seen with voluntary ethanol intake.  
The aim of the present study was to investigate the consequences of chronic moderate 
ethanol consumption on emotion-like and cognitive behaviors and glucose metabolism. We 
utilized two different rodent voluntary alcohol consumption paradigms that promote moderate-
to-high ethanol drinking and produce BECs of approximately 40–100 mg/dl during the initial 
30–120 min of access in Long-Evans rats (Barson et al. 2015; Carnicella et al. 2014; Nelson et 
al. 2016; Simms et al. 2008). Behavioral assays such as sucrose preference, elevated plus maze 
(EPM), and novel object recognition (NOR) tests were employed to respectively evaluate 
depressive-like, anxiety-like, and cognitive behaviors after weeks of moderate alcohol drinking. 
Glucose tolerance and insulin release were then assessed via oral glucose tolerance test (OGTT). 
We hypothesized that chronic moderate alcohol consumption will alter performance on the above 
behavioral tasks during abstinence. We further expected that long-term moderate alcohol 




Materials and methods 
Subjects and housing 
Male and female Long-Evans rats (n = 38/sex) that weighed 80–97 g (postnatal day 33, P33) 
upon arrival from Envigo (Indianapolis, Indiana) were the subjects. The colony was maintained 
in a climate-controlled vivarium where rats were individually housed in conventional laboratory 
cages on a 12-h/12-h light/dark photoperiod (lights on at 11:30 AM). Rats had ad libitum access 
to water and standard rodent chow (3.1 kcal/g; 24% protein, 58% carbohydrate, 18% fat from 
soybean oil; Harlan 2018, Madison, Wisconsin) during habituation. Chow and fluid accesses 
during experimental manipulations are described in the “Procedures” below. All experimental 
procedures were approved by IACUC at the University of Illinois, Urbana-Champaign and were 
in accordance with the guidelines of the National Institutes of Health. 
 
Test fluids 
0.1% saccharin solutions were prepared by mixing sodium saccharin (Sigma) with tap water. 
Sweetened ethanol solutions (5% and 10% v/v) were prepared by diluting 200 proof (100%) 
ethanol (Decon™ Labs, Inc., King of Prussia, Pennsylvania) with 0.1% saccharin. The 20% 
ethanol and 1% sucrose solutions were respectively prepared by diluting ethanol and sucrose 
(Sigma) with tap water. Fluids were presented in 250 ml glass bottles fitted with stainless steel 
sipper tubes that minimized spillage and evaporation. Bottles were weighed (to the nearest 0.1 g) 
to determine fluid intake. During the experiment, ethanol from a previous drinking session was 
discarded and replaced with freshly-prepared solutions before presentation to the rats. Water was 
replaced every 3–5 days. 
 
Procedures 
The experiment was performed with two separate cohorts of rats (cohort 1: n = 17/sex; cohort 2: 
n = 13/sex). Another set of 16 rats (n = 8/sex) was received from the same vendor during week 7 
of experimental procedures on cohort 2. They were used as a second control group as described 
in the “Procedure for food restricted (FR) group” below. After habituation, rats in each of the 
two cohorts were divided into EtOH and Water groups. Both groups had ad libitum access to 
chow except during food deprivation that preceded the OGTT. Experimental manipulations 
began when rats were juveniles (P39). Two paradigms of intermittent access to ethanol were 
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used, i.e., rats did not receive ethanol every day. This intermittent nature of ethanol consumption 
is to better parallel the intermittent drinking patterns in people who drink moderately (Eckardt et 
al. 1998). 
The first ethanol administration paradigm was a five consecutive day (Monday–
Friday/week) drinking schedule. All rats in the EtOH groups were introduced to the sweet taste 
of 0.1% saccharin solution from 8:00 AM to 3:30 PM (i.e., the last 3.5 h of the dark cycle and 
the first 4 h of the light cycle) to acquire voluntary drinking during this period. We chose this 
duration and timing of alcohol presentation based on the facts that 1) rats are nocturnal animals 
and can consume substantial amounts of food and fluid during the final hours of the dark cycle 
and 2) it approximates human alcohol consumption around meal or rest time (Clevidence et al. 
1995; Dixon et al. 2002). The following week, these rats had access to sweetened 5% ethanol, 
which was used to acclimate them to the ethanol plus 0.1% saccharin taste combination (Roberts 
et al. 1999). Subsequently, the 5% ethanol was replaced with 10% sweetened ethanol for the next 
seven weeks. The Water groups had ad libitum access to water throughout. Body weight and 
chow consumption were recorded daily at 8:00 AM. During Monday–Friday, 7.5-h/day fluid 
intakes by the Water and EtOH rats were recorded at 3:30 PM after which ethanol bottles were 
replaced with water bottles. Hence, all rats had access to one water bottle during the succeeding 
16.5 h. During weekends, no ethanol was provided and thus food and water intakes were 
measured only at 8:00 AM (24-h intake). All rats underwent the same behavioral tests during 
week 9 (Fig. 3.1). 
After the week of behavioral evaluations, ethanol access for the EtOH groups was 
switched to the second ethanol administration schedule: a weekly Monday, Wednesday, Friday 
(24-h/day) intermittent access to 20% ethanol in a 2-bottle choice drinking paradigm. This 
paradigm was established by other alcohol researchers as a protocol that induces moderate-to-
high ethanol drinking that often results in average blood alcohol levels of approximately 60 
mg/dl within a short time (Barson et al. 2015; Carnicella et al. 2014; Simms et al. 2008). We 
applied it to encourage drinking and to determine how rats would respond to an ethanol solution 
devoid of sweetener (Roberts et al. 1999) after they have had prior exposure to sweetened 
ethanol (Broadwater et al. 2013). During regular 8:00 AM measurements on alcohol access days, 
EtOH rats were presented with simultaneous access to one bottle each of 20% ethanol and tap 
water for 24 h. Rats in the Water groups were presented with two bottles of tap water. The 
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placement of the ethanol (right or left) was alternated on each drinking session to avoid 
development of side preference. During the intervening days (e.g., Tuesday, Thursday, and 
weekend days), the ethanol bottle from the EtOH rats and one water bottle from the Water rats 
were removed so that all rats had unlimited access to one water bottle. On these intervening days, 
food and water intakes were measured at 8:00 AM (24-h intake). This schedule of three ethanol 
intake sessions per week occurred for six weeks. Subsequently, another series of behavioral tests 
were performed with all rats during weeks 15 and 16 (Fig. 3.1).  
 
Procedure for food-restricted (FR) group  
Studies in our lab show that voluntary ethanol consumption suppresses food intake and has no 
effect on weight gain in Long-Evans rats (Nelson et al. 2016). The additional rats received 
during cohort 2 experiment (n = 8/sex) served as an additional group employed to control for the 
food intake suppression effect of alcohol that might confound result interpretation. The 
procedures for these rats began during week 7 of cohort 2 experiment. These rats were mildly 
food-restricted while their average body weight was closely monitored and made equivalent to 
that of the EtOH group of the respective sex (cohort 1 and 2 combined). The FR rats had free 
access to water, and the daily chow ration was provided during 8:00 AM measurements. All 
experimental procedures (daily measurements and behavioral tests) with the FR group were the 
same with those for rats in cohort 1 and 2.  
 
Blood ethanol concentration (BEC) analysis  
To determine BEC reached under the 20% ethanol administration paradigm, tail blood was 
collected from all rats. During week 15 (the last week of intermittent-access drinking), rats were 
presented with 20% ethanol or water per the experimental procedure. Intakes were recorded and 
tail blood (80 μl) was collected into a heparinized microcapillary tube 3 h after ethanol 
presentation and 5 h after ethanol removal on an intervening day of the 2-bottle choice drinking 
procedure. Accordingly, blood collection from all FR rats occurred during week 15.  
Tail blood for BEC measurement was not collected during the sweetened 10% ethanol 
drinking paradigm. To evaluate the resulting BEC at different time points under this drinking 
paradigm, we conducted a separate experiment with 18 alcohol-naïve Long-Evans rats (6 males, 
12 females), and the age at which these rats drank overlapped with rats in this study. These rats 
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were the progeny of those initially obtained from Envigo and were housed in the same animal 
facility. Daily handling of these rats was consistent with what was performed in this study. 
Alcohol access began when the rats were at P59–P61, and it was presented according to a 3-
h/day (8:00–11:30 AM) Monday–Friday access schedule. The ethanol access time was reduced 
to 3 h from the 7.5 h because results from the original experiment showed that rats consume most 
of their ethanol dose within the first 3 h of the 10% ethanol access. Prior to tail blood collection, 
the rats had voluntarily consumed sweetened 10% ethanol for one week. On separate days during 
weeks 2 and 3 of drinking, ethanol intakes were measured and tail blood was collected 
immediately after 1- or 3-h access. Ethanol access under this schedule continued until Monday of 
week 5. 
Blood samples were centrifuged at 1000 × g for 10 min at 4 °C after which plasma was 
collected and immediately stored at –80 °C. BEC was quantified using a colorimetric assay kit, 
which measures ethanol by an enzyme-driven oxidation reaction (STA-620; Cell Biolabs, Inc., 
San Diego, California) with a protocol supplied by the manufacturer. Ethanol concentrations 
were estimated using a standard curve per manufacturer's recommendations. 
 
Behavioral tests 
We employed a series of behavioral tests to examine the effects of chronic moderate ethanol 
consumption on cognitive and emotion-like behaviors. Elevated plus maze (EPM) and novel 
object recognition (NOR) tests were performed in the middle of the light cycle after 1 h 
habituation in a room adjacent to the sound-attenuated testing room. Both rooms were 
illuminated to approximately 800 lux by white fluorescent lights. A concealed ceiling-mounted 
camera connected to a computer in an adjacent room was applied to allow real-time behavioral 
analysis and video recording for offline analysis by individuals blind to group assignments. 
Between each animal, the apparatuses were cleaned with a non-alcohol based cleaning agent 
(Coverage Spray; STERIS Corp., St. Louis, Missouri). Behavioral data presented are the average 






Sucrose preference  
Among the constellation of symptoms that qualify for the diagnosis of clinical depression is 
anhedonia – the avoidance of an otherwise pleasurable stimulus (Anisman and Matheson 2005). 
Behavioral anhedonia was assessed by sucrose preference test (Monteggia et al. 2007). The tests 
were performed within three to seven days after the end of each ethanol drinking paradigm 
(P102, P103, P106, and P153; Fig. 3.1). Using the classic 2-bottle choice procedure (Monteggia 
et al. 2007), the rats were presented with two bottles, 1% sucrose vs. tap water, immediately after 
8:00 AM measurements. The positions of the bottles were alternated 12 or 24 h later to prevent 
the development of location preference for drinking. Sucrose preference ratio is equal to 
 
sucrose intake (g) 
sucrose + water intake (g)
× 100.  
 
EPM  
The EPM procedure we employed was adapted from that described elsewhere (Barson et al. 
2015; Walf and Frye 2007). The black wooden EPM had two open arms (OA), 50 cm × 10 cm, 
and two enclosed arms (CA), 50 cm × 10 cm with 40 cm high walls. All arms had an open roof. 
The OA and CA were elevated from the ground to a height of 93.5 cm. The tests were performed 
on day 6 of abstinence from ethanol (P105 and P154; Fig. 3.1). At the start of each trial, rats 
were placed at the intersection of the four arms of the plus-maze facing an OA and were allowed 
to explore for 5 min. Videos were scored for time spent on the OA, and for total arm entries. An 
arm (OA or CA) entry occurred when a rat had at least the fore paws on the arm (Barson et al. 
2015). Time spent on the OA was used as an index for anxiety-like behavior, while total arm 
entry (OA + CA entries) was used as a measure of general activity level in the maze (Carobrez 
and Bertoglio 2005; Monteggia et al. 2007; Walf and Frye 2007). 
 
NOR  
The NOR test exploits a rodents tendency to gravitate toward an unfamiliar object (Leger et al. 
2013). Performance on this task is believed to be an assessment of hippocampus and perirhinal 
cortex learning and memory functions (Ennaceur et al. 1996; Gaskin et al. 2010). Prominent 
alcohol researchers have utilized this task to assess rodents’ cognitive function (Pascual et al. 
2007; Vetreno et al. 2016). The test was performed from day one to four of abstinence from 
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ethanol (P149–P152; Fig. 3.1). On day 1, rats were habituated to an open-field arena for 5 min. 
The arena was composed of a black-colored high-density polyethylene panel (100 cm × 100 cm) 
with raised sides (35.5 cm high) constructed of black Plexiglas
®
. The central arena (60 cm × 60 
cm) was demarcated with white correction fluid. The open-field apparatus was elevated to 70 cm 
above the floor. Videos were scored for the number of crossings into and time spent in the 
central arena. Number of crossings was considered a metric of general activity level (Hale et al. 
2008; Hamezah et al. 2017). On days 2 and 3, rats explored two identical objects positioned in 
opposite corners along the border of the central arena. On day 4, one of the sample objects was 
replaced by a novel object. The position of the novel object (right or left) during the object 
recognition trial was alternated between rats to avoid the possible influence of side preference. 
Videos were scored for time spent exploring each object. Exploratory behaviors included direct 
contacts with the objects: touching while gazing at or sniffing within 3 cm of the objects. Non-
directed contacts or climbing an object without sniffing was not counted. Data from an EtOH 
male rat that did not approach either object on test day 4 were excluded from analysis. The 
percent time spent exploring the novel object relative to the total time spent exploring both 
objects was computed. A score above 50% signifies novel object recognition. 
 
Oral glucose tolerance test (OGTT) and plasma insulin ELISA  
From P149 after alcohol availability was discontinued, all rats had unlimited access to tap water. 
Rats in cohorts 1 and 2 were evenly divided into two groups for OGTT performed on the eighth 
(P156) or ninth (P157) day after ethanol access cessation. Accordingly, OGTT with the FR 
groups was conducted on P156. After an overnight 12-h fast with only water available, OGTT 
began at 12:30 PM, during which fasting blood glucose was measured (baseline) from tail blood 
using a handheld glucometer (AlphaTRAK2 blood glucose test strips, Abbott Labs). 
Subsequently, blood (80 μl) was collected into heparinized capillary tubes for fasting plasma 
insulin determination. Rats were then challenged with glucose (2.0 g/kg body weight, 20% 
glucose prepared with distilled water) administered by oral gavage. Blood glucose concentrations 
were measured at 15, 30, 60, and 120 min post-glucose challenge. Blood was drawn at those time 
points for plasma insulin measurements.  
Blood samples were kept on ice before immediate centrifuge at 1000 × g and 4 °C for 15 
min. Plasma was collected and stored at –80 °C until used for insulin measurements. Plasma 
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insulin was quantified using a commercially available rat insulin ELISA kit (ALPCO; Salem, 
New Hampshire), according to the manufacturer’s instructions.   
 
Data analysis 
Total caloric intake (kcal) comprised the sum of calories from chow (3.1 kcal/g) and ethanol (7 
kcal/g) for EtOH rats, or calories from only chow for Water and FR rats. BEC data were 
analyzed by one-way ANOVA. Sucrose preference, EPM, NOR, fasting glucose, fasting insulin, 
and area under curve (AUC) of the glucose and insulin data were analyzed by two-way ANOVA 
with group and sex as factors. EPM and NOR data of each sex were also independently analyzed 
by one-way ANOVA. Ethanol dose was analyzed by two-way repeated measures ANOVA, with 
time (in weeks) as a repeated measure. Caloric intake, body weight, glucose, and insulin data 
were analyzed by repeated measures factorial ANOVA with group, sex, and time as factors. 
Significant main effects and interactions (p < 0.05) were accompanied with Fisher LSD post hoc 
tests. Pearson correlation was used to assess the linear relationship between ethanol dose and the 
ensuing BEC. All data are presented as mean ± standard error of the mean (SEM), and analyses 
were conducted in Statistica 13.1 (Dell Inc.; Round Rock, Texas). Parts of data from the cohort 1 
experiment (n = 17/sex) were reported in our previous publication (Nelson et al. 2016).  
 
Results  
Ethanol intake and BEC 
Ethanol intake dose (g of pure ethanol per kg of body weight) is presented as the daily average 
across 5 and 3 measurement days per week during the weekday- and intermittent-accesses, 
respectively. Throughout the experiment, females consumed higher ethanol doses than males did 
[sex effect, F(1,32) = 29.86, p < 0.0001; Fig. 3.2]. As we previously reported (Nelson et al. 
2016), ethanol intake increased from week 1 to week 2 of drinking when the concentration of 
sweetened ethanol was switched from 5% to 10% [post hoc, male: 2.03 ± 0.14 g/kg to 2.49 ± 
0.09 g/kg, female: 2.99 ± 0.10 g/kg to 3.50 ± 0.13 g/kg, both p < 0.05]. When the ethanol 
administration paradigm was changed from 10% during weekdays to intermittent 20%, ethanol, 
intake decreased significantly [time effect, F(13,416) = 7.59, p < 0.0001]. Ethanol intake 
reduced to a similar extent in male and female rats during the transition from 10% to 20% 
ethanol access, i.e., intake during the last week of 10% ethanol drinking relative to intake during 
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the first week of 20% ethanol drinking [post hoc, male: 2.19 ± 0.11 g/kg to 1.58 ± 0.20 g/kg 
(28% reduction), p < 0.01; female: 3.23 ± 0.14 g/kg to 2.21 ± 0.33 g/kg (33% reduction), p < 
0.0001]. Despite the decrease, females maintained higher ethanol consumption relative to males. 
On the day tail blood was sampled during the weekly Monday, Wednesday, and Friday 
intermittent access to 20% ethanol, females consumed more ethanol during the first 3 h than 
males did [1.06 ± 0.11 g/kg vs. 0.68 ± 0.10 g/kg, F(1,32) = 7.10, p < 0.02]. Our efforts to detect 
BEC at 3-h after ethanol presentation and 5 h after next-day ethanol removal were unsuccessful, 
as BECs at these time points were mostly below the detection threshold of our kit.  
In the separate group of 6 male and 12 female rats given sweetened 10% ethanol, females 
consumed more daily ethanol dose than males did during the entire 21-day access [time and sex 
effects: F(20,320) = 2.66, p < 0.0002 and F(1,16) = 14.63, p < 0.002]. On blood sampling days 
during week 2 or 3 of drinking, the doses consumed after 1-h and 3-h accesses were measured 
and blood samples were collected for BEC measurement. Pearson correlations taking both male 
and female data into account indicated that BECs significantly correlated with ethanol intake 
after both 1-h [r = 0.77, p < 0.0002] and 3-h [r = 0.68, p < 0.002] access sessions (Fig. 3.3). The 
rats consumed 1.10 ± 0.08 g/kg and 2.29 ± 0.11 g/kg ethanol at the 1-h and 3-h sampling time 
points, respectively. BECs detected at these two time points were 52 ± 10 mg/dl and 59 ± 8 
mg/dl, respectively. On the day tail blood was sampled, females consumed an average ethanol 
dose that was comparable to that consumed by males [1-h: F(1,16) = 0.07; 3-h: F(1,16) = 0.10, p 
> 0.05]. Likewise, there was no sex difference in the BEC attained at the aforementioned 
sampling points [1-h: F(1,16) = 0.80; 3-h: F(1,16) = 0.45, p > 0.05]. 
 
Caloric intake and body weight 
Alcohol drinking resulted in reduced chow intake in male and female rats [group, sex, time, and 
group × sex × time effects: F(2,35) = 19.62, F(1,35) = 405.93, F(14,490) = 42.01, and F(28,490) 
= 3.54, respectively, all p < 0.0001]. EtOH males (post hoc, p < 0.0002) and females (p < 0.02) 
consumed less chow than their Water counterparts did (Fig. 3.4A and 3.4B). The significant 
main effects held true when data of the FR groups were excluded in another analysis [group, sex, 
and time effects: F(1,28) = 18.87, F(1,28) = 316.36, and F(14,392) = 37.09, respectively, all p < 
0.0002]. During food restriction, the FR groups consumed their entire daily chow ration. Their 
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chow intake was significantly lower than that of the Water groups (post hoc for both sexes, p < 
0.002). The average daily chow of the male and female FR groups was 87.4 ± 0.8% and 88.2 ± 
1.7%, respectively, of intake by their corresponding free-feeding Water groups. The respective 
average daily chow (kcal) consumed by male and female FR groups was 95.2 ± 0.9% and 95.3 ± 
1.8% of chow intake by the corresponding EtOH groups. Fluctuations in the amount of chow 
provided to the FR rats were pronounced early during the food-restriction procedure, especially 
in males. Despite these fluctuations, there were insignificant differences in amounts of chow 
consumed by EtOH and FR rats of both sexes (post hoc, p > 0.05). 
Whereas the chow diet was the only energy source for the Water and FR groups, calorie 
from ethanol was another energy source for the EtOH rats. Alcohol consumed by the male and 
female EtOH rats contributed approximately 5% of their daily total caloric intake. Analysis of 
total caloric intake indicated significant group, sex, time, and group × sex × time effects [F(2,35) 
= 17.58, F(1,35) = 395.20, F(14,490) = 47.74, and F(28,490) = 3.78, respectively; all p < 
0.0001]. Thus, total caloric intakes by Water and EtOH groups in both sexes did not differ (post 
hoc, p > 0.05).  Furthermore, the respective average daily chow (kcal) consumed by male and 
female FR groups was 90.6 ± 0.8% and 89.9 ± 1.7% of total caloric intake by their 
corresponding EtOH groups (total caloric intake post hoc for both sexes p < 0.004). That is, the 
significant overall group effect of total caloric intake was presumably driven by fluctuations of 
the chow diet provided to the FR rats. With the exclusion of FR rats in another analysis, the 
group and group × sex × time effects disappeared [F(1,28) = 2.24 and F(14,392) = 0.61, p > 
0.05]. Our analyses clearly indicate that 14 week moderate alcohol drinking did not alter total 
caloric intake in rats.    
Male rats gained weight at a faster pace and weighed significantly more than females 
(Fig. 3.4C and 3.4D). Analysis of all data revealed significant group [F(2,35) = 5.95, p < 0.006], 
sex [F(1,35) = 1131.91, p < 0.0001], time [F(14,490) = 3068.79, p < 0.0001], and group × sex × 
time effects [F(28,490) = 1.58, p < 0.05]. Body weight of male Water and EtOH rats did not 
differ, but Water males were heavier than FR males (post hoc, p < 0.005). Body weight of 
female Water and EtOH rats did not differ, and Water females were marginally heavier than FR 
females (p = 0.06). In addition, body weights of male and female EtOH rats were not different 
from that of their respective FR counterparts (both p > 0.05). Because the significant overall 
group effect was driven by the FR groups, their exclusion in a separate analysis clearly indicated 
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that 14 week voluntary ethanol consumption had no effect on weight gain [group and group × 
week × time effects: F(1,28) = 1.84 and F(14,392) = 1.28, p > 0.05].   
    
Sucrose preference 
Sucrose preference tests performed on P102, P103, and P106 were combined into a 72-h 
preference test, while that performed on P153 was analyzed as a 24-h preference test. Analysis of 
the 72-h sucrose preference test indicated a near-significant group effect [F(2,35) = 2.91, p = 
0.068; Fig. 3.5A]. This was driven by the tendency of EtOH male and female rats toward higher 
sucrose preference compared with the FR rats. Analysis of the 24-h sucrose preference test 
revealed insignificant group effect [F(2,34) = 0.11, p > 0.05; Fig. 3.5B].  
 
EPM 
EPM conducted on day 6 of abstinence from sweetened ethanol (P105) indicated a near-
significant group effect in time spent on the open arms (OA) [F(2,33) = 2.76, p = 0.078; Fig. 
3.6A]. An independent analysis of male rats’ data revealed a significant group effect [F(2,35) = 
7.43, p < 0.003]. Relative to Water and EtOH males, FR males spent more time on the OA (post 
hoc, both p < 0.002). In contrast, time on the OA was similar in all three groups of female rats. 
Analysis of total arm entries, a measure of general activity level (Walf and Frye 2007), revealed 
significant group and group × sex effects [F(2,33) = 3.43 and 3.78, respectively; both p < 0.05]. 
EtOH males exhibited reduced activity compared with Water and FR males (post hoc, p < 0.002 
and p < 0.03, respectively; Fig. 3.6C). EtOH males made fewer arm entries than Water and EtOH 
females did (post hoc, both p < 0.006).  
EPM conducted on day 6 of abstinence from 20% unsweetened ethanol (P154) indicated 
a near-significant group effect in OA time [F(2,35) = 2.76, p = 0.077]. Overall, females spent 
more time in the OA compared with males [sex effect, F(1,35) = 18.59, p < 0.0002; Fig. 3.6B]. 
Analysis of total arm entries indicated no significant group and group × sex effects [F(2,35) = 
1.02 and 2.03, respectively; both p > 0.05]. Albeit, females exhibited greater activity level 






Open field activity and NOR 
Relative to males, females spent more time in the center of the open-field arena [sex effect, 
F(1,33) = 28.96, p < 0.0001; Fig. 3.7A]. Females also demonstrated higher activity level 
compared with males, as indicated by more frequent crossings into the central arena [sex effect, 
F(1,33) = 25.03, p < 0.0002; Fig. 3.7B]. Group and group × sex effects were not significant 
[F(2,33) = 1.28 and 0.73, respectively; both p > 0.05]. These findings corroborate results from 
the EPM conducted on P154. 
There was a significant group effect [F(2,34) = 6.36, p < 0.005] and insignificant sex and 
group × sex effects [F(1,34) = 0.52 and F(2,34) = 0.34, respectively; both p > 0.05] in novel 
object exploration time. In males, FR rats explored the novel object for a longer duration than the 
Water and EtOH groups did [group effect, F(2,34) = 3.56, p < 0.04 in male one-way ANOVA; 
post hoc, both p < 0.03; Fig. 3.7C]. There were insignificant subgroup differences in total object 
exploration time among females [group effect, F(2,35) = 2.54, p = 0.093 in female one-way 
ANOVA]. Analysis of total object exploration time during the object recognition trial indicated 
significant group effect [F(2,34) = 4.85, p < 0.02], and insignificant sex and group × sex effects 
[F(1,34) = 1.84 and F(2,34) = 1.12, respectively; both p > 0.05]. In males, FR rats explored both 
objects for a longer duration than the Water and EtOH groups did, but the difference was 
marginally significant [group effect, F(2,34) = 3.10, p = 0.058 in male one-way ANOVA]. 
There were insignificant subgroup differences in total object exploration time among females 
[group effect, F(2,35) = 2.29, p > 0.05 in female one-way ANOVA]. All groups preferentially 
explored the novel object during the test session [percent novel object exploration time: group 
F(2,34) = 2.34 and sex F(1,34) = 0.41 effects, both p > 0.05; Fig. 3.7D]. An independent 
analysis of female rats’ data revealed a significant group effect [F(2,35) = 3.48, p < 0.05]. 
Relative to EtOH females, FR females spent more percent time exploring the novel object (post 
hoc, both p < 0.02). 
 
Glucose tolerance and insulin levels 
Fasting glucose levels were similar between male and female rats, and among subgroups of 
males and females (Fig. 3.8A and 3.8C). Chronic moderate ethanol consumption did not impair 
glucose clearance during OGTT [group effect, F(2,34) = 0.28, p > 0.05]. Blood glucose was 
cleared at comparable rates in males and females [time and sex effects: F(4,136) = 161.33, p < 
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0.0001 and F(1,34) = 3.69, p = 0.063]. Males demonstrated elevated overall glucose response 
relative to females [glucose AUC: sex effect, F(1,33) = 25.10, p < 0.0001; Fig. 3.8E].  
Male and female rats had similar fasting insulin levels, and there were no subgroup 
differences in both sexes of rats (Fig. 3.8B and 3.8D). Chronic moderate ethanol consumption 
was associated with elevated plasma insulin concentration in males during OGTT [group, sex, 
time, and group × sex × time effects: F(2,33) = 3.56, p < 0.04, F(1,33) = 37.34, p < 0.0001, 
F(4,132) = 85.14, p < 0.0001, and F(8,132) = 3.12, p < 0.003, respectively]. EtOH males had 
significantly more insulin in plasma at the 15-min time point compared with the Water and FR 
males (post hoc, both p < 0.0001). FR males had lower plasma insulin at the 15-min time point 
relative to Water males (p < 0.02). Post hoc tests revealed no significant subgroup differences in 
insulin levels among females. Additionally, male rats displayed elevated overall insulin response 
relative to females [insulin AUC: group F(2,33) = 3.09, p = 0.06, sex F(1,33) = 35.93, p < 
0.0001, and group × sex F(2,33) = 1.48, p > 0.05 effects; Fig. 3.8F]. An independent analysis of 
male rat’s insulin AUC revealed a significant group effect [F(2,35) = 3.49, p < 0.05]. EtOH 
males had a significantly higher AUC compared with FR males (post hoc, p < 0.03), and a 
marginally-higher AUC compared with Water males (p = 0.062). There were no group 
differences in insulin AUC in female rats. 
 
Discussion 
This study aimed to clarify the associations between chronic moderate alcohol consumption, type 
2 diabetes, and cognitive functions in rats. In support of our and others’ earlier work (Barson et 
al. 2015; Furuya et al. 2003; Nelson et al. 2016), rats that voluntarily ingested ethanol reduced 
their chow intake while their total daily caloric intake and body weight remained unaffected. 
Although female rats consumed higher ethanol doses as compared with males, most rats did not 
attain BEC above the defined intoxication level of 80 mg/dl. Such a kind of chronic voluntary 
moderate ethanol consumption in males led to a transiently potentiated plasma insulin level for 
proper blood glucose clearance during OGTT. It is important to note that the changes in plasma 
insulin concentration that we observed could represent an imbalance between insulin secretion 
from the pancreas and its degradation in the liver and kidneys. Further, neither male nor female 
rats showed depression- and anxiety-like behaviors and cognitive deficits, which indicates that 
the 14-week moderate drinking did not lead to alcohol dependence. Altogether, these findings 
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indicate that moderate alcohol consumption can pose a sex-dependent risk for pre-diabetes in 
normal-weight subjects who consume a relatively healthy diet.  
Contrary to some reports, rats in this study did not escalate their ethanol intake during the 
6-week period of intermittent 20% ethanol drinking. Nonetheless, escalation of ethanol intake 
under this paradigm was not universal to all rats (Carnicella et al. 2014). Our finding of reduced 
ethanol intake when the ethanol-access paradigm was changed may be due to absence of 
sweetener in the 20% ethanol after rats had previously consumed lower concentrations of 
sweetened ethanol as adolescents. In fact, other alcohol researchers have observed that male 
rodents with prior exposure to sweetened 10% ethanol solutions during adolescence do not 
increase their intake of unsweetened 20% ethanol during young adulthood (Broadwater et al. 
2013). Our results extend those findings and show that familiarity with the taste of sweetened 
ethanol during adolescence reduced intake of unsweetened ethanol by male and female adult rats.  
The sweetened ethanol-drinking paradigm used in this study produces average BECs 
close to 60 mg/dl in outbred rats within 30–120 min of drinking (Barson et al. 2015; Broadwater 
et al. 2013; Carnicella et al. 2014; Nelson et al. 2016; Simms et al. 2008). Similar BECs, 
measured 40–100 min after initiation of drinking, have been detected in humans that consumed 
moderate amounts of alcohol (Weissenborn and Duka 2003). Our inability to detect BEC when 
measured 3–5 h after intermittent 20% ethanol access suggests a near-complete metabolism of 
blood ethanol within the delay between ethanol accesses to blood sampling. The non-detectable 
BEC indicates that EtOH rats went from moderate drinking that can result in BECs of ~55 mg/dl 
during sweetened 10% ethanol exposure to mild drinking during the 20% ethanol exposure. 
Furthermore, in the locally bred rats given sweetened 10% ethanol, we observed an insignificant 
sex difference in ethanol intake and BEC attained on the day tail blood was sampled. This lack of 
sex difference in ethanol intake might be due to interruption to their drinking during the blood 
sampling procedure. Importantly, the results from this 14-week moderate-to-mild voluntary 
ethanol drinking study offered new insights into the association between alcohol consumption 
and the risk of prediabetes and type 2 diabetes.    
Our finding that chronic moderate alcohol consumption was associated with an increase 
in the amount of plasma insulin needed to maintain normal glucose clearance, i.e., an early sign 
of impairment in insulin sensitivity, concurs with that from studies with healthy humans, dogs, 
and standard rats (Cullmann et al. 2012; Dornhorst and Ouyang 1971; Lochner et al. 1967; Metz 
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et al. 1969; Phillips and Safrit 1971; Singh and Patel 1976). Most of these studies were designed 
to observe the acute effects of ethanol or ethanol plus glucose loads on glucose metabolism. 
Here, we show that early insulin insensitivity during an OGTT procedure occurred in male but 
not female rats that chronically consumed moderate amounts of ethanol. Similarly, increased risk 
of diabetes manifestation in male drinkers compared with females was observed in Swedish 
(Cullmann et al. 2012) and Japanese (Waki et al. 2005) populations. Our result is also consistent 
with a recent meta-analysis that concluded that decreased risk of type 2 diabetes among moderate 
alcohol drinkers is confined to women (Knott et al. 2015). Our finding is more remarkable 
considering that female rats consumed a higher cumulative ethanol dose. This observation 
reinforces the idea that females may be spared from some negative metabolic consequences of 
ethanol (Mumenthaler et al. 1999). This sex difference in the diabetogenic effect of ethanol 
alludes to the protective effect of ovarian hormones in alcohol-related toxicity (Kishimoto et al. 
2002; Mumenthaler et al. 1999). The mechanism still needs to be worked out, and future studies 
can explore this possibility. Additionally, since all animals consumed the same alcohol, our 
results imply that the differing types of alcohol cherished by men and women might not fully 
explain the contrasting vulnerabilities to diabetes observed in humans.  
Proponents of the notion that regular moderate alcohol consumption confers protection 
from cardiovascular diseases and type 2 diabetes in men and women often arrive at such 
conclusions based on data generated from surveys and questionnaires (Baliunas et al. 2009; 
Carlsson et al. 2005; Cullmann et al. 2012; Kao et al. 2001; Kiechl et al. 1996; Koppes et al. 
2005; Rasouli et al. 2014). While their conclusions have merits, methodological constraints limit 
their significance. Our findings suggest that moderate alcohol use may not be beneficial to 
everyone. In fact, the genetic make-up of subjects might interact with the metabolic effects of 
alcohol to modify diabetes outcome. This has been observed in humans (Vaeth et al. 2014) and 
demonstrated in rodents (Singh et al. 2015).  
Our results contrast with those of studies where a 4-week low-to-moderate ethanol 
consumption improved hepatic insulin sensitivity in standard laboratory rats via enhancement of 
the insulin signaling pathway (Furuya et al. 2003; Furuya et al. 2005). In one study, 3% ethanol 
was the only fluid source available, and rats were under anesthesia during the intravenous insulin 
tolerance tests employed (Furuya et al. 2003). Additionally, a recent study found that 10% 
ethanol intake improved tolerance to an intraperitoneal glucose injection in C57BL6 mice with 
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prolonged high-fat diet exposure (Gelineau et al. 2017). In both studies, insulin sensitivity and 
glucose tolerance were assessed during continuous ethanol access. By contrast, the oral glucose 
tolerance test in the present study was performed eight or nine days after alcohol access ended. 
In addition to differences in the timing of glucose tolerance assessment in relation to ethanol 
availability, other methodological disparities between the above studies hamper direct 
comparisons. Nonetheless, our findings underscore the need for closer examination of factors 
such as diet, genetics, and lifestyle that may contribute to potential sex and individual differences 
in the risk of type 2 diabetes among moderate alcohol drinkers.  
The lowered plasma insulin concentration observed in the FR males at 15 min post-
glucose challenge supports the hypothesis that calorie restriction is beneficial. Calorie restriction 
is known to improve insulin sensitivity and other indices of efficient glucose metabolism 
(reviewed in (Trepanowski et al. 2011)). Our results further show that improved insulin 
sensitivity is possible with minor weight loss. This finding should be interpreted cautiously since 
1) insulin AUC of the FR males was only reduced relative to that of the EtOH group but not the 
Water controls, and 2) we did not observe similar beneficial effects in females. Mild calorie 
restriction in male FR rats was associated with reduced anxiety-like behavior, evidenced by 
increased open-arm time during the EPM conducted soon after 8-week voluntary alcohol 
consumption. Because total arm entries during both EPM tests in FR and Water groups did not 
differ, it is unlikely that the significantly increased open-arm time displayed by the FR male rats 
was due to a higher activity level. We speculate that chronic mild calorie restriction might have 
made these rats immune to approach-avoidance stress in early adulthood. Furthermore, as 
indicated by the number of crossings into the central arena during the open-field test, FR male 
and female rats were as active as their respective Water and EtOH counterparts. By contrast, 
during the object recognition trial, male FR rats spent more time exploring both familiar and 
novel objects as compared with the Water and EtOH groups. Altogether, results of the behavioral 
tests suggest that the FR rats could be more exploratory in the presence of objects. 
  Moderate alcohol use can impair cognition in humans (Crews et al. 2007; Weissenborn 
and Duka 2003), and gender differences in alcohol-related cognitive impairment have been 
documented (reviewed in (Mumenthaler et al. 1999)). Abstinence from alcohol can also induce 
craving and mood disturbances (Becker 2000). We employed the sucrose preference, EPM, and 
NOR tests to respectively assess depression-like, anxiety-like, and cognitive behaviors in the rats 
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during abstinence from alcohol. To the extent that behavior on these tasks reveals the cognitive 
and emotional status of rodents, the 14-week voluntary, intermittent moderate ethanol 
consumption in this study did not elicit dependence and cognitive deficits in rats. Nonetheless, 
EtOH males displayed reduced general activity levels after 8-week ethanol drinking (on P105), 
which disappeared at the second EPM test (on P154). Such disappearance may be the 
consequence of reduced activity level of male rats with age (Hamezah et al. 2017). The time-
dependent appearance or disappearance of sex and group differences on behavior highlight the 
influence of several factors on rodents’ EPM performance (Carobrez and Bertoglio 2005).  
To reiterate, we showed that regular moderate alcohol consumption might not be 
innocuous as previously suggested. Male rats that chronically consumed ethanol expressed an 
early sign of insulin insensitivity (a marker of prediabetes) during an OGTT. This occurred 
without impaired glucose clearance or body weight disparity between ethanol consumers relative 
to controls. Additionally, abstinence from moderate ethanol consumption did not lead to 
emotion-like and cognitive behavioral deficits. Our findings reveal that regular moderate alcohol 
use can have negative metabolic consequences independent of weight gain. Despite the 
purported benefits of moderate drinking reported by other researchers, our data bolster the thesis 
that consumers should do a cost-benefit analysis in their decision to consume or abstain from 
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Figure 3.1: Timeline of ethanol consumption and behavioral tests. Long-Evans rats voluntarily 
consumed ethanol for 14 weeks under Monday–Friday, 7.5-h/day access to saccharin-sweetened 
5% and then 10% ethanol, and intermittent access (Monday, Wednesday, Friday, 24-h/day) to 
unsweetened 20% ethanol. After both drinking paradigms, rats underwent some behavioral 












Figure 3.2: Female rats consistently consumed higher doses of alcohol than males did. The 
break signifies transition from the alcohol access schedule of Monday–Friday (7.5-h/day) to 














Figure 3.3: Pearson correlation shows blood ethanol concentrations (BEC) significantly 
correlated with alcohol intake dose after both 1-h (r = 0.77, p < 0.0002) and 3-h (r = 0.68, 















Figure 3.4: Chronic voluntary ethanol consumption was associated with reduced daily chow 
intake and unchanged body weight in both male and female rats. (A and B) Average weekday 
chow intakes during ethanol access period. (C and D) Weekly body weight throughout the 
experiment. The breaks signify transition from the alcohol access schedule of Monday–Friday 
(7.5-h/day) to Monday, Wednesday, Friday (24-h/day). *Water vs. EtOH and FR; #Water vs. FR, 






Figure 3.5: Abstinence from chronic moderate alcohol consumption did not elicit depression-
like behavior as indicated by lack of effect on sucrose preference. (A) 72-h sucrose preference 
test conducted around day 3 to 7 (P102, P103, and P106) of abstinence from sweetened 10% 
ethanol. (B) 24-h sucrose preference test conducted on day 5 (P153) of abstinence from 
intermittent access to 20% ethanol. Bars represent percent of total fluid consumed that was 















Figure 3.6: Abstinence from chronic moderate ethanol consumption did not increase anxiety-
like behaviors in male and female rats on the elevated plus maze (EPM) conducted on day 6 of 
abstinence from 10% sweetened (P105) and intermittent access to 20% ethanol (P154). Bars 
represent time spent in the open arms (OA, A and B) and total number of arm entries (C and D). 
FR males spent more time on the OA than Water and EtOH males did on P105, but not on P154. 
Likewise, the reduced total arm entries displayed by EtOH males on P105 disappeared by P154. 
Females collectively spent more time on the OA and made more arm entries than males did on 




Figure 3.7: Abstinence from chronic moderate ethanol consumption did not alter behavior on 
open-field and novel object recognition tests (P149–P152). (A) Time spent in the center of the 
open-field arena. Females spent more time in the central arena than males did. (B) Number of 
crossings into the center of the open arena. Females made more center crossings compared with 
males. (C) Novel object exploration time. FR males and females spent more time exploring the 
novel object than the respective Water groups did. Male FR rats also spent more time exploring 
the novel object relative to EtOH males. (D) Percent novel object interaction time. All male and 
female groups spent more than 50% of exploration time on the novel object. Relative to EtOH 
females, FR females spent more percent time exploring the novel object. The dashed line 





Figure 3.8: Blood glucose levels and plasma insulin responses in male (A and B) and female (C 
and D) rats after oral gavage of 2.0 g/kg glucose solution. *EtOH vs. Water and FR; #Water vs. 
FR, p < 0.05. Areas under glucose (E) and insulin (F) curves (AUC) were calculated by the 
trapezoid method. Males showed greater glucose and insulin responses compared with females. 
EtOH males showed greater insulin response compared with FR males, and a marginally greater 





CHAPTER 4: COMBINED ∆
9
-TETRAHYDROCANNABINOL AND MODERATE 
ALCOHOL ADMINISTRATION: EFFECTS ON INGESTIVE BEHAVIORS AND 





Whereas co-use of alcohol and marijuana is prevalent in adolescents, the effects of such drug co-
exposure on ingestive behaviors, cognition, and glucose homeostasis remain largely unexplored. 
We hypothesized that co-exposure to alcohol and ∆
9
-tetrahydrocannabinol (THC), the main 
psychoactive constitute of marijuana, alters feeding behavior, cognition, and glucose 
homeostasis differently from either drug alone. Male rats received daily THC (3–20 mg/kg/day) 
or oil vehicle through subcutaneous injection or consumption of a cookie with access to 
saccharin or saccharin-sweetened alcohol during adolescence (P30–P45). Barnes maze and 
sucrose preference tests were applied to assess spatial memory and behavioral flexibility and 
abstinence-related anhedonia, respectively. Subsequently, an oral glucose tolerance test (OGTT) 
was used to assess glucose homeostasis nine days following the last subcutaneous THC and oral 
alcohol administration. Cannabinoid-1 receptor (CB1R) and basal glycogen synthase kinase-3 
beta (GSK-3β) activity were measured in the medial prefrontal cortex, mediobasal 
hypothalamus, and hippocampus via immunoblot at 1–5 weeks after last drug exposure. 
Subcutaneous THC did not affect alcohol intake, but dose-dependently increased acute (3-h) 
chow intake and reduced weight gain. Moderate alcohol consumption reduced the acute 
hyperphagic effect of subcutaneous THC. By contrast, oral THC at a dose > 5 mg/kg robustly 
reduced alcohol intake without affecting 3-h chow intake. At this dose, some rats stopped 
consuming the THC-laced cookies. Furthermore, oral THC reduced weight gain, and co-
exposure to alcohol alleviated this effect. Chronic subcutaneous, but not oral, THC reduced 
sucrose intake during abstinence. Neither treatment impaired cognitive behaviors in the Barnes 
maze. Finally, alcohol and THC co-exposure differently changed insulin response to a glucose 
load during the OGTT. We observed insignificant effects of separate or combined drug use on 
                                                          
2
 This chapter is an updated version of a manuscript previously published as: Nelson NG, Law WX, 
Weingarten MJ, Carnevale LN, Das A, Liang NC (2019) Combined ∆
9
-tetrahydrocannabinol and 
moderate alcohol administration: effects on ingestive behaviors in adolescent male rats 
Psychopharmacology (Berl) doi:10.1007/s00213-018-5093-3. The copyright owner has granted 
permission to reprint. 
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CB1R and GSK-3β protein expressions. Moderate alcohol and THC consumption can interact to 
elicit unique outcomes on ingestive behaviors, energy balance, and glucose homeostasis. 
Importantly, this study established a novel model of voluntary alcohol and THC consumption for 
studying mechanisms underlying the consequences of adolescent onset co-use of the two drugs. 
 
Introduction 
Alcohol and marijuana/hashish are among the most widely used drugs. The 2016 National 
Survey on Drug Use and Health estimates that 81% and 44% of individuals aged 12 or older in 
the United States have used alcohol or marijuana at least once in their lifetime, respectively 
(SAMHSA 2017). The ease of access to alcohol and the growing popularity and 
decriminalization of marijuana  increase the likelihood for both drugs to be used in combination 
(Mechoulam and Parker 2003). Despite this increasing trend, how alcohol and marijuana co-use 
uniquely affects ingestive and cognitive behaviors and glucose homeostasis in adolescents and 
young adults remain unclear. 
In the human and animal literature, reports on the effects of alcohol on appetite, 
cognition, and glucose homeostasis are mixed (Dry et al. 2012; Spear 2018; Steiner et al. 2015; 
Yeomans 2010). We previously showed that the route of alcohol administration (oral vs. 
parenteral) and the time course of blood ethanol concentration (BEC) dictate the effects of 
alcohol on food intake in rats (Nelson et al. 2016). Rats that drank moderate amounts of alcohol 
aptly reduced their food intake to maintain their daily caloric intake and weight gain at the level 
of controls. Furthermore, most rodent studies that reported memory impairments administered a 
dose of alcohol that rapidly elevates BEC above the defined intoxication threshold of 80 mg/dl 
(Coleman et al. 2014; Kuzmin et al. 2012; Pascual et al. 2007). By contrast, we recently showed 
that chronic moderate alcohol consumption from adolescence to young adulthood did not alter 
object recognition memory in rats (Nelson et al. 2017). In that study, glucose tolerance was also 
altered by the long-term alcohol exposure (Nelson et al. 2017). How the effects of moderate 
alcohol consumption on food intake, cognitive behavior, and glucose homeostasis will be 
modified by simultaneous marijuana use is yet to be explored. 
∆
9
-tetahydrocannabinol (THC) is one of over 100 different phytocannabinoids derived 
from the marijuana plant (Cannabis sativa). The psychoactive effects of marijuana are mediated 
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mainly by the actions of THC within the brain endocannabinoid system (Kirkham et al. 2002; 
Manwell et al. 2014b). THC activates cannabinoid receptors 1 and 2 (CB1R and CB2R) in the 
central nervous system and in select peripheral tissues to modulate appetite, cognition, mood, 
glucose homeostasis, and other physiological functions (Di Marzo and Matias 2005; Earleywine 
2002; Merroun et al. 2009; Muniyappa et al. 2013; Pertwee 2008). In healthy human volunteers, 
smoked marijuana increased caloric intake (Foltin et al. 1988; Greenberg et al. 1976) and acutely 
altered glucose homeostasis (Podolsky et al. 1971). Notwithstanding, an epidemiological study 
documented some beneficial metabolic effects of chronic marijuana use (Penner et al. 2013). In 
rats, exogenous cannabinoids (THC, WIN 55,212-2, and CP 55,940) dose-dependently increased 
not only food intake (Merroun et al. 2009; Williams and Kirkham 2002b; Williams et al. 1998), 
but also operant responding for sucrose and alcoholic beverages (Gallate et al. 1999; Malinen 
and Hyytia 2008). Other rodent studies, however, concluded that CB1R agonists either decreases 
or have no effect on food intake (Drews et al. 2005; Graceffo and Robinson 1998; Rubino et al. 
2008). The effects of THC on glucose homeostasis can differ depending on the cannabinoid 
receptor subtype it mostly activates, where stimulation of CB1R or CB2R impaired or improved 
systemic glucose homeostasis, respectively (Bermudez-Siva et al. 2006; Maccarrone et al. 2015). 
These observations underscore the need for more research aimed at dissecting the factors that 
predict the effects of THC on ingestive behaviors and glucose homeostasis. To our knowledge, 
the potential for the route of THC administration to dictate the outcome of its interaction with 
popular appetite-altering compounds (e.g., alcohol) has not been explored. 
The effects of THC on cognitive functions are equivocal. The smoking of a 20 mg/kg 
THC cigarette impaired performance in tests of attention and reaction time (Leirer et al. 1991) 
whereas medicinal marijuana use is associated with modest improvement in some aspects of 
executive function (Gruber et al. 2016). Notwithstanding, establishing cause-effect relationship 
between marijuana use and cognitive deficits in humans can be difficult (Earleywine 2002). 
Experiments with rodents have also documented cognitive impairment (Han et al. 2012; Murphy 
et al. 2017), lack of impairment (Cha et al. 2007), and even improved spatial memory (Bilkei-
Gorzo et al. 2017) following THC exposure. These reports reinforce the idea that, amongst 
others, the effects of THC may depend on subtle experimental paradigms like the THC dosage, 
duration and age of exposure, sensitivity of cognitive tasks employed, and timing of drug 
exposure relative to behavioral testing.  
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Research to understand the neurobiological underpinnings of the unique effects of 
alcohol and THC co-use on brain and behavior are warranted. Among several possibilities, 
alterations to glycogen synthase kinase-3 beta (GSK-3β; the widely expressed GSK-3 isoform in 
the central nervous system) and CB1R activity deserve attention. Normal GSK-3β and CB1R 
activity in many brain regions are crucial for maintaining synaptic plasticity and cellular 
homeostasis (Beurel et al. 2015; Han et al. 2012). Chronic exposures to cannabinoids or alcohol 
can transiently downregulate or desensitize CB1R in many brain regions (Breivogel et al. 1999; 
Ceccarini et al. 2013; Ceccarini et al. 2014; Rubino et al. 2008; Zamberletti et al. 2015). Heavy 
alcohol use is also associated with impaired GSK-3β activity in many brain regions (Neznanova 
et al. 2009; van der Vaart et al. 2018). Alterations in central CB1R and GSK-3β expression or 
activity are implicated in many metabolic, neurological, and psychiatric diseases (Beurel et al. 
2015; Di Marzo et al. 2009b). How chronic moderate alcohol and THC co-use will affect CB1R 
protein expression and GSK-3β activity is currently unknown. 
The purpose of this study is to establish a rodent model of alcohol and cannabinoid co-
administration to examine how the route of THC administration (parenteral vs. oral) interacts 
with the effects of moderate alcohol to modify ingestive and cognitive behaviors. We 
hypothesized that moderate alcohol consumption would suppress acute chow intake with no 
effect on daily total caloric intake. Regardless of administration route, THC would dose-
dependently increase acute and daily caloric intake, and alcohol would lessen the hyperphagic 
effect of THC. Alcohol and THC co-administration will alter glucose homeostasis differently 
than either drug alone would. We further predicted that memory impairments, abstinence-related 
anhedonia, and alteration to CB1R expression and GSK-3β activity would be severe in rats 
exposed to combinations of alcohol and THC compared with those only exposed to either drug 
alone.  
 
Materials and methods 
Animal husbandry 
Preadolescent male Long-Evans rats weighing 35–50 g (Envigo, Indianapolis, IN, USA) were 
semi-pair housed in large polyethylene tubs with transparent Plexiglas cage dividers that 
contained six spaced-out holes (~4 mm radius) that permitted visual, tactile, and olfactory 
interactions between cage pairs. This arrangement enabled us to track individual rats’ food and 
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fluid intake. All animals arrived at postnatal day 22 (P22) except those used for Experiment 2a 
that arrived at P25. A total of 148 rats were used – 40 each in Experiments 1a and 1b, and 32 and 
36 in Experiments 2a and 2b, respectively. Colony was maintained in a temperature and 
humidity-controlled vivarium on a 12-h:12-h light/dark cycle (lights on at 11:30 AM). Rats had 
ad libitum access to tap water and a standard rodent chow (3.1 kcal/g; 58% carbohydrate, 24% 
protein, and 18% fat from soybean oil; 2018 Teklad global rodent diet, Indianapolis, IN, USA) 
and varying accesses to fluids as described in the “Experimental designs” below. Daily animal 
handling and care occurred at 8:00 AM when body weight, food, and water intakes were 
recorded. All experiments were approved by IACUC at the University of Illinois, Urbana-
Champaign, and they conformed to the guidelines stipulated in the Guide for the care and use of 
laboratory animals by the National Research Council, 2011. 
 
Drug 
The contents of 10 mg dronabinol capsules, a commercially-available synthetic ∆
9
-
tetrahydrocannabinol (Actavis Pharm, Inc.; Parsippany, NJ, USA), were suspended in sesame oil 
vehicle (Fisher Scientific) for the 3, 5, and 10 mg/kg subcutaneous (s.c.) injections. In 
Experiment 1, the 3 mg/kg THC doses were administered in a volume of 3 ml/kg body weight, 
while both the 5 and 10 mg/kg doses were administered at a volume of 1.5 ml/kg body weight. In 
Experiment 2, dronabinol to be overlain on cookies (Goldfish Grahams Fudge Brownie, 
Pepperidge Farm; Norwalk, CT, USA) was diluted with sesame oil for the 1.5, 3, 5, and 10 
mg/kg doses. The 1.5 and 3 mg/kg THC doses were applied onto cookie at a volume of 0.383 
ml/kg body weight; the 5 and 10 mg/kg doses were respectively applied at 0.639 and 0.444 ml/kg 
body weight. Oil vehicle was administered isovolumetrically to the different THC doses.  
 
Test fluids: saccharin and alcohol 
Saccharin (0.1%) and sweetened ethanol (10% and 5% v/v) solutions were prepared as we have 
previously described (Nelson et al. 2016). Test fluids were presented at home cages in 50 ml 
graduated plastic bottles fitted with stainless steel sipper tubes that minimize spillage and 
evaporation. Bottles were weighed (to the nearest 0.1 g) to determine fluid intake. We recorded 
spillage of < 0.2 g from empty drip cages and thus, statistical analyses were based on raw intake 
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measurements (i.e., not corrected from the empty drip cages). Ethanol solution from a previous 
drinking session was discarded, and freshly-prepared solution was presented to the rats daily. 
 
Experimental designs 
Experiment 1: Chronic moderate alcohol drinking and subcutaneous THC administration, alone 
or in combination 
Experiment 1a: Spatial learning after chronic alcohol and THC exposure 
Forty pair-housed rats were habituated to the vivarium for four days. At 8:00 AM on the fourth 
habituation day, a cage divider was inserted in the center of each cage to enable separate tracking 
of individual animals’ intake. Over the next four days (P26–P29), the animals were entrained to 
consume 0.1% saccharin along with chow during the last 3 h of the dark cycle (8:30–11:30 AM). 
After 11:30 AM measurements, saccharin bottles were replaced with water bottles. Rats were 
assigned to one of four groups (n = 10/group) by matching average body weight and saccharin 
intake during entrainment: control (CTL) given saccharin and oil injection, ethanol (EtOH) given 
10% ethanol and oil injection, THC given saccharin and THC injection, and combination (COM) 
given 10% ethanol and THC injection. At 8:30 AM from P30–P45, animals received daily 
subcutaneous THC or oil injections immediately before test fluid access in their home cages. 
Chow and test fluid intakes were measured at 11:30 AM (3-h intakes) when test fluids were 
supplanted by tap water. Drug and test fluid exposures spanned 16 days (P30–P45) that 
overlapped with the onset of adolescence. The 3 mg/kg/day dose lasted for eight days, while 5 
and 10 mg/kg/day doses each lasted for four days (Rubino et al. 2009; Rubino et al. 2008). The 
doses were increased across time to control for drug tolerability and to model the escalation of 
drug intake commonly observed in humans. From P32, preputial separation – the complete 
manual retraction of the prepuce from the glans penis of male rats – was assessed during 11:30 
AM measurements to determine how drug exposure would affect puberty onset (Korenbrot et al. 
1977). One rat in the EtOH group was discovered dead at 8:00 AM on P42. Another EtOH rat 
was accidentally injected with 10 mg/kg THC on P43. The subsequent data from this rat were 
excluded from analysis. Except during the behavioral tests, chow and water were freely available 





Blood ethanol concentration (BEC) analysis 
To determine how low-to-moderate THC doses would affect BEC in rats exposed to both drugs 
concurrently, tail blood was sampled on the eighth (P37) and second (P43) day of 3 and 10 
mg/kg/day THC doses, respectively. On those days, rats were presented with 10% alcohol or 
saccharin per the experimental procedure. After a 1-h (3 mg/kg THC) or 3-h (10 mg/kg THC) 
free access, intakes were recorded and tail blood (80 μl) collected into heparinized 
microcapillary tubes. The blood samples were centrifuged at 1000 × g for 10 min at 4 °C after 
which plasma was collected and immediately stored at –80 °C. BEC was quantified in plasma 
gotten from EtOH and COM rats using a colorimetric assay kit (STA-620; Cell Biolabs, Inc., San 
Diego, CA) with a protocol supplied by the manufacturer. Ethanol concentrations were estimated 
using a standard curve per manufacturer's recommendations (Nelson et al. 2016). 
 
Behavioral tests 
Sucrose preference  
During abstinence from THC and alcohol, sucrose preference test was used to assess intake of a 
mildly rewarding sucrose solution (Carlin et al. 2016; Nelson et al. 2017). On the test days (Fig. 
4.1A), rats were presented with two bottles, 1% sucrose vs. tap water, immediately after 8:00 
AM measurements. The positions of the bottles were alternated on each day to prevent the 
development of location preference for drinking. After the sucrose preference tests, all rats were 
returned to ad libitum water access. Sucrose preference (%) was calculated 
as 
sucrose consumption
sucrose + water consumption
× 100.  
 
Barnes maze 
Rats were submitted to the Barnes maze (BM) test to examine the effects of periadolescent 
alcohol and THC exposure on spatial learning, memory, and cognitive flexibility. The BM has 
been used by other researchers to assess such behaviors following different experimental 
manipulations (Coleman et al. 2014; Kuzmin et al. 2012). The maze consisted of a circular dark 
grey high-density polyethylene panel (122 cm diameter) with 20 holes (10 cm diameter) that are 
2 cm away from the edge and evenly distributed around the circumference of the platform. An 
escape chamber (39 cm × 12.5 cm × 14.5 cm) constructed of black Plexiglas
®
 was mounted on a 
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rotatable wooden support that permitted a 360°
 
rotation on the horizontal plane to align the box 
underneath any hole of the maze. The escape chamber had a 20°
 
incline base that allowed the rats 
to carefully descend into the box. Only one hole led to the escape chamber. The entire set-up was 
supported on a 99 cm high movable pedestal with adjustable wheels that remained locked during 
testing.                                                                
BM testing began four days after the last drug exposure (Fig. 4.1A) and was performed in 
the middle of the light cycle after 1 h habituation in a room adjacent to the sound-attenuated 
testing room. Both rooms were illuminated to approximately 900 lux white diffuse fluorescent 
lights. The testing room contained five apparent visuo-spatial cues. In the BM, rats must use the 
spatial cues to locate the escape chamber. A concealed ceiling-mounted camera connected to a 
computer in an adjacent room enabled real-time behavioral analysis and video recording for 
offline analysis by individuals blind to the group assignments. The time it took a rat to locate and 
enter the escape chamber (escape latency) was manually scored by trained scorers. Where 
reported, average distance travelled in the maze was tracked by TopScan (CleverSystems Inc.; 
Reston, VA, USA). Between each animal, the apparatus was cleaned with a non-alcohol-based 
cleaning agent (Coverage Spray; STERIS Corp., St. Louis, MO, USA) to eliminate odor cues. 
Spatial learning and memory 
Spatial learning occurred on two consecutive days (P49–P50), and each daily session consisted 
of four trials with an inter-trial interval of at least 1 h. At the start of a trial, a rat is placed in the 
center of the maze and allowed to explore for 3 min. A trial ended when the rat entered the 
escape chamber or when the 3 min elapsed, whichever occurred first. In the situation when a rat 
did not enter the chamber by the end of a trial, it was gently guided into the chamber where it 
remained for 90 sec before being returned to its cage.  
Twenty-four hours after the spatial learning task, rats underwent spatial memory 
evaluation (P51). The procedure was identical to that used for spatial learning, except that the 
starting orientation of a rat during the four trials alternated between the North, East, South, and 






Four behavioral flexibility trials were conducted on the day after the spatial memory test (P52). 
The arrangement of the first trial was identical to that of the spatial learning trials. In the second, 
third, and fourth trials, the escape chamber was rotated 180° or 90° relative to its position during 
the first trial. Hence, the escape chamber alternated among the four quadrants corresponding 
with its cardinal location during each of the four trials in this order: South, North, West, and 
East. The rotations of the escape chamber ensured that rats were unable to escape the maze using 
acquired spatial cues but had to identify the new locations – a measure of cognitive/behavior 
flexibility (Coleman et al. 2014; Kuzmin et al. 2012; Pattij et al. 2008).  
 
Oral glucose tolerance test (OGTT)   
Rats were returned to their home cages at the conclusion of the Barnes maze testing. Following 
an overnight 16-h fast, we performed the OGTT on P54 (Fig. 4.1A) according to our  established 
protocol (Nelson et al. 2017). After we measured fasting blood glucose from a drop of tail blood 
using an AlphaTRAK glucometer (Abbott Labs) and collected tail blood using 80 µl heparinized 
microcapillary tubes, we administered an oral gavage of 2.0 g/kg body weight glucose with a 
20% glucose solution. We then collected glucose readings and tail blood at 15, 30, 60, and 120 
min post glucose dosing. The blood samples were transported on ice and centrifuged at 1000 × g 
for 15 min at 4 °C. Plasma was collected and stored at –80 °C
 
for later insulin measurement as 
we have previously done (Nelson et al. 2017).  
 
Brain extraction and western blot 
Within 1 h after the OGTT, the animals were rapidly decapitated and their brains immediately 
extracted and snap-frozen in powdered dry ice. Brains were stored at –80 °C until they were 
processed for western blotting. The medial prefrontal cortex (mPFC, +4.20 to +2.52 mm relative 
to bregma), mediobasal hypothalamus (MBH, -1.72 to -3.36 mm), and hippocampus (HIP, -2.40 
to -4.56 mm) were punched from 400–500 µm thick frozen coronal sections using a 2.0 mm 
diameter Miltex biopsy punch (Electron Microscopy Sciences; Hartfield, PA, USA) based on 
published coordinates for the rat brain (Paxinos and Watson 2007).  
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Tissues for western blot were homogenized in cold RIPA buffer containing protease 
(Sigma; Cat. # P8340) and phosphatase (Sigma; Cat. # P5726) inhibitor cocktails and allowed to 
incubate on ice for 40 min. The homogenates were then centrifuged at 12,000 rpm, 4 °C for 15 
min, after which the supernatant was carefully collected. Total protein concentration was 
quantified via bicinchoninic acid method (Pierce BCA Protein Assay Kit; Thermo Fisher 
Scientific, Cat. # 23227). Equal amounts of protein per sample (10 µg) was mixed in a 3:1 ratio 
with 4x laemmli buffer containing 2-mercaptoethanol and denatured at 95 °C for 5 min. Proteins 
(10 µg/20 µl) were fractionated by SDS/PAGE in 4–15% pre-cast polyacrylamide gels (Mini-
Protean TGX Gels; Bio-Rad, Cat. # 456-1084) at 100 V before transfer onto polyvinylidene 
difluoride membrane (Bio-Rad). Portions of the membrane containing CB1R and vinculin 
molecular weights were cut and blocked for 40 min at room temperature with 5% non-fat dry 
milk in TBS-T (Tris Buffered Saline with 0.05% Tween 20). The pre-incubations were followed 
by overnight incubation at 4 °C with gentle shaking in anti-cannabinoid 1 receptor or vinculin 
antibody in 2.5% milk solutions (see Table 4.1 for information on the specific primary antibodies 
and dilutions used in this chapter). Primary incubations were followed by four 10 min washes 
with TBS-T before the membranes were incubated in HRP-linked anti-rabbit IgG (1:2000; Cell 
Signaling Technology, Cat. # 7074) with gentle shaking for 2 h at room temperature and 
protected from light. Blots were washed and incubated for 4 min in Clarity Western ECL 
Substrate (Bio-Rad, Cat. # 170-5060). Chemiluminescent protein bands were visualized and 
imaged with a ChemiDoc Touch Imaging System (Bio-Rad). Using Image J software (NIH; 
Bethesda, MA, USA), relative CB1R protein quantity was determined by normalized intensity to 
loading control vinculin. The average density of the EtOH, THC, and COM groups were 
normalized to that of the CTL. 
 
Experiment 1b: Spatial learning during alcohol and THC exposure  
During the BM procedure in Experiment 1a, we noticed that drug exposure during adolescence 
had no effect on performance. We reasoned that the drug might interfere with BM performance if 
1) we increased the cumulative THC dose administered to the rats, 2) drug exposure overlapped 
with training in the maze, and 3) spatial memory and cognitive flexibility were assessed a few 
days after BM training. The 40 rats (n = 10/group) were housed under identical conditions as in 
Experiment 1a. Habituation and drug administration procedure were also consistent with that of 
67 
 
Experiment 1a, except that the THC and COM groups in Experiment 1b received 3, 5, 10, and 20 
mg/kg/day THC injections (s.c.), each dose lasting for four days for a total of 16 drug exposure 
days (Fig. 4.1B). Importantly, to minimize THC-induced locomotor depression (Manwell et al. 
2014b; McGregor et al. 2005; Williams and Kirkham 2002a), the 20 mg/kg/day dose was 
administered as two separate 10 mg/kg doses. The first was administered at 8:30 AM as per the 
usual protocol, while the second was given at 9:30 PM (i.e., 2 h before dark onset). Two 48-h 
sucrose preference tests were performed (Fig. 4.1B).  
The Barnes maze set-up and procedure employed here was consistent with that of 
Experiment 1a. The 12-day BM procedure spanned a 15-day period that was punctuated by three 
days within which the first 48-h sucrose preference test was performed (Fig. 4.1B). Rats 
underwent eight days of training (1 trial/day) that overlapped with the last eight days of alcohol 
and THC exposures. Spatial memory (2 trials/day) was assessed on days 4 and 5 after the last 
drug exposure. Behavioral flexibility test (2 trials/day) occurred on abstinence days 6 and 7 (P51 
and P52). Except for days when sucrose preference tests were performed, rats were maintained 
on free access to chow and water during a 2-week abstinent period. 
Between four (P73) to five (P81) weeks after the last drug exposure day (P45), a subset 
of the rats (n = 6/group) were decapitated and their brains were rapidly removed and frozen in 
powdered dry ice. [The other subset of rats was processed for pilot electrophysiological 
recordings in collaboration with the Gulley Lab (the preliminary data are not presented in this 
dissertation)]. The mPFC, MBH, and HIP were micropunched and processed for quantification 
of protein levels of CB1R, phosphorylated GSK-3β, total GSK-3β, and vinculin via western blot 
as described above. The GSK-3β membranes were first probed with the phosphorylated protein 
that was stripped before membranes were probed for total protein. Relative protein densities 
were determined by normalized intensity to house-keeping protein vinculin (CB1R) or to total 
protein (GSK-3β) in the same lane. Average density of the EtOH, THC, and COM groups were 






Experiment 2: Chronic moderate alcohol drinking and oral THC consumption, alone or in 
combination 
Experiment 2a: Spatial learning during voluntary alcohol and THC consumption 
Although smoking or vaping is the preferred route of human THC administration, consumption 
of edibles laced with cannabis extracts is becoming popular (Grella et al. 2014; National 
Academies of Sciences 2017). THC-containing edible products like beverages (tea, coffee, 
cannabis cocktails), confectionaries (cookie, brownies, candy, chocolate), and cooking 
condiments are available in states where recreational and medicinal marijuana are legal (Grella et 
al. 2014; Vandrey et al. 2015). To enhance the relevance of our model by mimicking this 
growing pattern of THC ingestion, we sought to administer it to the rats via cookies. The 32 rats 
(n = 8/group) were aged P25 at arrival. The drug treatment timeline employed here was 
consistent with that of Experiment 1b, except that drink training began on P26. The initial plan 
was to present rats with cookie overlaid with 3, 5, 10, and 20 mg/kg/day THC in their home 
cages. Each dose was to last for four days, and the 20 mg/kg/day THC was to be given as two 10 
mg/kg doses. After the first 5 mg/kg/day THC consumption, THC and COM rats consumed less 
test fluids which became pronounced after the first two 10 mg/kg/day doses when food intake 
also reduced (see Results). Consequently, we modified our protocol to where lower THC doses 
were provided to the same rats twice a day: 1 h after the end of test fluid consumption, i.e., 1 h 
after light onset (12:30 PM), and 3 h before dark onset (9:00 PM). We also reduced the 
concentration of sweetened alcohol solution from 10% to 5% to mitigate any potential aversive 
effects caused by the interaction of THC (and its metabolites) and the higher alcohol 
concentration (Fig. 4.2A). The 5% alcohol solution was first introduced to the EtOH and COM 
rats on P40 when oil cookie was provided to all groups. Under this modified protocol (P41–P45), 
rats were first presented with 3-h access to saccharin or 5% alcohol solution (8:30–11:30 AM). 
After chow and test fluid intakes were recorded, the first and second THC-laden cookies of the 
day were respectively presented at 12:30 and 9:00 PM. Barnes maze set-up and timeline were 
consistent with that of Experiment 1b. Except for days of sucrose preference tests (Fig. 4.2A), 






Experiment 2b: Testing the modified voluntary alcohol and THC consumption paradigm 
Experiment 2b tested the modified drug administration paradigm developed in Experiment 2a in 
a new cohort of rats. After habituation to the animal facility, the 36 rats (CTL and COM, n = 
10/group; EtOH and THC, n = 8/group) were entrained to the new drug exposure schedule. 
Immediately after daily care during the 4-day training period, rats had 3-h access to 0.1% 
saccharin solution and chow (last 3 h of the dark cycle, 8:30–11:30 AM). Following 
measurement of chow and saccharin consumption, the first and second oil-laden cookies were 
respectively provided at 12:30 PM and 9:00 PM. During the 16-day treatment period, rats first 
had 3-h access to saccharin or sweetened 5% alcohol solution followed by a cookie laced with oil 
or THC (1.5, 3, or 5 mg/kg) presented twice per day at 12:30 PM and 9:00 PM (Fig. 4.2B). Each 
cumulative daily dose of 3, 6, 8, and 10 mg/kg THC lasted for four days. To ascertain how oral 
THC consumption would affect BEC kinetics, we measured BEC at different time points (see 
Supplemental Information). Barnes maze test was not performed in Experiment 2b. Except on 
the days when sucrose preference tests were conducted (Fig. 4.2B), rats had ab libitum access to 
chow and water for three weeks following the last drug exposure day. 
 
Plasma levels of THC and its metabolites 
In Experiments 1b and 2b, tail blood was collected shortly after light onset on the day after the 
last THC exposure (i.e., 14 h after). This timing for blood collection was chosen mainly because 
it coincided with a period when daily measurements were performed. The blood samples were 
centrifuged, and plasma was immediately stored at –80 °C. Lipid components of the plasma 
samples were extracted, and levels of THC, 11-OH-THC, and THC-COOH were quantified by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) as we have previously done 
(Arnold et al. 2018; Tiscione et al. 2016).  
 
Statistical analysis 
In Experiment 1, daily caloric intake in CTL and THC rats consisted of calories from chow (3.1 
kcal/g), while EtOH and COM rats consumed calories from chow and alcohol (7 kcal/g). The 
loss of one rat and the mishap during THC injection in Experiment 1a reduced the number of 
EtOH rats to 8. Furthermore, some volume of glucose was spilled during the oral gavage 
procedure in Experiment 1a. The OGTT data from the correspondent rat were eliminated from 
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analysis (the eventual sample sizes are provided in the legend of Fig. 4.6). In Experiment 2, daily 
caloric intake in CTL and THC rats included calories from chow and cookie (4.7 kcal/g), while 
EtOH and COM rats consumed calories from chow, cookie, and alcohol. The inconsistency with 
which rats consumed THC cookies prompted us to apply separation or exclusion criteria (see 
Experiment 2 results below). In Experiment 2a, the respective final sample sizes of the THC and 
COM cookie-consuming groups (THC_C and COM_C) were 5 and 4, and that of the cookie-
avoiding groups (THC_A and COM_A) were 3 and 4. In Experiment 2b, the final sample size of 
the COM group was seven. The dose-response effects of THC on alcohol, saccharin, and caloric 
intakes were analyzed using the average value from the respective doses. These intake analyses 
were repeated with body weight-adjusted intakes, which were computed as intake per 100 g body 
weight of individual rat. 
Alcohol, saccharin, and caloric intake during treatments were analyzed by one-way 
ANOVA (paradigm 2 of Experiment 2a) or by two-way repeated-measures ANOVA with 
treatment as a between-subject factor and THC dose or day as the repeated measure. Likewise, 
Barnes maze data were analyzed by two-way repeated-measures ANOVA with treatment as a 
between-subject factor and trial session as the repeated measure. The blood glucose and insulin 
concentrations from the OGTT were analyzed by two-way repeated-measures ANOVA with 
time (in min) after oral glucose gavage as the repeated measure. The effects of specific THC 
dose on caloric intake, alcohol intake, and BEC were determined by one-way ANOVA, as was 
analysis of weight gain during treatment, caloric intake and weight gain during abstinence, 
protein expression, fasting blood glucose and insulin concentrations during the OGTT, areas 
under the glucose and insulin curves (AUC), sucrose preference, and fluid intakes during the 
preference tests. Significant main effects and interactions (p < 0.05) from the ANOVAs were 
accompanied with Tukey’s HSD post hoc tests. Plasma levels of THC and its major metabolites 
were analyzed via Student’s t-test. Pearson correlation was used to assess the linear relationship 
between ethanol dose and the ensuing BEC. Data are presented as mean ± standard error of the 








Experiment 1: Chronic moderate alcohol drinking and subcutaneous THC administration, alone 
or in combination 
Subcutaneous THC reduced saccharin intake, but had no effect on alcohol intake and BEC 
In Experiments 1a and 1b, THC and CTL groups increased their saccharin intake across 
treatment days [F(2,36) = 40.33 and F(3,54) = 21.24, respectively; both p < 0.0001]. Compared 
with the CTLs, subcutaneous THC reduced saccharin intake in Experiment 1b [F(1,18) = 7.83, p 
< 0.02], but not in 1a. The above result held true for body weight-adjusted saccharin intakes. 
Ethanol consumed by EtOH and COM rats did not differ at any of the administered THC dose 
(Fig. 4.3A and 4.8A).  
The effects of subcutaneous THC on blood ethanol concentration (BEC) were assessed in 
Experiment 1a. After a 3 mg/kg THC injection, EtOH (1.54 ± 0.13 g/kg) and COM (1.4 ± 0.18 
g/kg) rats consumed similar alcohol dose within 1 h. Both groups attained comparable BECs of 
4.60 ± 1.41 mg/dl – a value near the lower detection limit of our kit. BEC attained after 1 h of 
alcohol access significantly correlated with the ingested dose in only the EtOH group (Fig. 
4.3B). After a 10 mg/kg THC injection, EtOH (1.93 ± 0.13 g/kg) and COM (2.11 ± 0.19 g/kg) 
rats consumed similar alcohol dose within 3 h to achieve BECs of 18.07 ± 8.39 and 22.81 ± 9.68 
mg/dl, respectively. BEC achieved after 3-h alcohol drinking significantly correlated with the 
ingested dose in both EtOH and COM groups (Fig. 4.3C). 
 
Subcutaneous THC stimulated short-term chow intake, and reduced weight gain and caloric 
intake during abstinence 
Subcutaneous THC dose-dependently increased while moderate alcohol consumption reduced 3-
h chow intake in Experiments 1a [group and group × time effects: F(3,35) = 14.16 and F(6,70) = 
5.47, respectively; both p < 0.0002; Fig. 4.3D] and 1b [group and group × time effects: F(3,36) 
= 11.46 and F(9,108) = 3.55, respectively; both p < 0.0007; Fig. 4.8B]. In both experiments, the 
reduced caloric intake by the EtOH group relative to the CTL group (post hoc, both p < 0.02) did 
not persist when alcohol calorie was included. The respective hyperphagic and hypophagic effect 
of THC and alcohol appeared to oppose each other as chow intake of the COM group did not 
differ from that of the CTLs in both experiments. The significant main effects on 3-h chow 
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intake outlined above persisted when intake was adjusted to individual body weight (see 
Supplementary table 4.1).  
Regardless of body weight adjustment, daily caloric intake did not differ between groups. 
In parallel with the total daily caloric intake results of Experiment 1a, there were no group 
differences in weight gain during drug exposure. In Experiment 1b, however, THC and COM 
rats gained less weight than did CTL and EtOH rats [F(3,36) = 7.84, p < 0.0004; post hoc, all p 
< 0.02; Fig. 4.8C]. 
In Experiment 1a, prior drug exposure did not significantly affect average caloric intake 
during the week of abstinence, though COM rats consumed fewer calories per body weight 
compared with the CTLs [F(3,34) = 3.27, p < 0.04; post hoc, p < 0.05]. During this period, 
COM rats gained less weight than did EtOH rats and tended to weigh less than THC rats [F(3,34) 
= 4.30, p < 0.02; post hoc, p < 0.02 and = 0.057, respectively; Fig. 4.3E]. 
During the 2-week abstinent period in Experiment 1b, THC rats consumed fewer daily 
calories than did CTL and EtOH rats [F(3,36) = 6.87, p < 0.0009; post hoc, both p < 0.02], but 
analysis of weight-adjusted energy intake revealed no treatment effect. Finally, THC rats gained 
less weight than EtOH rats did during abstinence [F(3,36) = 3.32, p < 0.04; post hoc, p < 0.02; 
Fig. 4.8D]. 
 
Subcutaneous THC reduced sucrose intake during abstinence 
Abstinence from chronic subcutaneous THC and voluntary alcohol drinking had no effect on 
sucrose preference as all the groups preferred 1% sucrose solution to plain water during the 48-h 
sucrose preference tests. In Experiment 1a, subcutaneous THC, but not moderate alcohol 
drinking, reduced sucrose consumption in the THC and COM groups compared with the CTL 
group [F(3,33) = 4.46, p < 0.01; post hoc, p = 0.058 and < 0.05, respectively; Fig. 4.4A]. THC 
and COM groups consumed less total fluid compared with the CTL group [F(3,33) = 4.25, p < 
0.02; post hoc, p = 0.086 and < 0.04, respectively]. These effects persisted with body weight-
adjusted analyses.   
In the first sucrose preference test of Experiment 1b (P47–P48), THC rats consumed less 
sucrose and total fluid than did the CTL and EtOH rats [sucrose: F(3,36) = 8.37, p < 0.0003; 
post hoc, p < 0.02 and 0.0004, respectively; total fluid: F(3,36) = 10.21, p < 0.0001; post hoc, p 
< 0.02 and 0.0002, respectively; Fig. 4.9A]. In the second sucrose preference test (P54–P55), 
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THC rats also consumed less sucrose and total fluid compared with the CTL and EtOH groups 
[sucrose: F(3,36) = 5.37, p < 0.004; post hoc, p < 0.04 and 0.004, respectively; total fluid: 
F(3,36) = 5.18, p < 0.005; post hoc, p < 0.05 and 0.004, respectively; Fig. 4.9B]. All the 
significant main findings outlined above held true for body weight-adjusted sucrose and total 
fluid intakes. 
 
Subcutaneous THC, moderate alcohol, and their combination had no effect on Barnes maze 
performance 
In Experiments 1a and 1b, escape latency decreased equivalently in all groups across learning 
sessions [Experiment 1a, F(7,238) = 135.11 and Experiment 1b, F(7,252) = 148.10; both p < 
0.0001; Fig. 4.5 and 4.10A, respectively]. There were no group differences in this parameter 
during spatial memory tests, and all groups displayed equal facility in locating the new escape 
chambers during behavioral flexibility sessions. In Experiment 1b, all groups of rat travelled 
progressively reduced distance across learning sessions [F(7,245) = 90.36, p < 0.0001; Fig. 
4.10B]. There were no enduring effects of treatment on spatial memory and behavioral 
flexibility. 
 
Combined subcutaneous THC and moderate alcohol consumption differently altered glucose 
tolerance 
The 16 days of subcutaneous THC and moderate alcohol treatment did not alter fasting blood 
glucose levels (Fig. 4.6A). All the groups of rats comparably cleared blood glucose across time 
during the OGTT [time effect, F(4,136) = 94.95, p < 0.0001; Fig. 4.6B]. The fasting plasma 
insulin concentration of the COM group was mildly lower than that of the THC group [group 
effect, F(3,27) = 3.00, p < 0.05; post hoc, p = 0.051; Fig. 4.6C]. Rats in each group had a 
slightly different profile of plasma insulin concentration during the 2-h following the intragastric 
2.0 g/kg glucose load [group, time, and group × time effects: F(3,27) = 2.58, p = 0.075, F(4,108) 
= 73.90, p < 0.0001, and F(12,108) = 2.01 , p < 0.03, respectively]. At the 15-min time point, 
plasma insulin level of the COM group was lower than that of both the EtOH (post hoc, p < 
0.009) and THC (p = 0.068) groups. Finally, the COM group demonstrated a trend for an overall 
reduced insulin response compared with the CTLs [insulin AUC: group effect, F(3,27) = 2.45, p 
= 0.085; post hoc, p = 0.087; Fig. 4.6D]. In support of our a priori hypothesis that drug 
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combination will elicit unique effects, independent samples t-test revealed that the area under the 
insulin curve of the COM group was significantly lower than that of the CTLs [t(15) = 2.19, p < 
0.05]. 
 
Subcutaneous THC, moderate alcohol, and their combination had no effect on brain CB1R 
expression and basal GSK-3β activity 
Animals in Experiment 1a were sacrificed nine days after the last drug treatment. Western blot 
analysis of the brain revealed no effect of 16-day separate or combined THC and alcohol 
exposure on CB1R protein expression in the medial prefrontal cortex (mPFC), mediobasal 
hypothalamus (MBH), and hippocampus (HIP) [main effects: F(3,34) = 0.33, 1.38, and 0.41, 
respectively; all p > 0.05; Fig. 4.7]. In the MBH, a priori t-test revealed that the COM group had 
lower CB1R protein expression compared with the CTL group [t(18) = 2.40, p < 0.03]. 
 In Experiment 1b, animals were sacrificed 4–5 weeks after the last day of drug treatment. 
There were nonsignificant changes to CB1R expression and GSK-3β activity in the three brain 
regions we analyzed (Fig. 4.11A and 4.11B). However, in the mPFC, a priori t-test revealed that 
the EtOH group had higher GSK-3β activity (or lower pGSK-3β to tGSK-3β ratio) compared 
with the CTL group [t(10) = 3.13, p < 0.02]; while in the MBH, a priori t-test revealed that the 
THC group had lower GSK-3β activity compared with the CTL group [t(10) = -2.80, p < 0.02]. 
 
Experiment 2: Chronic moderate alcohol drinking and oral THC consumption, alone or in 
combination 
Individual differences in voluntary THC consumption 
Simultaneous cookie and test fluid exposure (paradigm 1): during the 16-day treatment period, 
all CTL and EtOH rats that received oil cookie consumed it within 1 h. Six of the eight THC rats 
and five of the eight COM rats that received cookie overlaid with 3 mg/kg, 5 mg/kg, and the first 
10 mg/kg THC consumed it within 3 h. One THC and three COM rats utterly avoided the 10 
mg/kg THC cookie.  
 
Cookie exposure following test fluid access (paradigm 2 and Experiment 2b): when this schedule 
of drug exposure was implemented during the last five days of Experiment 2a (Fig. 4.2A), three 
THC and four COM rats sporadically had bits of leftover THC-laden cookies. Thus, we 
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separated both groups into cookie consumers (THC_C, n = 5; COM_C, n = 4) and cookie 
avoiders (THC_A, n = 3; COM_A, n = 4). The “cookie avoiders” were rats with left-over 
cookies on two or more days. Throughout Experiment 2b (Fig. 4.2B), except for three COM rats 
that intermittently had bits of leftover cookies, all rats that received THC cookie consumed it 
before the next cookie was provided.  
 
Oral THC dose-dependently reduced alcohol intake when alcohol was simultaneously consumed 
with THC-laden cookie 
In Experiments 2a and 2b, THC and CTL rats increased their saccharin intake across treatment 
days [F(2,24) = 9.52 and F(3,48) = 42.51, respectively; both p < 0.001]. Weight-adjusted 
analyses of saccharin intake revealed no significant group differences, but THC rats tended to 
consume less saccharin in Experiment 2a [F(1,12) = 3.60, p = 0.08]. The effect of oral THC on 
alcohol consumption depended on the temporal order of their consumption. Under paradigm 1 of 
Experiment 2a when sweetened 10% alcohol solution and THC-laden cookies of increasing 
doses were simultaneously available, COM_C rats progressively reduced their alcohol 
consumption compared with the EtOH rats [group and group × time, F(1,11) = 8.33 and F(2,22) 
= 5.37, p < 0.02, respectively; both p < 0.02; Fig. 4.12A]. Throughout paradigm 2 of 
Experiment 2a when rats consumed sweetened 5% alcohol solution before THC-laden cookies, 
both COM_C and COM_A rats continued to consume less alcohol compared with the EtOH rats 
[F(2,103 = 8.00, p < 0.006; Fig 4.12C]. Although EtOH rats appeared to reduce their alcohol 
intake when the concentration of alcohol solution was reduced from 10% (cookie simultaneously 
available) to 5% (cookie not simultaneously available), the COM rats still consumed 
significantly less alcohol. When alcohol was presented prior to THC-laden cookies of increasing 
doses in Experiment 2b, the EtOH and COM rats consumed similar alcohol doses i.e., intake was 
not THC dose-dependent (Fig. 4.13A).  
Tail blood was sampled during drug exposure in Experiment 2b to ascertain how oral 
THC consumption would affect BEC kinetics. EtOH (1.53 ± 0.15 g/kg) and COM (1.24 ± 0.10 
g/kg) rats consumed similar alcohol doses within 1 h following 8 mg/kg/day THC consumption. 
BECs attained by the EtOH and COM groups were 24.8 ± 8.2 mg/dl and 25.4 ± 11.6 mg/dl, 
respectively. The BECs significantly correlated with the consumed dose only in the EtOH group 
(Fig. 4.13B). After 3 h of alcohol access following 10 mg/kg/day THC consumption, EtOH (1.64 
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± 0.18 g/kg) and COM (1.36 ± 0.18 g/kg) rats consumed comparable alcohol doses and BECs 
were barely-detectable (< 1.0 mg/dl) at this time point. 
 
Oral THC, moderate alcohol, and their interaction reduced short-term chow intake 
The temporal order of THC and alcohol consumption differently affected 3-h chow intake. In 
paradigm 1 of Experiment 2a, the EtOH group consumed less 3-h chow compared with the CTL 
and THC groups [F(3,23) = 8.93, p < 0.0005; post hoc, both p < 0.004; Fig. 4.12B]. But in 
paradigm 2, EtOH, THC, and COM groups consumed less 3-h chow relative to the CTLs 
[F(5,26) = 9.72, p < 0.0001; post hoc, all p < 0.008; Fig. 4.12D]. In Experiment 2b, although 
THC-laden cookies were not available during the last 3 h of the dark cycle, COM and EtOH rats 
consumed less 3-h chow compared with the CTLs [F(3,29) = 3.64, p < 0.03; post hoc, p < 0.03 
and = 0.086, respectively; Fig. 4.13C]. However, this treatment effect was only marginal (p = 
0.089) with body weight-adjusted analyses (see Supplementary table 4.1).  
In Experiment 2a, daily caloric intake and weight gain were unaffected during drug 
exposure and the 2-week abstinent period. In Experiment 2b, THC rats consumed fewer daily 
calories compared with the CTLs [F(3,29) = 3.71, p < 0.03; post hoc, p < 0.03], but this effect 
became insignificant when the intake data were adjusted by body weight. However, the THC rats 
gained less weight compared with the CTLs [F(3,29) = 3.77, p < 0.03; post hoc, p < 0.02; Fig. 
4.13D]. Such group difference in weight gain did not persist into the third week of abstinence. 
 
Oral THC, moderate alcohol, and their combination had no effect on sucrose intake during 
abstinence 
In Experiment 2a, abstinence from oral THC and voluntary alcohol drinking had no effect on 
sucrose preference as all the groups preferred 1% sucrose solution to tap water during the 48-h 
(P47–P48) and 72-h (P54–P56) preference tests. There were no group differences in sucrose and 
total fluid intakes. Experiment 2b showed identical findings (Fig. 4.14A and 4.14B). 
 
Oral THC, moderate alcohol, and their combination had no effect on Barnes maze performance 
In Experiment 2a, escape latency and distance travelled decreased across learning sessions 
[latency, (F(7,175) = 65.62 and distance travelled, F(7,140) = 57.23; both p < 0.0001]. There 
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were no enduring effects of treatment on spatial memory and behavioral flexibility 
(Supplementary Fig. 4.1). 
 
THC, alcohol, or their combination did not alter age of puberty onset 
Pre-pubertal drug treatment had no effect on the age of puberty onset in Experiments 1 and 2. 
The average age of puberty onset was 37 days (P34–P41 among rats in all four groups) in 
Experiment 1, and 38 days (P33–P42) in Experiment 2. 
 
Subcutaneous and oral THC resulted in significant plasma cannabinoid levels 
Significant plasma levels of THC and THC-COOH were detected 14 h after injection of 10 
mg/kg (Experiment 1b) or access to a 5 mg/kg THC-laced cookie (Experiment 2b) in both THC 
and COM rats (Table 4.2). However, significant levels of 11-OH-THC were detected only in rats 
that received THC injection. Finally, 11-OH-THC levels were significantly lower in the COM 




The present study is the first to examine the effects of adolescent alcohol and THC exposure, 
alone or when combined, on ingestion, cognition, glucose homeostasis, and brain CB1R and 
GSK-3β   protein expressions in male rats. It revealed that the effects of co-exposure to the two 
drugs on ingestive behaviors depend on the route of THC administration. Consistent with our 
hypothesis, moderate alcohol suppressed acute chow intake and subcutaneous THC dose-
dependently induced acute hyperphagia without affecting alcohol intake. By contrast, oral THC 
can alleviate the hypophagic effect of moderate alcohol, but doses higher than 5 mg/kg blunted 
alcohol intake. These drug administrations did not significantly change total daily caloric intake. 
However, higher cumulative doses of subcutaneous and oral THC suppressed weight gain. 
Inconsistent with our hypothesis, co-exposure to alcohol and subcutaneous or oral THC did not 
impair spatial learning and memory in a Barnes maze. Also inconsistent was our observation that 
16 days of alcohol and subcutaneous THC co-exposure mildly improved glucose homeostasis 
without altering CB1R protein expression and basal GSK-3β activity in the cortex, hippocampus, 
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and mediobasal hypothalamus. Finally, chronic subcutaneous but not oral THC reduced intake of 
1% sucrose solution during abstinence, with no significant interaction with alcohol.  
 
Caloric intake and body weight 
The route and schedule of THC administration dictated its dose-dependent effects on caloric 
intake in rats. Results of Experiment 1 indicate that rats compensated for the immediate 
hyperphagic effect of THC by reducing chow intake during the subsequent period of the day. 
The acute hyperphagic effects of subcutaneous THC injection concur with early studies with low 
dose (< 1 mg/kg) intraperitoneal THC injection in rats (Jarbe and DiPatrizio 2005). Other studies 
with THC doses > 1 mg/kg, however, reported no change or reduced food intake immediately 
following intraperitoneal THC injection (Drewnowski and Grinker 1978; Graceffo and Robinson 
1998). Thus, compared with intraperitoneal injection, higher doses (> 5 mg/kg) of subcutaneous 
THC are required to produce immediate increase in appetite. 
Previous studies have shown that oral gavage of THC increases short-term (within 2 h) 
food intake at a dose as low as 0.50 mg/kg in adult rats (Farrimond et al. 2010; Williams et al. 
1998). By contrast, in Experiment 2a, voluntary oral THC consumption did not produce 
immediate (3-h) hyperphagia. The progressive increase in food intake during adolescence may 
mask the moderate hyperphagic effects of oral THC that may appear given a larger sample size. 
Furthermore, the use of calorie-rich cookie (approximately 4 kcal/cookie) to deliver THC might 
have precluded a hyperphagic response by making the rats consume less chow. But it is unlikely 
that the calorie from cookie masked the hyperphagic effect of THC because the rats could 
consume greater than 20 kcal as shown in Experiment 1 or greater than half of their daily energy 
intake within 15 min when they are hyperphagic (Liang et al. 2013). Alternatively, the decrease 
in 3-h chow intake observed in the THC-exposed groups in Experiment 2a (paradigm 2) and 2b 
is possibly a compensatory response to the acute effects of the previous oral THC dose since 
daily total caloric intake was unaltered. 
The divergent effects of subcutaneous versus oral THC on caloric intake may relate to the 
bioavailability and pharmacokinetic profiles of THC. Compared with injected or inhaled THC, 
orally-consumed THC peaks slowly in plasma (Grotenhermen 2003; Manwell et al. 2014a). The 
lipophilic nature of THC permits its easy permeation across the blood brain barrier. Thus, the 
timeline of plasma THC and its major active metabolite (11-OH-THC) reflects changes to brain 
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levels (Tseng et al. 2004; Wiley and Burston 2014) where they act on select brain regions that 
regulate appetite and motivation (Di Marzo and Matias 2005; Gallate et al. 1999; Kirkham et al. 
2002; Williams and Kirkham 2002a). THC can either stimulate or suppress appetite depending 
on the relative proportion of presynaptic glutamatergic or GABAergic terminals on which it acts, 
and the ensuing effects on hormone signaling (Bellocchio et al. 2010; Gatta-Cherifi and Cota 
2015; Mazier et al. 2015). Moreover, cannabinoid activity in mitochondria and glia, hepatocytes, 
adipocytes, myocytes, and other tissue types are involved in energy balance regulation as 
reviewed in (Gatta-Cherifi and Cota 2015) and (Patel and Cone 2015). Paradoxically, low-
concentration THC can antagonize the canonical synaptic effects of the endocannabinoid – 2-
arachidonyl glycerol (2-AG), and of the full agonist – WIN 55,212-2 (Kelley and Thayer 2004) 
especially in brain areas containing lower CB1R density with varying coupling efficiencies 
(Pertwee 2008). The effects of THC on food intake in rodents are complex and can be dictated 
by an array of biological and methodological factors. Compared with existing involuntary 
alcohol and cannabinoid co-administration models (Khatri et al. 2018; Swartzwelder et al. 2012), 
our novel voluntary alcohol and THC co-use model will be useful for studies aimed to explore 
the underlying biological mechanisms that mediate the effects of oral drug consumption. As an 
added advantage, our model can be adapted to examine the dose-dependent effects of alcohol 
and THC co-use on behavior and energy balance. 
Rats exposed to alcohol alone adequately regulated their caloric intake, and alcohol 
interacted differently with subcutaneous and oral THC to modify caloric intake. In Experiments 
1 and 2, EtOH rats reduced their chow intake during the 3-h alcohol access period to compensate 
for the calories from alcohol. That is, chow intake during the other period of the day did not 
differ between EtOH rats and the controls. These results are consistent with others and our 
previous reports (Cornier et al. 2002; Nelson et al. 2016; Nelson et al. 2017). Furthermore, 
subcutaneous THC minimized the immediate hypophagic effect of alcohol in the COM group 
(Fig. 4.3D and 4.8B). Eating of < 5 mg/kg THC-laced cookie also reversed the hypophagic effect 
of alcohol (Fig. 4.12B). But when the oral THC dose reached 10 mg/kg, alcohol intake was 
robustly reduced (Fig. 4.12A) and some rats stopped consuming the THC-laced cookie. 
Individual differences in voluntary THC consumption has been observed among humans where 
some experience euphoria and others experience dysphoria or paranoia upon initial 
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experimentation with cannabis (Earleywine 2002). Future studies should explore individual 
differences in alcohol and THC co-use in-depth.  
The unique effects of combined alcohol and THC reported in this study might relate to 
some pharmacokinetic interactions between both drugs. Exposure to THC after alcohol 
consumption can modestly increase circulating levels of THC and 11-OH-THC (Hartman et al. 
2015a; Lukas and Orozco 2001). Concurrent alcohol consumption also increases and prolongs 
the pleasurable effects of smoking or inhaling vaporized cannabis (Hartman et al. 2016; Lukas 
and Orozco 2001). Our study shows that moderate alcohol consumption had insignificant effect 
on plasma levels of THC and THC-COOH in rats that received THC subcutaneously or orally. 
This observation concurs with prior studies that documented no significant effect of alcohol on 
blood or salivary THC concentrations, as well as on the subjective effects of smoked cannabis 
due to wide individual variations in these variables (Hartman et al. 2015b; Perez-Reyes et al. 
1988). Interestingly, whereas 11-OH-THC was undetected 14 h following oral consumption of 5 
mg/kg THC (via cookie), 11-OH-THC was significantly lower in alcohol-consuming rats 
injected with 10 mg/kg THC (Table 4.2). Future studies should elucidate the mechanisms by 
which moderate alcohol drinking alters metabolism of THC administered via different routes.  
 Subcutaneous and oral THC modestly influenced body weight. The high cumulative THC 
dose administered in Experiments 1b and 2b (152 and 108 mg/kg, respectively), compared with 
Experiments 1a and 2a (84 and 73.5 mg/kg, respectively), was associated with suppressed weight 
gain. Our results, in conjunction with findings from other groups (Drewnowski and Grinker 
1978; Keeley et al. 2015b; Rubino et al. 2008), suggest that the effects of THC on weight gain 
may have more to do with the cumulative dose and frequency of daily administrations than with 
the route of administration. Intriguingly, whereas moderate alcohol drinking alone did not 
influence body weight, it interacted differently with subcutaneous versus oral THC to affect 
weight gain as observed in the results of the COM groups. In Experiment 1a, the COM group 
had the lowest weight gain during abstinence (Fig. 4.3E). When the THC dose increased in 
Experiment 1b, similar daily moderate alcohol drinking mildly alleviated the enduring 
suppressed weight gain associated with injected THC (Fig. 4.8D). Moderate alcohol drinking 
also modestly alleviated the suppressed weight gain caused by voluntary THC consumption 
during treatment in Experiment 2b (Fig. 4.13D).  
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Saccharin and alcohol intake and BEC 
The results that THC administered subcutaneously or orally could reduce saccharin intake 
contradict previous reports that systemic or central administration of endocannabinoid or THC 
increases intake and palatability of sweet solutions (Gallate et al. 1999; O'Brien et al. 2013; 
Shinohara et al. 2009). Likewise, that oral THC can robustly reduce alcohol intake contrasts with 
previous findings where systemic injection of CB1R agonists increases voluntary ethanol 
drinking (Colombo et al. 2002; Linsenbardt and Boehm 2009). These intake suppression effects, 
however, are in line with the notion that THC can be aversive for rodents. Intraperitoneal 
injection of THC can support conditioned taste as well as place aversion in both rats and mice 
(Han et al. 2017; Manwell et al. 2014b; Wakeford and Riley 2014). Although the procedures in 
our experiments were not specifically designed to examine the aversive property of THC, the 
results of alcohol intake support that rats are more tolerant to the aversive effects of 
subcutaneous than of oral THC. Conversely, alcohol may enhance the aversive effects of THC 
because more COM than THC rats stopped eating THC-laced cookies in Experiments 2a (4 vs. 3 
rats) and 2b (3 vs. 0 rats). This phenomenon, colloquially termed being “crossfaded”, can 
manifest in individuals who simultaneously use alcohol and cannabis to achieve an enhanced 
high (Patrick et al. 2018). It may result from high-potency or -dose THC interacting with alcohol 
to reverse the rewarding effects or to potentiate the aversive effects of their combined use. The 
dose-dependent effect of oral THC in reducing alcohol intake suggests that the phenomenon is 
not likely due to cookie availability. Additionally, the unchanged alcohol intake following 
subcutaneous 20 mg/kg/day THC administration that resulted in higher plasma levels of THC 
and its active metabolite than oral 10 mg/kg/day THC did suggests that the sedative effect of 
THC played a minor role in the robust alcohol intake reduction following oral THC 
administration.   
We found no significant differences in BEC between the EtOH and COM groups. This 
finding is in line with the observation that smoking THC has no effect on BEC in humans (Chait 
and Perry 1994; Downey et al. 2013; Perez-Reyes et al. 1988). Yet, our results was unexpected 
considering evidence showing that alcohol dehydrogenase also metabolizes THC (Wall et al. 
1983), and that THC inhibits alcohol metabolizing enzymes (Marselos et al. 1991). Thus, we 
expected BEC to be elevated in the COM group compared with the EtOH group, as has been 
observed in humans (Chesher et al. 1976). A previous study, however, demonstrated that 
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smoking cannabis can attenuate BEC and the psychoactive effects of alcohol in humans (Lukas 
et al. 1992). Overall, these results indicate that the unique effects of alcohol and THC co-use on 
the pharmacokinetics of each drug and on behavioral processes is an important avenue for further 
research. 
       
Sucrose preference 
As we previously observed (Nelson et al. 2017), abstinence from chronic moderate alcohol 
consumption did not elicit behavioral anhedonia measured by sucrose preference (Kang et al. 
2016). Here we did not observe an effect on sucrose preference following abstinence from 
chronic THC, alone or when combined with moderate alcohol intake. Our findings are consistent 
with the report that chronic combined moderate alcohol consumption and marijuana smoking had 
no influence on mood in humans (Chait and Perry 1994). We also found that rats previously 
exposed to subcutaneous, but not oral, THC consumed less sucrose during abstinence compared 
with controls. Such behavioral manifestation may resemble an endophenotype of 
psychophathology and a sequela of drug abstinence (e.g., avolition) (Renard et al. 2014; Renard 
et al. 2017). However, other factors such as changes in taste detection and perception could have 
contributed to the reduced sucrose intake. This is the first study to demonstrate changes in 
sucrose intake during abstinence from THC and its combined use with alcohol. The differential 
effects of subcutaneous and oral THC and their interaction with moderate alcohol to affect 
sucrose intake during abstinence warrant further investigation.  
 
Learning, memory, and behavioral flexibility  
Cognitive dysfunction is a predisposing factor for drug use disorder, and it contributes to poor 
addiction treatment outcomes (Spear 2018). Our study is the first to investigate the combined 
effects of chronic THC and moderate alcohol exposure on cognitive functions assessed in the 
Barnes maze during adolescence. Surprisingly, exposure to neither drugs impaired spatial 
learning, memory, and behavioral flexibility (Fig. 4.5 and 4.10). Several factors may explain our 
inability to detect behavioral impairments in the rats, including the ease of the Barnes maze tasks 
we employed and the fact that THC is a partial CB1R agonist. Congruent with both points, 
cognitive deficits have been observed when 1) sensitive behavioral tasks like novel object 
recognition (Murphy et al. 2017; O'Shea et al. 2004; Swartzwelder et al. 2012), eight-arm radial 
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maze (Rubino et al. 2009), Morris water maze (Cha et al. 2007; Tomas-Roig et al. 2017), and 
fear conditioning (Tomas-Roig et al. 2017) are employed, and 2) more potent CB1R agonist like 
WIN 55,212-2 and CP 55,940 are used (O'Shea et al. 2004; Tomas-Roig et al. 2017). Finally, the 
coincident peak blood THC and alcohol concentrations attained in this study might have been 
subthreshold to that required to uncover interactive effects between THC and moderate alcohol 
(Ramaekers et al. 2006).  
 
Glucose homeostasis 
The OGTT performed on the ninth day following the last drug exposure revealed modest 
changes to systemic glucose tolerance. The plasma insulin content of the COM group was lower 
than that of the CTL group at the 15-min time point following an oral glucose load. The plasma 
insulin AUC showed that, compared with the CTLs, rats co-exposed to alcohol and THC for 16 
days required slightly lower plasma insulin for proper glucose clearance. Ours is the first 
preclinical animal study to document mild beneficial effects of moderate alcohol and THC co-
use on glucose homeostasis in adolescent male rats. Our finding corroborates the observation of 
null or favorable effects of moderate alcohol or THC use on glucose homeostasis in humans and 
rodents (Baliunas et al. 2009; Furuya et al. 2003; Penner et al. 2013; Permutt et al. 1976; 
Pietraszek et al. 2010; Steiner et al. 2015). To my knowledge, there exist no clinical or 
epidemiological research that has systematically investigated the metabolic effects of joint 
alcohol and marijuana use. The published epidemiological studies that investigated the metabolic 
effects of alcohol or marijuana use often statistically controlled for use of other drugs or screened 
for and excluded participants with a history of poly-substance use. Further study of the effects of 
alcohol and marijuana co-use on glucose homeostasis is warranted, as is investigations of the 
cellular mechanisms that mediate the outcomes.  
 
Neurobiological changes 
Studies have shown that adolescent alcohol or cannabinoid use can alter the developmental of 
diverse brain systems, and some of the changes can persist into adulthood (Crews et al. 2007; 
Ellgren et al. 2008; Gulley and Juraska 2013; Philpot et al. 2009; Spear 2016). CB1R, an 
essential component of the endocannabinoid system, is the most widely expressed metabotropic 
receptor in the mammalian brain and plays an essential role in adolescent brain development and 
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functioning (Fernandez-Ruiz et al. 2000; Long et al. 2012). The kinase GSK-3β is an important 
player in the signaling cascades stimulated by diverse ligands in the brain (Sutherland 2011). 
Phosphorylation of GSK-3β at the N-terminal serine 9 residue disrupts its interaction with 
diverse cellular substrates (Beurel et al. 2015; Sutherland 2011). Thus, the ratio of 
phosphorylated to total GSK-3β protein expression serves as a proxy of its enzymatic activity. 
Reduced enzyme activity (via higher pGSK-3β to tGSK-3β ratio) correlates with many beneficial 
neurobiological and metabolic effects.  
In Experiments 1a and 1b, we assayed how separate or combined alcohol and THC 
exposure would alter CB1R and GSK-3β expression and activity in brain regions essential for 
regulating executive function (mPFC), energy balance (MBH), and memory (HIP). When 
measured 1–5 weeks after drug exposure, we did not detect significant changes in the expression 
of both proteins. Our inability to detect significant changes in CB1R expression can be explained 
by its dynamic homeostatic regulation in the brain, but it does not preclude the fact that the 
receptors could have been desensitized by the repeated exposure to THC during adolescence 
(Farquhar et al. 2019; Rubino et al. 2008). Desensitized receptors sub-optimally respond to 
stimulation by ligands. Importantly, a previous study observed nonsignificant changes to CB1R 
protein by western blot when measured five weeks after chronic THC exposure in adolescent 
male mice (Kasten et al. 2017). Another study observed nonsignificant changes in CB1R 
expression in the hippocampus and frontal cortex of rats measured two weeks after chronic 
intermittent alcohol consumption (Marco et al. 2017). In vivo PET imaging studies have also 
generated inconsistent findings regarding the effects of alcohol on CB1R dynamics. Human and 
rat PET studies have observed increases and decreases in CB1R availability in several brain 
regions after acute and chronic alcohol administration, respectively (Ceccarini et al. 2013; 
Ceccarini et al. 2014). Further, the nonsignificant changes to basal GSK-3β activity in the brains 
of drug-abstinent rats could reflect compensation by the diverse signaling pathways reliant on the 
enzyme. Our a priori pairwise comparisons revealed opposite changes in GSK-3β activity in the 
mPFC and MBH. The implications of the modestly increased GSK-3β activity in the mPFC of 
EtOH rats relative to CTLs, and the modestly reduced GSK-3β activity in the MBH of THC rats 
relative to CTLs (Fig. 4.11B) are unclear in this preliminary study. The fact that rats in our study 
consumed moderate doses of alcohol, were administered relatively moderate doses of THC, and 
were abstinent for several weeks before their brains were harvested could explain the null or 
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modest results. Perhaps, the evolutionary importance of GSK-3β activity makes it resilient when 
perturbed by minor environmental insults. Other researchers have observed that moderate to high 
doses of alcohol acutely inhibits GSK-3β activity in rodent medial prefrontal cortex and nucleus 
accumbens (Neasta et al. 2011; Neznanova et al. 2009; van der Vaart et al. 2018).  
 
Puberty timing 
Prior studies found that prepubertal alcohol and cannabinoid exposure can alter puberty onset 
and estrous cycling in female rats (Dees and Skelley 1990; Marusich et al. 2014; Wenger et al. 
1988). No much is known about the separate or combined effects of alcohol and THC exposure 
on puberty onset in male rats. Using preputial separation as a marker for puberty onset 
(Korenbrot et al. 1977), we found that THC and alcohol, alone or when combined, had no effect 
on puberty onset relative to controls. The male rats in this study, however, attained puberty at 
around P38, which is a few days earlier than what the literature suggests (P40–P48) (Juraska and 
Willing 2017).  
Because our animals were received from the vendor around weaning (P22–P25), the 
hastened puberty onset may be the outcome of early life stresses (maternal/sibling separation and 
environmental changes associated with shipping or transportation) or interactions between early-
life stresses and the injection exposure. The stress of the injection procedure in Experiment 1 
might have masked any THC-specific effect on preputial separation. The enduring effects of 
injection procedure have been suspected to account for neuroanatomical and behavioral 
differences in adult rats that were injected during adolescence (Keeley et al. 2015a). 
Notwithstanding, the early age of puberty onset we observed may not be attributable to 
subcutaneous injection experience since rats not injected also attained puberty early (Experiment 
2). Moreover, a previous study observed no effect of injection procedure on puberty onset in 
male Long-Evan rats (Kang et al. 2016).  
 
Conclusion 
Co-use of alcohol and cannabis is in vogue despite the lack of empirical data on how it affects 
brain and behavior. In establishing novel rodent models of alcohol and THC co-use, we found 
that injected or orally administered THC can dose-dependently interact with alcohol to 
differently influence feeding behaviors and glucose homeostasis. Importantly, our established 
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method of voluntary THC and alcohol ingestion is an improvement over the existing involuntary 
alcohol and cannabinoid co-administration models (Ciccocioppo et al. 2002; Khatri et al. 2018; 
Swartzwelder et al. 2012), and approximates the manner of human consumption. Our methods 
can be easily adapted for investigations of the behavioral, metabolic, and neurobiological 
mechanisms of joint alcohol and cannabinoid use in adolescent and adult subjects.     
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Tables and Figures 
Table 4.1: Tabulation of the primary antibodies we used for Western blotting 
Antibody Source and Cat. # Isotype Molecular 
weight (kDa) 
Dilution used 





































Table 4.2: Plasma levels of THC and its major metabolites in Experiments 1b and 2b 
         Route 
Group 
Subcutaneous THC injection Oral THC consumption 
THC 11-OH-THC THC-COOH THC 11-OH-THC THC-COOH 
THC 16.9 (2.89) 5.0 (0.66)* 7.1 (1.02) 1.3 (0.28) nd 1.8 (0.44) 
COM 15.1 (1.29) 2.1 (0.36)* 5.5 (1.79) 8.6 (5.11) nd 3.1 (0.81) 
 
Data are mean (± SEM) concentrations (ng/ml) in each treatment group (n = 5–6). *: 















Figure 4.1: Timeline of chronic subcutaneous THC injection and voluntary alcohol drinking. (A) 
In Experiment 1a (EtOH, n = 8; CTL, THC, and COM, n = 10/group), 3 mg/kg/day THC lasted 
for eight days, while the 5 and 10 mg/kg/day THC each lasted for four days. Sucrose preference 
(SP), Barnes maze (BM), and oral glucose tolerance test (OGTT) were performed as indicated. 
(B) In Experiment 1b (n = 10/group), the four THC doses (3, 5, 10, and 20 mg/kg/day) each 
spanned four days. BM and SP tests were performed as indicated. Spatial learning (BM
L
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Figure 4.2: Timeline of chronic oral THC consumption and voluntary alcohol drinking. 
Treatments indicated in the shaded part of the tables occurred during the last 3 h of the dark 
cycle. (A) Manipulations in Experiment 2a (CTL and EtOH, n = 8/group; THC_C, n = 5; 
THC_A, n = 3; COM_C and COM_A, n = 4) are indicated in the dotted boxes and top table. The 
“A” or “C” following the underscores denote “Avoiders” and “Consumers” of THC-laden 
cookie, respectively. The transition from paradigm 1 to 2 occurred on P40. (B) Manipulations in 
Experiment 2b (CTL, n = 10; EtOH and THC, n = 8/group; COM, n = 7) are indicated in the 







Figure 4.3: Chronic subcutaneous THC and voluntary alcohol consumption, alone or when 
combined, differently affected caloric intake and weight gain (Experiment 1a: EtOH, n = 8; 
CTL, THC, and COM, n = 10/group). (A) EtOH and COM rats consumed similar doses of 
sweetened 10% alcohol. (B) Blood ethanol concentration (BEC) correlated with 1-h alcohol 
intake in the EtOH group (r = 0.90, p < 0.001). (C) BEC correlated with 3-h alcohol intake in 
the EtOH group (r = 0.80, p < 0.04) and with 3-h alcohol intake in the COM group (r = 0.83, p 
< 0.006) after subcutaneous 10 mg/kg THC. (D) THC injection dose-dependently stimulated 3-h 
chow intake. Alcohol consumption reduced 3-h chow intake and blunted the hyperphagic effect 
of THC. THC vs. EtOH and COM: *p < 0.004; CTL vs. EtOH and THC: #p < 0.03. (E) COM 
rats gained the least weight during drug abstinence. COM vs. EtOH: *p < 0.02; COM vs. THC: 






Figure 4.4: Chronic subcutaneous THC alone or when combined with voluntary alcohol 
consumption reduced sucrose and total fluid intake during a 48-h sucrose preference test 
conducted 2–3 days (P47–P48) after drug treatment ended (Experiment 1a: EtOH, n = 8; CTL, 









Figure 4.5: Chronic subcutaneous THC injection and voluntary alcohol consumption, alone or 
when combined, had no effect on cognitive behaviors assessed in the Barnes maze (Experiment 
1a: EtOH, n = 8; CTL, THC, and COM, n = 10/group). There were no group differences in 








Figure 4.6: Chronic subcutaneous THC injection and voluntary alcohol consumption differently 
altered glucose tolerance. The OGTT was conducted nine days following the last drug exposure 
in Experiment 1a (CTL, n = 9; EtOH and THC, n = 7; COM, n = 8). (A and B) alcohol and THC 
alone or in combination had no effect on glucose clearance. (C) Combined chronic alcohol and 
THC exposure was associated with reduced plasma insulin content at 15 min following the oral 
glucose load. COM vs. EtOH: *p < 0.009; COM vs. THC: ^p = 0.068 and @p = 0.051. (D) The 
COM group had a moderately reduced AUC of the insulin curve compared with the CTLs. CTL 





Figure 4.7: Chronic subcutaneous THC injection and voluntary alcohol consumption, alone or 
when combined, had negligible effect on CB1R protein expression in the medial prefrontal cortex 
(mPFC), mediobasal hypothalamus (MBH), and hippocampus (HIP) of the male rats 
(Experiment 1a: EtOH, n = 8; CTL, THC, and COM, n = 10/group). In the MBH, the COM 
group had reduced CB1R protein expression compared with the CTLs: ^p = 0.028 by t-test. Rats 
were sacrificed nine days after the last drug treatment. Representative CB1R (60 kDa) and 













Figure 4.8: Chronic subcutaneous THC and voluntary alcohol consumption, alone or when 
combined, differently affected caloric intake and weight gain (Experiment 1b: n = 10/group). (A) 
EtOH and COM rats consumed similar doses of sweetened 10% alcohol solution. (B) THC 
injection dose-dependently increased 3-h chow intake only in the COM relative to the EtOH 
group. Alcohol consumption reduced 3-h chow intake, but THC averted the hypophagic effect of 
alcohol. THC vs. EtOH: *p < 0.05; EtOH vs. COM: @p < 0.05; CTL vs. EtOH: #p < 0.02. (C) 
Subcutaneous THC suppressed weight gain in the THC and COM groups. THC or COM vs. CTL 
or EtOH: *p < 0.02. (D) Reduced weight gain of the THC group persisted during the 2-week 






Figure 4.9: Chronic subcutaneous THC alone or when combined with voluntary alcohol 
consumption reduced sucrose and total fluid intake during sucrose preference tests (Experiment 
1b, n = 10/group). (A) Sucrose and total fluid intake during the first 48-h sucrose preference test 
conducted 2–3 days (P47–P48) after drug treatment ended. THC vs. CTL and EtOH: *p < 0.02; 
COM vs. EtOH: #p < 0.02. (B) Sucrose and total fluid intake during the second 48-h sucrose 
preference test conducted 9–10 days (P54–P55) after drug treatment ended. THC vs. CTL and 












Figure 4.10: Chronic subcutaneous THC injection and voluntary alcohol consumption, alone or 
when combined, had no effect on cognitive behaviors assessed in the Barnes maze (Experiment 
1b, n = 10/group). There were no group differences in the (A) escape latency, and (B) distance 













Figure 4.11: Chronic subcutaneous THC injection and voluntary alcohol consumption, alone or 
when combined, had negligible effect on (A) CB1R protein expression and (B) GSK-3β activity 
in the mPFC, MBH, and HIP of the male rats (Experiment 1b, n = 6/group). Independent 
samples t-tests revealed that GSK-3β activity was greater in the mPFC of EtOH rats compared 
with CTLs: ^p = 0.011, and that GSK-3β activity was lower in the MBH of THC rats compared 
with CTLs: ^p = 0.019. Rats were sacrificed 4–5 weeks after the last drug treatment. 
Representative CB1R (60 kDa), phosphorylated and total GSK-3β (46 kDa), and Vinculin (124 







Figure 4.12: Chronic oral THC consumption reduced alcohol intake, while alcohol alone or 
when combined with oral THC reduced 3-h chow intake (Experiment 2a: CTL and EtOH, n = 
8/group; THC_C, n = 5; THC_A, n = 3; COM_C and COM_A, n = 4). (A) In paradigm 1 (P30–
P39), COM_C rats consumed lower doses of sweetened 10% alcohol solution than did EtOH 
rats: *p < 0.009. COM_C rats also consumed reduced alcohol doses during 5 and 10 mg/kg/day 
THC consumption than they did during 3 mg/kg/day THC consumption: ^p < 0.03. (B) 
Moderate 10% alcohol consumption suppressed 3-h chow intake in EtOH rats. EtOH vs. CTL 
and THC_C: *p < 0.03. (C) When THC or oil cookie was consumed after sweetened 5% alcohol 
access in paradigm 2 (P40–P45), COM_C and COM_A rats continued to consume less alcohol 
than the EtOH rats did. EtOH vs. COM_C and COM_A: *p < 0.05. (D) The EtOH, THC_C, 
COM_C, and COM_A groups consumed significantly lower 3-h chow compared with the CTLs. 
CTL vs. EtOH, THC_C, COM_C, and COM_A: *p < 0.008; THC_A vs. COM_C and COM_A: 





Figure 4.13: Chronic oral THC consumption mildly reduced alcohol intake and suppressed 
caloric intake and weight gain (Experiment 2b: CTL, n = 10; EtOH and THC, n = 8/group; 
COM, n = 7). (A) EtOH and COM rats consumed similar doses of 5% alcohol solution. COM 
rats consumed lower alcohol doses during 6 and 10 mg/kg/day THC consumption than during 3 
mg/kg/day THC consumption: ^p < 0.008. (B) BEC correlated with 1-h alcohol intake in the 
EtOH group (r = 0.89, p < 0.004). (C) Drinking 5% alcohol reduced 3-h chow intake and 
augmented the somewhat hypophagic effect of oral THC. CTL vs. EtOH: p = 0.086; CTL vs. 
COM: *p < 0.03. (D) THC consumption suppressed weight gain in the THC group compared 





Figure 4.14: Chronic oral THC and voluntary alcohol consumption, alone or when combined, 
had no effect on sucrose and total fluid intake during the (A) first and (B) second 48-h sucrose 

















Table: p-values of main group effects from raw and body weight-adjusted data analysis 
Exp. Parameter Main group effect 
Raw data 





24-h calorie (abstinence) 
Sucrose 
Sucrose + Water 
ns (p = 0.27) 
p < 0.0001 
ns (p = 0.94) 
ns (p = 0.07) 
p < 0.01 
p < 0.02 
ns (p = 0.32) 
p < 0.0001 
ns (p = 0.96) 
p < 0.04 
p < 0.03 




24-h calorie (abstinence) 
Sucrose (SP 1) 
Sucrose + Water (SP 1) 
Sucrose (SP 2) 
Sucrose + Water (SP 2) 
p < 0.02 
p < 0.0001 
ns (p = 0.25) 
p < 0.0009 
p < 0.0003 
p < 0.0001 
p < 0.004 
p < 0.005 
p < 0.02 
p < 0.0003 
ns (p = 0.60) 
ns (p = 0.54) 
p < 0.009 
p < 0.004 
p < 0.03 
p < 0.04 
2a Saccharin 
3-h chow (P 1) 
3-h chow (P 2) 
24-h calorie (P 1) 
24-h calorie (P 2) 
24-h calorie (abstinence) 
Sucrose (SP 1) 
Sucrose + Water (SP 1) 
Sucrose (SP 2) 
Sucrose + Water (SP 2) 
p < 0.05 
p < 0.0005 
p < 0.0001 
ns (p = 0.23) 
ns (p = 0.13) 
ns (p = 0.07) 
ns (p = 0.18) 
ns (p = 0.49) 
ns (p = 0.78) 
ns (p = 0.74) 
ns (p = 0.08) 
p < 0.0002 
p < 0.0001 
ns (p = 0.13) 
ns (p = 0.42) 
ns (p = 0.47) 
ns (p = 0.12) 
ns (p = 0.45) 
ns (p = 0.64) 




24-h calorie (abstinence) 
Sucrose (SP 1) 
Sucrose + Water (SP 1) 
Sucrose (SP 2) 
Sucrose + Water (SP 2) 
ns (p = 0.99) 
p < 0.03 
p < 0.03 
ns (p = 0.26) 
ns (p = 0.58) 
ns (p = 0.64) 
ns (p = 0.70) 
ns (p = 0.71) 
ns (p = 0.67) 
ns (p = 0.09) 
ns (p = 0.48) 
ns (p = 0.15) 
ns (p = 0.51) 
ns (p = 0.48) 
ns (p = 0.39) 
ns (p = 0.39) 
 
Supplementary Table 4.1 compares the p-values of main group effects for raw and body 
weight-adjusted saccharin, calorie, and sucrose intake data. Almost all significant findings are 
consistent under both analyses; ns = non-significant (p > 0.05), SP = sucrose preference test, P 





Supplementary Figure 4.1: Chronic oral THC and voluntary alcohol consumption, alone or 
when combined, had no effect on cognitive behaviors assessed in the Barnes maze (Experiment 
2a: n = 8/group). There were no group differences in the (A) escape latency, and (B) distance 














CHAPTER 5: ADOLESCENT MODERATE ALCOHOL AND ∆
9
-
TETRAHYDROCANNABINOL CONSUMPTION: BEHAVIORAL AND METABOLIC 
EFFECTS IN ADULTHOOD 
 
Abstract 
Obesity and the consequent metabolic syndrome are common, serious, and costly. Poor early-life 
environment, including exposures to drugs of abuse and obesogenic diets can predispose an 
individual to metabolic diseases later in life. Repeated alcohol or ∆
9
-tetrahydrocannabinol (THC) 
use during adolescence can alter the maturation and function of brain systems that regulate 
energy balance. Little is known about how combined use of both drugs affects energy balance 
and glucose homeostasis in adolescents and young adults. Here, we investigated how co-use of 
both drugs during adolescence will affect feeding behavior and some metabolic parameters 
during early adulthood. Male Long-Evans rats voluntarily consumed saccharin or alcohol (3-
h/day) before cookie laced with oil or increasing THC doses (1.5–5 mg/kg, twice per day) for 16 
consecutive days during adolescence (P30–P45). Sucrose preference tests were used to measure 
abstinence-induced anhedonia. Following a three-week drug abstinent period, some rats in each 
group began consuming 45% high-fat diet (HFD). An oral glucose tolerance test (OGTT) and an 
intraperitoneal insulin tolerance test (ITT) were performed after four and nine days on the new 
diet regimen, respectively. Animals were sacrificed soon after the ITT for fat and plasma tissue 
harvest. Alcohol-consuming rats consumed fewer chow when alcohol was simultaneously 
available. THC-only-consuming rats ingested less saccharin solution and gained the least weight. 
Drug treatment had no effect on intakes of either 1% sucrose or daily calorie during abstinence. 
HFD-fed rats demonstrated hyperphagia and gained more weight, with no influence of prior drug 
exposure. Rats exposed to HFD for four days during drug abstinence presented with modest 
hyperglycemia and hyperinsulinemia at baseline and during the OGTT compared with those that 
continuously consumed chow. Nine days of HFD consumption resulted in elevated percent 
visceral fat and plasma leptin concentration. Surprisingly, HF diet feeding had no effect on 
insulin sensitivity during the ITT. Prior drug exposure had no effect on all the metabolic 
parameters. In this study, 16 days of moderate alcohol and THC co-use in adolescent rats had 
null effects on glucose homeostasis and insulin sensitivity under both chow and short-term HFD 
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feeding conditions during early adulthood. More studies are needed to clearly define the effects 
of combined alcohol and THC use on metabolic outcomes. 
 
Introduction 
The wide prevalence and burdensome nature of obesity and metabolic syndrome echoes the need 
for more studies to shed light on the predisposing and protective factors at play. Previous studies 
have established that early-life nutritional deficits or surfeits can influence neurological and 
metabolic health throughout the lifespan (Bouret et al. 2015; Paradis et al. 2017), as do active or 
passive exposure to exogenous drugs like alcohol and cannabinoids (Grant et al. 2018; Lopez-
Gallardo et al. 2012; Thompson et al. 2009). Protracted consumption of diets rich in calorie, salt, 
saturated fatty acids, and refined sugars but low in fiber (“Western diet”) coupled with sedentary 
lifestyle are notable contributors to the overweight/obese phenotype (Eckel et al. 2005; Kanoski 
and Davidson 2011; Moody et al. 2015). The allure of fatty and sweetened foods are partly 
responsible for the high incidence of adolescent obesity and type 2 diabetes (ACOG 2017), 
especially because adolescents are susceptible to the negative metabolic effects of Western diets 
(Hsu et al. 2015).  
 Use and co-use of alcohol and marijuana often begin during adolescence (Briere et al. 
2011; Subbaraman and Kerr 2015). This drug use behavior is worrisome considering the 
cornucopia of empirical evidences suggesting that the adolescent brain is susceptible to the 
influence of exogenous compounds (Ernst et al. 2009; Nixon and McClain 2010; Tomas-Roig et 
al. 2017). Notably, alcohol or cannabis use during adolescence can alter the ontogeny of neural 
systems that regulate cognitive and reward-related behaviors (Ellgren et al. 2008; Gulley and 
Juraska 2013; Philpot et al. 2009; Rubino et al. 2015), to provoke aberrant brain functioning later 
in life (Broadwater et al. 2017; Crews et al. 2016; Higuera-Matas et al. 2015; Renard et al. 2014). 
Such neural alterations can translate into increased motivation to consume palatable/energy-
dense diets during adulthood (Carlin et al. 2016; Figlewicz et al. 2013). Adolescents are also 
susceptible to the diabetogenic effects of alcohol (Liang and Chikritzhs 2014). Additionally, 
removal of access to alcohol or cannabis following protracted use can engage the stress system 
(Bruijnzeel and Gold 2005; Zorrilla et al. 2014), which, depending on severity, can in-turn lead 
to overconsumption of calorie-dense diets as a compensatory/coping mechanism (Liang et al. 
2013; Torres and Nowson 2007). Despite the popularity of alcohol and cannabis co-use, there is 
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paucity of studies on how such co-use affects energy balance and metabolic outcomes during 
abstinence. 
Epidemiological data have implicated chronic alcohol use with central adiposity and 
some facets of metabolic syndrome, including leptin resistance, insulin resistance, and type-2 
diabetes (Fernandez-Sola 2015; Pietraszek et al. 2010; World et al. 1985). Other researchers 
conclude that moderate alcohol consumption may either be beneficial to cardio-metabolic health 
or can have null effects [(Baliunas et al. 2009); reviewed in (Nelson et al. 2017)]. Several central 
and peripheral mechanisms can directly mediate the detrimental metabolic effects of alcohol. For 
example, chronic exposure to excessive amounts of alcohol has been found to not only impair 
hepatocyte and pancreatic β-cell functions, but to also alter brain glucose utilization and insulin 
action (Carmiel-Haggai et al. 2003; de la Monte et al. 2012; Lee et al. 2015; Lindtner et al. 
2013). The metabolic effects of marijuana use are also less clear (Penner et al. 2013; Sidney 
2016). Human laboratory studies have documented that marijuana smoking can acutely increase 
plasma insulin concentration – a marker of prediabetes (Podolsky et al. 1971), impair glucose 
tolerance (Hollister and Reaven 1974),  or may have no effect on glucose homeostasis (Permutt 
et al. 1976) in adults subjects. A cross-sectional, case-control study reported that chronic 
marijuana smoking can reduce circulating HDL-cholesterol and increase adipose tissue 
hypertrophy and insulin resistance without significant detriment to pancreatic β-cell function 
(Muniyappa et al. 2013). The negative metabolic effects of cannabinoids are assumed to be 
mediated by the action of THC on cannabinoid sybtype-1 receptor in the brain and peripheral 
tissues (Bermudez-Siva et al. 2006; Jourdan et al. 2016; Liu et al. 2012; Maccarrone et al. 2015; 
Matias and Di Marzo 2007; Nogueiras et al. 2008; Silvestri and Di Marzo 2013). In addition to 
potential methodological limitations, the inconsistent reports on the metabolic effects of 
marijuana in humans may relate to the action of other potent compounds in the plant on diverse 
receptor targets (Maccarrone et al. 2015; Muniyappa et al. 2013). Hence, animal studies are 
needed to understand the metabolic effects of THC.  
In Chapter 3 of this dissertation, we demonstrated that male rats that chronically 
consumed moderate alcohol doses showed early signs of glucose intolerance (Nelson et al. 
2017). In Chapter 4, we further showed that adolescent alcohol and THC co-use altered glucose-
mediated insulin release early during abstinence. The lack of systematic investigation of the 
lasting behavioral and metabolic effects of alcohol and THC co-use prompted the undertaking of 
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this study using an adolescent rodent model of voluntary consumption of the two drugs. Given 
the negative metabolic outcomes of short-term Western diet consumption in young subjects 
(Brons et al. 2009; Kraegen et al. 1991), we sought to investigate whether high-fat diet (HFD) 
exposure would exacerbate the impact of prior alcohol and THC use. Importantly, to our 
knowledge, this will also be the first study on the metabolic effects of THC consumed via an 
edible product. We hypothesized that, compared to separate use of alcohol and THC, their co-use 
during adolescence will lead to lasting alterations in feeding behavior that will prime the subject 
for heightened reactivity to metabolic challenge in adulthood. Hence, we predicted that rats 
previously co-exposed to alcohol and THC will demonstrate hyperphagia and increased adiposity 
when presented with HFD compared with the drug naïve rats. Combined drug co-use and HFD 
overconsumption would greatly impair glucose tolerance and insulin sensitivity during 
adulthood.     
 
Materials and methods 
Animal husbandry 
A total of 100 male Long-Evan rats (Envigo, Indianapolis, IN, USA) that arrived at postnatal day 
22 (P22) were used. They were semi-pair housed in large polyethylene tubs with transparent 
Plexiglas cage dividers that enabled measurement of food and fluid intake for each rat. The 
colony was maintained in a temperature and humidity-controlled vivarium on a 12-h light/dark 
cycle (lights on at 11:30 AM). During habituation and drug exposure, rats had ad libitum access 
to a standard rodent chow (3.1 kcal/g; 58% carbohydrate, 24% protein, and 18% fat from 
soybean oil; 2018 Teklad global rodent diets 2018, Indianapolis, IN, USA). See the 
“Experimental procedures” below for diet manipulation during drug abstinence. Tap water was 
provided in glass bottles fitted with stainless steel sippers. Daily animal handling and care 
occurred at 8:00 AM when body weight, food, and water intakes were recorded. All study 
protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the 
University of Illinois at Urbana-Champaign, and they conformed to the guidelines stipulated in 






Test fluids (saccharin, alcohol) and ∆
9
-tetrahydrocannabinol (THC) 
Saccharin (0.1%) and sweetened 5% ethanol solutions were prepared as previously described 
(Nelson et al. 2019). Test fluids were presented at home cages in 50 ml graduated plastic bottles 
fitted with stainless steel sipper tubes that minimize spillage and evaporation. Bottles were 
weighed (to the nearest 0.1 g) to determine fluid intake. Alcohol and solution from a previous 
drinking session was discarded, and freshly-prepared solutions were presented to the rats daily. 
The contents of 10 mg dronabinol capsules, a commercially-available synthetic THC 
(Actavis Pharm, Inc.; Parsippany, NJ, USA) to be overlain on cookies (Goldfish Grahams Fudge 
Brownie, Pepperidge Farm; Norwalk, CT, USA) was diluted with sesame oil vehicle (Fisher 
Scientific). The 1.5 and 3 mg/kg THC doses were applied onto cookie at a volume of 0.383 
ml/kg body weight; the 5 mg/kg dose was applied at 0.639 ml/kg body weight (Nelson et al. 
2019). Oil vehicle was applied onto cookie isovolumetrically to the different THC doses.  
 
Experimental procedures  
Drug exposure 
Drug training and exposure procedures were performed as we have previously described (Nelson 
et al. 2019). Rats were first habituated to the vivarium for four days. During the initial three 
habituation days, they were pair-housed without cage dividers. Body weight of individual rat and 
food and water intakes of each pair were recorded daily. At 8:00 AM on the fourth habituation 
day, a cage divider was inserted in the center of each cage to enable tracking intakes of 
individual animal. Over the next four days (P26–P29), the animals were entrained to consume 
0.1% saccharin along with chow during the last 3 h of the dark cycle (8:30–11:30 AM). 
Following measurement of chow and saccharin consumption, saccharin bottles were replaced 
with water bottles and the first and second oil-laden cookies were respectively provided at 12:30 
PM and 9:00 PM. At the end of training, rats were assigned to one of four groups by matching 
average body weight and saccharin intake during entrainment: control (CTL, n = 26) given 
saccharin and oil-laden cookie, ethanol (EtOH, n = 24) given 5% ethanol and oil-laden cookie, 
THC (n = 24) given saccharin and THC-laden cookie, and combination (COM, n = 26) given 
5% ethanol and THC-laden cookie. During the 16-day treatment period, rats first had 3-h access 
to saccharin or 5% alcohol solution followed by a cookie laced with oil or THC (1.5, 3, or 5 
mg/kg) presented twice per day at 12:30 PM and 9:00 PM (Fig. 5.1). Each cumulative daily dose 
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of 3, 6, 8, and 10 mg/kg THC lasted for four days. One of the CTL rats, which had a deformed 
incisor that prevented it from consuming solid food, was maintained on wet pulverized chow and 
excluded from further experimentation. During 11:30 AM measurements starting on P32, we 
assessed how drug exposure would affect puberty onset in each rat by checking for preputial 
separation or the complete manual retraction of the prepuce from the glans penis (Korenbrot et 
al. 1977). To ascertain how oral THC would affect blood ethanol concentration (BEC) in these 
rats, tail blood (80 μl) was sampled at 1-h during the second/third day of 8 mg/kg/day THC 
consumption, and at 3-h during the first/second day of 10 mg/kg/day THC consumption. BEC 
was analyzed in those samples as we have previously described (Nelson et al. 2019).  
 
Sucrose preference test 
The first (P47–P48) and second (P54–P55) tests respectively began two and nine days after the 
last drug and test fluid exposure day. On the test days, rats were presented with two bottles, 1% 
sucrose versus tap water, immediately after 8:00 AM measurements. The positions of the bottles 
were alternated on each day to prevent the development of location preference for drinking. 
After the sucrose preference tests, all rats were returned to ad libitum water access. Sucrose 
preference (%) was calculated as 
sucrose consumption (g)
sucrose + water consumption (g)
× 100.  
 
High-fat diet exposure and oral glucose tolerance test (OGTT) 
For the next three weeks after the last drug exposure day (P46–P66), except during the sucrose 
preference tests, rats were maintained on ad libitum access to chow and water. Starting on P67, 
rats in all four groups were subdivided into a chow group that continued consuming regular 
chow diet (CTL and COM, n = 14/group; EtOH and THC, n = 12/group) or a high-fat diet 
(HFD) group whose diet was switched to a 45% high-fat diet (4.73 kcal/g; 45% fat from lard and 
soybean oil, 35% carbohydrate, and 20% protein; D12451, Research Diets, New Brunswick, NJ, 
USA; CTL, n = 11; EtOH, THC, and COM, n = 12/group). On the fourth day on this diet 
regimen (P70), rats were overnight food-restricted such that their intake was 70% of their 
respective intake on P69. OGTT was performed in the middle of the light cycle (between 2:00 
and 7:00 PM) on P71 according to our established protocol (Nelson et al. 2017). Fasting blood 
glucose was measured with an AlphaTRAK2 blood glucose monitoring system (Abbots 
Laboratories) before 80 μl of tail blood was drawn with heparin-coated capillary tubes for fasting 
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plasma insulin determination. Rats received 2.0 g/kg body weight glucose with a 20% glucose 
solution delivered via an oral gavage. Blood glucose was measured, and tail blood was drawn for 
plasma insulin measurement at 15, 30, 60, and 120 min after delivery of the glucose load. Blood 
samples were centrifuged at 1000 × g, 4 °C for 15 min, and the plasma was collected and stored 
at –80 °C for later insulin measurement using a rat enzyme-linked immunosorbent assay 
(ELISA) kit (Cat. # 80-INSTRU-E01, ALPCO, Salem, NH, USA) according to the 
manufacturer's instructions (Nelson et al. 2017).  
 
Insulin tolerance test (ITT) and tissue harvest 
After the OGTT, rats were returned to their home cages to resume ad libitum access to their 
respective new diets for four more days (P71–P74). On the fifth day (P75), they were mildly 
food-restricted to 90% of their average free-feeding intakes on previous two consecutive days 
(P72 and P73) following the OGTT. Between 2:00 and 7:00 PM on P76, fasting blood glucose 
measurements were taken before rats were intraperitoneally injected with 1.0 U/kg body weight 
of insulin (Humulin R, U-100; Lilly USA, LLC, Indianapolis, IN, USA). The 1.0 U/kg insulin 
dose was chosen based on its use by other researchers to assess systemic insulin sensitivity 
(Underwood and Thompson 2016). Seventy-five min later, blood glucose was measured before 
rats were rapidly decapitated. The trunk blood was collected into EDTA-coated tubes and the 
brains rapidly extracted and immediately frozen in powdered dry ice before storage at –80 °C. 
The blood samples were centrifuged and plasma collected to measure plasma levels of insulin 
(ALPCO) and leptin (Cat. # 90040; Crystal Chem, Elk Grove Village, IL, USA). Animal 
carcasses were stored at 4 °C overnight. Epididymal and retroperitoneal fat pads were dissected 
and weighed by researchers blinded to the group assignment. Percent visceral fat composition 
was calculated with reference to the body weight on the day of sacrifice (Nelson et al. 2016).  
 
Statistical analysis 
Subsequent data from rats with bits of leftover cookie on two or more days were excluded from 
analyses. Hence, the eventual sample sizes of the THC_chow, COM_chow, and COM_HF 
groups were 10, 11, and 11, respectively. Caloric intake, saccharin intake, alcohol intake dose 
during drug exposure, and blood glucose concentrations from the ITT were analyzed by two-way 
repeated-measures ANOVA. Blood glucose and insulin concentrations from the OGTT were 
112 
 
analyzed by three-way repeated-measures ANOVA with drug, diet, and time as factors. Caloric 
intake and weight gain during diet manipulation (i.e., during HFD or chow exposure), mild 
fasting blood glucose and insulin concentrations during the OGTT, areas under glucose and 
insulin concentration curves, percent visceral fat, and trunk plasma insulin and leptin 
concentrations were analyzed by two-way ANOVA. Weight gain during drug treatment, alcohol 
intake 1–3 h before blood draw, BEC, sucrose preference, and fluid intake during the preference 
tests were analyzed by one-way ANOVA. Comparison between two groups within a diet 
condition was conducted with independent samples t-test. The linear relationship between 
ingested alcohol dose and BEC, as well as between plasma leptin and percent visceral fat were 
analyzed by Pearson’s correlation. Statistically significant main effects were accompanied by 
post hoc Tukey’s honestly significant difference tests. Data are presented as mean ± SEM. 
Analyses were performed in Statistica 13.3 (TIBCO Software Inc.; Palo Alto, California), and 
differences with p < 0.05 were considered significant. 
 
Results  
Voluntary THC consumption 
Most rats consumed the THC-laced cookie within 3 h. Two and four rats from the THC and 
COM groups, respectively, had bits of left-over cookies. The subsequent data of these rats were 
excluded from analyses. 
 
Effects of oral THC on saccharin intake, alcohol intake, and BEC 
The CTL and THC rats consumed increasing amounts of saccharin across treatment days [F(3, 
135) = 78.37, p < 0.0001]. But the THC rats consumed less saccharin compared with the CTLs 
[F(1, 45) = 4.93, p = 0.031; Fig. 5.2A]. This group difference did not remain after saccharin 
intake was normalized to body weight [F(1, 45) = 3.32, p = 0.075]. The THC and COM groups 
consumed similar doses of alcohol across treatment days (Fig. 5.2B). Despite no group effect on 
alcohol intake, COM rats appeared to reduce alcohol intake during consumption of higher doses 
of THC (6 and 10 mg/kg/day). On the days BECs were measured, EtOH (1.36 ± 0.07 g/kg) and 
COM (1.20 ± 0.08 g/kg) rats consumed similar dose of alcohol within 1 h following 8 mg/kg/day 
THC consumption. Both groups of rats attained comparable BECs of 25.50 ± 4.08 mg/dl and 
25.95 ± 5.67 mg/dl, respectively. After 3 h of alcohol access following 10 mg/kg/day THC 
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consumption, EtOH (1.65 ± 0.10 g/kg) and COM (1.45 ± 0.13 g/kg) rats consumed comparable 
alcohol doses and attained BECs of 13.57 ± 3.63 mg/dl and 18.35 ± 5.30 mg/dl, respectively. 
The BECs attained after both 1- and 3-h alcohol drinking significantly correlated with the 
ingested dose in both the EtOH [r = 0.74, p < 0.0002 and r = 0.64, p < 0.008, respectively] and 
COM [r = 0.65, p < 0.004 and r = 0.91, p < 0.0001, respectively] groups (Fig. 5.2C and 5.2D).  
 
Effects of THC and alcohol consumption on food intake, sucrose consumption, and weight gain 
Consumption of THC cookie on the previous day blunted chow intake during the last 3 h of the 
dark cycle on the next day in the THC and COM groups relative to the CTLs [F(3, 89) = 8.46, p 
< 0.0001; post hoc, both p < 0.007; Fig. 5.2E]. The EtOH group consumed less 3-h chow 
compared with the CTL group (p < 0.04). The lower 3-h chow intake by THC and COM rats 
compared with the CTLs was retained after intake was normalized to body weight. There were 
no group differences in daily caloric intake during the 16-day treatment period, but the THC rats 
gained less weight than did the EtOH and CTL rats [F(3, 89) = 5.39, p < 0.002; post hoc, both p 
< 0.02; Fig. 5.2F]. 
One-way ANOVA revealed no effect of prior oral THC and alcohol consumption on 
sucrose and water intakes during the sucrose preference tests (Fig. 5.3A and 5.3B). Based on our 
a priori hypothesis that combined alcohol and THC consumption will elicit unique effects, an 
independent samples t-test revealed that the COM group consumed less sucrose compared with 
the CTLs [t(46) = 2.00, p = 0.051] during the first preference test. The COM group also tended 
to consume less total fluid compared with the CTLs during the first preference test [t(46) = 1.78, 
p = 0.082].  
Rats that consumed 45% HFD for four days (P67–P70) demonstrated hyperphagia [F(1, 38) 
= 412.58, p < 0.0001] and modest weight gain [F(1, 38) = 3.64, p = 0.064]. There were no drug 
effects on daily chow or HFD intake during the 9-day test period (P67–P75). As expected, the 
HFD-fed rats consumed approximately 30% more daily calories [F(1, 38) = 252.48, p < 0.0001; 
Fig. 5.4A] and gained slightly more weight [F(1, 38) = 25.23, p < 0.0001; Fig. 5.4B] compared 
with the chow-fed rats. Under the HFD condition, the COM group gained more weight than the 
CTLs did [t(20) = -2.21, p < 0.04]. Importantly, the significant diet effect remained when the 




Effects of THC and alcohol consumption on glucose and insulin tolerance during abstinence 
The HFD consumers had elevated basal blood glucose and insulin concentrations relative to the 
chow consumers following a mild fast [F(1, 24) = 42.25 and 28.92, respectively; both p < 
0.0001; Fig. 5.5A, 5.5B, 5.5D, and 5.5E]. During the OGTT, three-way repeated-measures 
ANOVA uncovered no effect of drug treatment and diet on blood glucose clearance and plasma 
insulin concentrations across time. The HFD groups demonstrated greater area under curve 
(AUC) of blood glucose [F(1, 24) = 78.52, p < 0.0001; Fig. 5.5C] and plasma insulin [F(1, 24) 
= 32.78, p < 0.0001; Fig. 5.5F] concentrations compared with the chow groups. Within each diet 
condition, there were no effects of prior alcohol and THC exposure on the metabolic parameters. 
Because there was no effect of prior drug exposure on blood glucose levels during the ITT, we 
collapsed the groups by diet condition. The HFD-fed groups had higher fasting blood glucose 
concentration compared with the chow-fed groups [diet × time effect: F(1, 88) = 4.61, p < 0.04; 
post hoc, p < 0.002; Fig. 5.6A]. There was, however, no diet effect on blood glucose level at the 
75-min time point – indicating that the nine-day HFD consumption did not alter insulin 
sensitivity in the rats. Furthermore, the HFD-fed rats had higher trunk plasma leptin 
concentration [F(1, 23) = 10.48, p < 0.004; Fig. 5.6B] and percent visceral fat [F(1, 38) = 84.56, 
p < 0.0001; Fig. 5.6C], with no effect of prior alcohol or THC exposure. Under the HFD 
condition, and mirroring the body weight results, the COM group had slightly higher percent 
visceral fat content compared with the CTLs [t(20) = -2.02, p = 0.057]. Neither drug treatment 
nor diet condition influenced trunk plasma insulin concentration (Fig. 5.6D). Finally, percent 
visceral fat significantly correlated with plasma leptin in both the chow both the chow- [r = 0.39, 
p < 0.009] and HFD-fed [r = 0.58, p < 0.0007] groups (Fig. 5.6E).  
 
Effects of oral THC and moderate alcohol, alone or when combined on age of puberty onset 
Neither drug, alone or when combined, altered age of puberty onset. The average age of puberty 
onset was P37 (range: P34–P42). 
 
Discussion  
We designed this study to explore the lasting behavioral and metabolic outcomes of adolescent 
alcohol and THC co-use in male rats. Our principal aim was to observe how prior alcohol and 
THC exposures will interact with the metabolic effects of a high-fat diet (HFD) to affect glucose 
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homeostasis and insulin sensitivity in adulthood. In consonant with our previous findings 
(Nelson et al. 2019), rats that consumed THC-laced cookie subsequently consumed less 
saccharin solution during the last 3 h of the dark cycle. Although oral THC consumption had no 
effect on daily calorie intake, it modestly suppressed weight gain during treatment. THC 
consumption immediately after alcohol access also had no effect on blood alcohol concentration 
and intake of a mildly-rewarding 1% sucrose solution during abstinence. Novel findings from 
this experiment were that separate or combined alcohol and THC use by adolescent male rats did 
not alter intake of a preferred HFD and had no effect on glucose tolerance and insulin sensitivity 
when assessed during young adulthood following a three-week abstinent period. The lack of 
metabolic effects of the drugs was observed under both chow and short-term HFD feeding 
conditions. Notably, HFD feeding altered glucose homeostasis. Four days of HFD feeding 
increased mild fasting glucose and insulin concentrations following a brief fast, and mildly 
altered glucose tolerance during the OGTT. But nine days of HFD feeding had no effect on 
insulin sensitivity measured via the ITT. 
Voluntary alcohol consumption during the last 3 h of the dark cycle resulted in reduced 
chow intake. The calorie deficit was compensated for during the subsequent hours of the day as 
demonstrated by unchanged daily caloric intake and weight gain by the EtOH group relative to 
the CTL group. Such finding has been previously demonstrated by us and others (Cornier et al. 
2002; Furuya et al. 2003; Nelson et al. 2019; Nelson et al. 2016; Nelson et al. 2017). Our finding 
that voluntary consumption of low to moderate cumulative THC doses did not alter daily caloric 
intake also concur with our previous results (Nelson et al. 2019) and supports that of other 
researchers (Williams et al. 1998). Notwithstanding, our observed null effect of oral THC on 
daily caloric intake goes against the acclaimed hyperphagic effects of THC (Cota et al. 2003; 
Pagotto et al. 2006; Williams et al. 1998). Our findings, instead, reinforce the conclusion that the 
effects of THC on appetite is influenced by several experimental variables (Pagotto et al. 2006). 
The complexities of cannabinoid signaling in the brain feeding circuits, sensory systems, and 
peripheral tissues involved in energy balance regulation are yet to be untangled, and research 
efforts in these domains have blossomed in recent years (Bellocchio et al. 2010; Gatta-Cherifi 
and Cota 2016; Koch et al. 2015; Maccarrone et al. 2015; Mazier et al. 2015). For example, 
activation of known (CB1R and CB2R) and putative cannabinoid receptors in not only hindbrain 
circuits, but also in hypothalamic circuits that include POMC and AgRP neurons and glial cells 
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prominently modulate the neuroendocrine control of feeding behavior and energy balance (Koch 
2017; Koch et al. 2015; Mazier et al. 2015; Morozov et al. 2017).  
We expected that the impact of alcohol and THC on the adolescent rat brains will 
translate into the overconsumption of calories in the absence of metabolic need that is 
reminiscent of overeating in humans. Instead, we observed that separate or combined alcohol and 
THC exposure did not exacerbate hyperphagia on a palatable 45% HFD during abstinence. This 
contrary observation can be due to several factors. First, although researchers who have used 
similar adolescent THC exposure timeline (parenteral administration) observed persistent neural 
and behavioral abnormalities during abstinence (Renard et al. 2017; Rubino et al. 2008), our 16-
day oral drug exposure duration may have been insufficient to elicit brain changes that can 
engender abnormal feeding behavior during abstinence. The voluntary nature of our alcohol and 
THC exposure may have permitted the rats to titrate their drug intake to avert aversive 
consequences. The circulating levels of THC and its major active metabolite, 11-OH-THC, can 
vary based on the route of administration, with oral THC leading to slow elevation in serum drug 
levels in rodents and humans (Grotenhermen 2003; Nelson et al. 2019). Second, any brain 
abnormalities caused by drug treatments might have been mitigated during the three-week 
abstinent/washout period. Studies have observed brain-region-specific downregulation and 
desensitization of CB1R following chronic alcohol or THC exposure that resolved to varying 
extent during abstinence (Breivogel et al. 1999; Ceccarini et al. 2014; Hirvonen et al. 2012; 
Rubino et al. 2008). Hence, a shorter washout period or even an earlier onset and simultaneous 
consumption of HFD with drug treatment may uncover robust drug/diet interaction. Third, the 
short duration (nine days) of high-fat diet exposure and the type of HFD used (45%) may have 
precluded observation of over eating behavior. In typical diet-induced obese models, the rodents 
are maintained on diets containing ≥ 50% calories from fat for several weeks to months 
(Almeida-Suhett et al. 2019; Douglass et al. 2017; Pistell et al. 2010; Thaler et al. 2012). 
Prolonged exposure to HFD alters the organization and function of neurons and glia in the 
hypothalamus to promote obesity and metabolic dysfunctions (McNay et al. 2012). Moreover, 
several classic studies have shown that long-term HFD feeding stimulates astrocyte and 
microglia (the resident immune cell of the central nervous system) transition from resting to 
reactive/pro-inflammatory with concomitant obesity and metabolic disturbances (Douglass et al. 
2017; Thaler et al. 2012; Valdearcos et al. 2018). In support of this third scenario, chronic (over 
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16 weeks) consumption of 60% HFD elicited reactive microgliosis and impaired cognition 
whereas 41% HFD had no such effect, though both diets promoted obesity and astrocyte 
activation (Pistell et al. 2010). Thus, it is also likely that an extended access to the 45% HFD 
might be necessary to observe an interaction between HFD and the lingering effects of prior drug 
exposure.  
We found that short-term HFD consumption led to increased caloric intake and modest 
weight gain and altered glucose homeostasis but not insulin sensitivity in young male rats. 
Specifically, the OGTT performed on P71 (Fig. 5.1) immediately following a mild overnight fast 
revealed that the HFD-fed rats had elevated basal glucose and insulin concentrations, and areas 
under the glucose and insulin curves (AUC) compared with the chow-fed rats. There were no 
effects of drug treatment or drug by diet interaction on these findings. After nine days on the 
distinct diets, the HFD-fed rats had elevated basal blood glucose and plasma leptin 
concentrations and visceral adiposity compared with chow-fed rats. An elevated fasting glucose 
concentration within normal physiological ranges is an independent risk factor for the later onset 
of type 2 diabetes in otherwise healthy male subjects (Park et al. 2006). In support of our a priori 
hypothesis, pairwise comparison revealed that the COM rats that consumed HFD gained more 
weight and had higher visceral adiposity compared with the CTLs on the same diet. Although the 
HFD-consuming rats in our study were not obese per se, it is plausible that the increased visceral 
adiposity may be associated with alterations to endocannabinoid tone in peripheral tissues like 
pancreas and visceral fat. Accordingly, previous studies have observed increases in the 
endocannabinoid content and cannabinoid receptor activity in sensory systems (taste buds, 
olfactory neurons) during food deprivation or in hepatic, pancreatic, visceral adipose, blood, 
muscle, and gastrointestinal tissues following diet-induced obesity in mice (Argueta and 
DiPatrizio 2017; Mazier et al. 2015; Osei-Hyiaman et al. 2005; Pagotto et al. 2006; Starowicz et 
al. 2008). Similar changes to the peripheral endocannabinoid tone have been observed in obese 
as compared with non-obese humans (Matias and Di Marzo 2007; Matias et al. 2006). What’s 
more, the increased adiposity in our HFD-exposed rats could have translated into increased 
expression of cytokine markers of inflammation and oxidative stress (TNF-α, IL-1β, IL-6, and 
other adipocytokines) that have been linked with altered energy balance and metabolic fitness 
(Lavin et al. 2011).  
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The lack of significant group differences in plasma insulin concentration 75 min after 1 
U/kg insulin administration suggest that prior drug and diet manipulations did not alter insulin 
break-down by insulin degrading enzymes (IDEs) in the liver and kidneys. Our observation is 
significant considering that alcohol, cannabinoid, and HFD exposure can compromise hepatic 
enzyme function to promote hyperinsulinemia and impair insulin signaling (Bermudez-Siva et al. 
2006; Carr et al. 2013; de la Monte et al. 2009; Liu et al. 2012). Thus, it appears that our limited 
drug and HFD exposure regimen precluded us from observing the full spectrum of drug- and 
diet-induced metabolic alterations. Further, we observed no effect of drug or diet on insulin 
tolerance. Besides the fact that we should have measured blood glucose concentration at least 
once before the 75-min time point post insulin injection during the ITT, the 1 U/kg insulin dose 
we administered to the rats may have been too high to reveal subtle drug- or diet-induced 
changes in insulin sensitivity. An insulin clamp experiment would have provided a more reliable 
assessment of insulin sensitivity compared with the ITT (Bowe et al. 2014; Carr and Correnti 
2015). Utilizing the insulin clamp, others have shown that 1) three days of HFD (59% fat) 
feeding induced hepatic and adipose insulin resistance in rats (Kraegen et al. 1991), and 2) a 
five-day overconsumption of a diet containing 60% fat increased fasting blood glucose and 
induced hepatic insulin resistance and other metabolic aberrations in young healthy men (Brons 
et al. 2009). Future studies should also measure plasma corticosterone levels because HFD-
induced elevation of corticosterone alters glucose homeostasis (Underwood and Thompson 
2016) via an endocannabinoid mechanism (Bowles et al. 2015). 
Proper insulin signaling in the brain and peripheral tissues mediate a broad range of 
biological functions, including reward, cognition, appetite, and energy balance (Heni et al. 2015; 
Kullmann et al. 2015; Xu et al. 2010). The detrimental metabolic and behavioral effects of 
alcohol, cannabinoids, and HFD can be transduced via alteration of brain insulin signaling (de la 
Monte et al. 2009; Maccarrone et al. 2015; Nogueiras et al. 2008; Silvestri and Di Marzo 2013). 
The HFD-induced alteration of glucose homeostasis in our study did not reveal how insulin 
signaling might have been impacted. Impaired insulin-induced phosphoinositide 3-kinase/protein 
kinase B (PI3K/AKT) signaling is a likely mechanism. A mouse genetic study demonstrated that 
dysregulated PI3K/AKT signaling in steroidogenic factor-1 expressing neurons of the 
ventromedial hypothalamus predisposes rodents to diet-induced obesity due to reduced energy 
expenditure (Xu et al. 2010). In keeping with that finding, alterations to brain insulin signaling 
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via PI3K/AKT/GSK pathway in rodents promoted “addiction-like” behaviors that manifested as 
overconsumption of energy dense diets and the eventual development of obesity (Dadalko et al. 
2015). An fMRI study showed that, following intranasal insulin treatment, subjects with higher 
visceral adiposity had impaired insulin action in the prefrontal cortex and hypothalamus and 
expressed increased wanting for sweet foods compared with lean subjects (Kullmann et al. 
2015). Intriguingly, reduced monoamine turnover in the mesolimbic system and striatum of 
rodents exposed to HFD can be mediated by aberrant insulin signaling via the AKT pathway 
(Dadalko et al. 2015; Speed et al. 2011). Data presented in Chapter 4 of this dissertation show 
that low-to-moderate doses of alcohol and THC may have no effect on basal GSK-3β enzyme 
activity in the mediobasal hypothalamus, medial prefrontal cortex, and hippocampus. 
Accordingly, we did not observe significant drug-induced hyperphagia on HFD during 
abstinence (Fig. 5.4A). Follow-up work in our lab investigates the effects of drug and diet 
treatment on insulin-stimulated AKT 
/GSK-3β activity in the brain, with a focus on sex differences.  
In summary, this is the first study to our knowledge that examines the long-term effects 
of adolescent alcohol and THC co-use on feeding behavior and metabolic outcome during young 
adulthood. We also examined the effects of prior drug exposure on glucose and insulin 
homeostasis in the context of HFD feeding. We observed no persistent metabolic effects of 16-
day moderate alcohol and oral THC consumption in the male rats under both chow and HFD 
feeding conditions. We did, however, found that short-term (4–9 days) HFD feeding resulted in 
modest signs of glucose intolerance, and elevated mild fasting blood glucose concentration, 
visceral adiposity, and plasma leptin concentration. It is worth noting that we compared the 
behavioral and metabolic effects of 45% HFD to that of standard chow diet. Use of control low-
fat diet (LFD) is a preferable option for metabolic studies (Warden and Fisler 2008), but standard 
chow diet (SD) can be a bona fide substitute when low-fat diet is not available. This point is 
buttressed by the recent observation that an 18-week consumption of SD or LFD elicited similar 
phenotypic, behavioral, and metabolic effects in rodents (Almeida-Suhett et al. 2019). Further 
studies on the effects of moderate alcohol and THC use on energy balance and glucose 
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Figure 5.1: Experimental timeline. Drug exposure spanned 16 days (P30–P33). Treatments 
indicated in the shaded part of the table occurred during the last 3 h of the dark cycle. From P67, 
some rats continued consuming regular chow diet while the others received 45% high-fat diet. 
Glucose and insulin tolerance tests were performed on P71 and P76, respectively [Chow (CTL, n 
= 14; EtOH, n = 12; THC, n = 10; COM, n = 11) and HF (CTL and COM, n = 11/group; EtOH 













Figure 5.2: Chronic oral THC consumption reduced saccharin intake, chow intake during the 
last 3 h of the dark cycle and weight gain, whereas moderate alcohol alone or when combined 
with oral THC reduced 3-h chow intake (CTL, n = 25; EtOH, n = 24; THC and COM, n = 
22/group). (A) THC rats consumed less saccharin compared with the CTL rats. *p < 0.04. (B) 
EtOH and COM rats consumed similar doses of alcohol during each THC dose. COM rats’ 
alcohol intake during 6 and 10 mg/kg/day THC consumption was lower than their intake during 
3 mg/kg/day THC consumption: ^p < 0.03. (C) Blood ethanol concentration (BEC) correlated 
with 1-h alcohol intake in the EtOH group (r = 0.74, p < 0.0002) and with intake in the COM 
group (r = 0.65, p < 0.004) after oral 8 mg/kg/day THC. (D) BEC correlated with 3-h alcohol 
intake in the EtOH group (r = 0.64, p < 0.008) and with intake in the COM group (r = 0.91, p < 
0.0001) after oral 10 mg/kg/day THC. (E) Drinking 5% alcohol reduced 3-h chow intake and 
augmented the somewhat hypophagic effect of oral THC. CTL vs. COM: *p < 0.005; CTL vs. 
THC and COM: #p < 0.004; CTL vs. EtOH: ^p = 0.051; EtOH vs. COM: @p < 0.03. (F) Oral 
THC suppressed weight gain in the THC group compared with both the CTL and EtOH groups: 







Figure 5.3: Chronic combined oral THC and voluntary alcohol consumption reduced sucrose 
and total fluid intake during the (A) first but not during the (B) second 48-h sucrose preference 
test. CTL vs. COM: ^p and +p = 0.051 and 0.082, respectively, by t-test. Alcohol and THC alone 
had no effect on sucrose and total fluid intake during both sucrose preference tests (CTL, n = 25; 














Figure 5.4: Chronic oral THC and voluntary alcohol consumption, alone or when combined, had 
no effect on daily caloric intake and weight gain during abstinence (from P67–P75) [Chow 
(CTL, n = 14; EtOH, n = 12; THC, n = 10; COM, n = 11) and HFD (CTL and COM, n = 
11/group; EtOH and THC, n = 12/group)]. (A) Rats maintained on 45% high-fat diet consumed 
more average daily calories compared with intake by those maintained on regular chow diet: *p 
< 0.0001. (B) HFD-fed rats gained more weight compared with the chow-fed rats: *p < 0.0001 
by ANOVA. Under the HFD condition, the COM rats gained more weight compared with the 














Figure 5.5: Effects of oral THC, moderate alcohol, and diet on glucose tolerance [Chow (CTL, 
EtOH, THC, and COM, n = 10–12/group) and HFD (CTL, EtOH, THC, and COM, n = 7–
8/group)]. Prior drug exposure had no effect on glucose clearance in both the groups of rats (A) 
perpetually maintained on chow diet, and those (B) that consumed HFD for 4 days (P67–P70) 
after the diet switch (see Fig. 5.1). (C) Area under curve revealed that 4-day HFD consumption 
altered glucose tolerance with no significant effect of prior drug exposure: *p < 0.0001. Prior 
drug exposure had no effect on insulin release in response to the oral glucose loads in both 
groups of rats that were (D) perpetually maintained on chow diet, and those (E) that consumed 
HFD for 4 days (P67–P70) after the diet switch. (F) Area under curve revealed that 4-day HFD 
consumption potentiated insulin release with no significant effect of prior drug exposure: *p < 










Figure 5.6: Effects of oral THC, moderate alcohol, and diet on some metabolic parameters 
[Chow (CTL, EtOH, THC, and COM, n = 10–12/group) and HFD (CTL, EtOH, THC, and 
COM, n = 7–12/group)]. Nine days of HF diet feeding (A) increased fasting blood glucose with 
no effect on insulin sensitivity during the insulin tolerance test: *p < 0.002, (B) increased plasma 
leptin concentration: *p < 0.004, (C) increased percent visceral fat: *p < 0.0001, and (D) had no 
effect on plasma insulin concentration. Prior alcohol or oral THC consumption did not 
significantly influence the above measures. However, under the HFD condition, t-test revealed 
that the COM rats tended to have higher percent visceral adiposity compared with the CTLs: ^p 
= 0.057 and lower trunk insulin compared with the EtOH group #p < 0.007. (E) Percent visceral 
fat significantly correlated with leptin measured in trunk plasma in both the chow- (r = 0.39, p < 









CHAPTER 6: SUMMARY AND FUTURE DIRECTIONS 
The objective of this dissertation is to examine the effects of separate and combined chronic 
alcohol and ∆
9
-tetrahydrocannabinol (THC) use on energy balance, glucose homeostasis, and 
cognitive behavior. Our work shows that chronic THC or moderate alcohol exposure differently 
influences energy balance and glucose homeostasis and reveals unique effects of the co-use of 
both drugs. Importantly, this doctoral research established a novel rodent model of alcohol and 
THC co-use that can be adapted to study the behavioral and biological effects of polydrug use in 
other experimental models. This work advanced our understanding of the metabolic effects of 
alcohol and cannabinoid use. 
As reviewed in Chapter 1, the caloric value of alcohol (7 kcal/g) is nestled between that 
of carbohydrate (4 kcal/g) and fat (9 kcal/g). Alcohol drinkers are often not cognizant of the 
calories supplied by alcoholic beverage when they consume it alone or alongside meals; and the 
extent to which alcohol-derived calories contribute to the high incidence of obesity and 
metabolic syndrome begs for further clarification (Suter 2005; Yeomans 2010). We previously 
demonstrated that the appetite-reducing effects of binge doses of alcohol were related to the time 
course of blood alcohol concentration (Nelson et al. 2016). Chapter 3 of this dissertation further 
reported that rats who consumed moderate alcohol doses compensated for the extra calories as 
demonstrated by the reduced solid food intake and unchanged daily caloric intake and body 
weight relative to controls (Nelson et al. 2017). We also observed that chronic moderate alcohol 
consumption could predispose males to prediabetes and that mild caloric restriction produced 
beneficial effects on glucose homeostasis. We did not explore the mechanisms that mediate the 
reduced food intake during alcohol consumption. Future work in this domain should investigate 
how alcohol affects the activity of cells and signaling molecules within the hypothalamus and 
other feeding centers in a dose- or time-dependent manner. Moreover, metabolic studies that 
employ a Comprehensive Lab Animal Monitoring System (CLAMS) will reveal whether the 
briefly reduced food intake in rats who consume alcohol is related to an acute imbalance between 
caloric intake and energy expenditure or whether it is mainly mediated by reduced appetite. 
Additionally, islet function assay and further metabolic phenotyping using the euglycemic-
hyperinsulinemic clamp and insulin tolerance tests will provide more insight into the 
mechanisms that mediate altered glucose tolerance and insulin sensitivity (Bowe et al. 2014). To 
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understand the molecular underpinnings of the altered glucose homeostasis in male rats that 
chronically consume alcohol, future studies should explore any correspondent change to insulin 
signaling in the brain and peripheral tissues (e.g., muscle, fat, liver, heart, and pancreas). Sex 
differences in the diabetogenic effects of alcohol may be explored by surgically or 
pharmacologically manipulating sex hormones in rodents and observing the correspondent 
effects on glucose homeostasis. If sex differences are observed, further analysis of the molecular 
mechanisms that mediate the effects of sex steroids on energy balance and metabolism should be 
pursued. The involvement of other hormones involved in metabolism (e.g., growth hormone, 
thyroid hormone, epinephrine, orexin, and glucocorticoid) also deserves attention. 
Alcohol and marijuana are the most commonly used legal and illegal drugs, respectively 
(Johnston et al. 2018). It is concerning that both substances are commonly used in combination 
by adolescents (Patrick et al. 2018), despite the paucity of studies on the health implications of 
their co-use (Briere et al. 2011; Yurasek et al. 2017) including the effects on energy balance and 
glucose homeostasis. There is also a lack of preclinical models of voluntary alcohol and THC co-
use that reliably approximates human use pattern. To fill these gaps, we established a rodent 
model of alcohol and THC co-use in Chapter 4 and investigated its effects on energy balance, 
glucose homeostasis, cognitive behaviors, and some neurobiological changes. We showed that 
subcutaneous or oral THC administration combined with moderate alcohol consumption 
differently alters feeding behaviors in adolescent male rats. THC elicited a hyperphagic effect 
within 3 h after subcutaneous administration and moderate doses of orally consumed alcohol 
reduced this effect. Alternatively, oral THC consumption via cookie had null effect on food 
intake during the initial 3 h after administration, and both subcutaneous and oral THC had no 
effect on daily caloric intake (Nelson et al. 2019). Similar time- and route-of-administration-
dependent effects of THC on food intake have been noted by other researchers. For example, in 
rodents, high doses of THC produce anorectic-like effects, while low doses produce hyperphagic 
effects often within the initial 1–6 h following drug administration (Pagotto et al. 2006; Williams 
et al. 1998). The different outcomes we observed when THC was administered subcutaneously 
or orally may be explained by the fact that orally consumed THC undergoes first-pass hepatic 
metabolism that can reduce the effective concentration of the drug in circulation or favor more 
sequestration of the lipophilic drug into fat depots in the body (Grotenhermen 2003). In 
consonant with the above possibilities, 11-hydroxy-THC (a potent CB1R ligand) was 
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undetectable in plasma obtained from rats that consumed THC cookie (Nelson et al. 2019). 
Furthermore, compared with their separate use, we observed that co-administered alcohol and 
THC differently altered glucose homeostasis. Nine days after the 16 days of subcutaneous THC 
and moderate alcohol consumption (P30–P45), the COM rats had reduced plasma insulin content 
in response to a glucose load that was indicative of improved systemic insulin sensitivity. To 
clearly dissect the effects of separate or combined THC and alcohol use on feeding behavior and 
metabolism, meal pattern analyses (meal size, meal frequency, latency to a feeding bout, and 
feeding rate) will be useful (Argueta and DiPatrizio 2017; Drewnowski and Grinker 1978; Higgs 
et al. 2003), as would further metabolic phenotyping as previously mentioned (Bowe et al. 2014).  
In both Chapters 3 and 4 summarized above, we were unable to detect detrimental effects 
of separate or combined THC and alcohol administration on short-term object recognition 
memory and on spatial learning, memory, and behavioral flexibility measured in the Barnes 
maze. An essential next step would be to adopt more sensitive measures of behavioral flexibility, 
especially attentional set-shifting or operant strategy shifting tasks. Additionally, modifications 
of our novel object recognition (reducing the inter-trial intervals) and Barnes maze (slightly 
increasing its difficulty) tasks may make them sensitive to subtle drug-induced changes in 
cognition. Preliminary Barnes maze data from a follow-up study in our lab lend credence to the 
latter scenario. In Chapter 4, we also expected that exposure to alcohol and THC will affect the 
expression of the chief metabotropic receptor in the central nervous system (CB1R) and 
dysregulate the activity of the vital signaling molecule glycogen synthase kinase-3 beta (GSK-
3β) in the medial prefrontal cortex (mPFC), hippocampus (HIP), and mediobasal hypothalamus 
(MBH). We observed insignificant changes in CB1R expression and basal GSK-3β activity in the 
mPFC, HIP, and MBH of rats when measured 4–5 weeks following drug treatment. Future 
studies should analyze more brains soon after the termination of chronic drug exposure.  
The long-term effects of marijuana use on energy balance and glucose homeostasis are 
unclear (Muniyappa et al. 2013; Penner et al. 2013; Permutt et al. 1976). There is also a scarcity 
of studies on the interactive effects of alcohol and THC combination in conjunction with western 
diet consumption on metabolic fitness. We investigated whether any lingering effects of prior 
alcohol and THC exposure will interact with that of a high-fat diet (HFD) to generate heightened 
metabolic dysregulation in Chapter 5. Utilizing the voluntary oral drug co-use model that we 
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established in Chapter 4, male rats consumed alcohol and THC-infused cookies during 
adolescence (P30–P45) with ad libitum access to chow diet and subsequently consumed a 45% 
HFD ad libitum for a few days during young adulthood (P67–P75). Surprisingly, adolescent 
onset alcohol and THC exposure under our paradigm had no lingering effects on the phenotypic 
and metabolic parameters we assessed during young adulthood. Moreover, previous drug 
consumption and subsequent HFD exposure did not interact. This is the first study to 
systematically investigate whether adolescent alcohol and/or THC use can affect energy balance 
and metabolism upon HFD challenge in adulthood.  
The seemingly beneficial effects of moderate alcohol and THC co-use on glucose 
homeostasis observed in Chapter 4 but not in Chapter 5 may be explained by notable differences 
in experimental design, including the disparate route of THC administration (subcutaneous in 
Chapter 4 vs. oral in Chapter 5), the cumulative dose of THC administered (84 mg/kg/rat in 
Chapter 4 vs. 108 mg/kg/rat in Chapter 5), the frequency of THC administration (once per day in 
Chapter 4 vs. twice per day in Chapter 5), and the interval between drug treatment relative to 
execution of the glucose tolerance test (8 days in Chapter 4 vs. 25 days in Chapter 5). Thus, it 
appears that there is a J-shaped relationship, where the beneficial effects of moderate alcohol and 
THC co-use manifest soon after brief exposure to lower cumulative doses that were less 
frequently administered and no benefit is obtained as the cumulative dose and length of exposure 
increase. Accordingly, a previous study found that the effects of THC on glucose homeostasis 
may be dose-dependent, route-of-administration-dependent, or modified by a history of 
marijuana use (Hollister and Reaven 1974). In that study, intravenous 6 mg of THC impaired 
glucose tolerance in healthy men who casually smoked marijuana, while smoking of marijuana 
that contained 16 mg of THC had no effect on glucose tolerance possibly due to the development 
of tolerance to the effects of smoked THC (Hollister and Reaven 1974). It is important to note 
that not all the THC contained in a marijuana cigarette is bioavailable following smoking. 
Because of loss associated with combustion, the systemic bioavailability of smoked THC 
typically ranges from 5 to 30% depending on the users’ smoking history (Grotenhermen 2003). 
Consequently, between 0.8–4.8 mg THC is expected to be present in plasma following smoking 
of the 16 mg THC cigarette in the study by Hollister and Reaven (1974).  
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Although 16 days of exposure to moderate alcohol and THC had null effects on glucose 
and insulin tolerance in Chapter 5, our finding in the COM group in Chapter 4 is partly in line 
with reports that brief low alcohol consumption can improve insulin sensitivity in rats (Furuya et 
al. 2003), and THC-mediated CB2R stimulation in peripheral tissues enhances insulin sensitivity 
(reviewed in (Maccarrone et al. 2015)). Moving forward, in addition to calculating the amount of 
glucose and insulin to administer during OGTT and ITT using lean body mass rather than total 
body mass, utilizing metabolic cages to assess energy balance, and performing further metabolic 
phenotyping experiments as previously suggested (also see Chapter 5), analyses of brain, muscle, 
adipose, liver, and other tissues involved in energy metabolism may unveil whether drug-induced 
alterations that might not have manifested at the behavioral level can portend future metabolic 
dysregulations. Planned future studies in our lab will investigate the effects of alcohol and THC 
co-use on IRS-1/AKT/GSK-3β activity in the aforementioned tissues following application of 
exogenous insulin. The lab will also explore the interactive effects of HFD.  
As can be expected of any new field of scientific endeavor, the avenues for advancement 
of research on alcohol and cannabinoid co-use are innumerable. In addition to those previously 
mentioned, there is more knowledge to be gleaned from studies on the impact of the drug co-use 
on synaptic plasticity, immune function, neuroanatomy, gastrointestinal physiology, and 
behavior, including possible sex-dependent and transgenerational or epigenetic effects. Our lab is 
currently studying the effects of alcohol and THC co-use on energy balance and cognitive 
functions in female rats and has plans to investigate the sex-dependent effects of drug co-use and 
HFD exposure on homeostatic synaptic plasticity. It will also be important for future studies to 
investigate whether and how the effects of moderate alcohol and THC co-use on physiology are 
modified by genetics (individual differences). It is likely that they would because there is 
evidence of individual differences on the neurobiological or behavioral effects of alcohol (Singh 
et al. 2015; Vaeth et al. 2014) and THC (Earleywine 2002; Nelson et al. 2019; Polissidis et al. 
2010). Although the preclinical rat model may not perfectly reproduce the complexities of 
human drug use (e.g., the erratic schedule of alcohol and/or THC use), it nonetheless grants us 
the flexibility to pursue research that is otherwise unethical or cumbersome to conduct in 
humans. Emergent data from this field of work could hopefully open doors to management of 
metabolic and behavioral disorders caused by chronic alcohol and cannabinoid use. There is 
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